Processing 00000000.tx.1: Blockade of Long-Term Potentiation by -Amyloid Peptides in the CA1 Region of the Rat Hippocampus In Vivo Darragh B. 

Phrase: "Blockade of Long-Term Potentiation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0332206:Blockade [Functional Concept]
   760   C3540676:Blockade [Pharmacologic Substance]

Phrase: "by -Amyloid Peptides"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0011560:Amyloid [Pathologic Function]
   861   C0030956:Peptides [Amino Acid, Peptide, or Protein]
   861   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "in the CA1 Region"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   861   C0017446:Region [Geographic Area]
   861   C0205147:Region [Spatial Concept]
   789 E C0205276:Regional [Spatial Concept]
   789 E C1947913:Regional [Spatial Concept]

Phrase: "of the Rat Hippocampus In Vivo Darragh B."
Processing 00000000.tx.2: Freir, Christian Holscher, and Caroline E. 

Phrase: "Freir,"

Phrase: "Christian Holscher,"

Phrase: "and"

Phrase: "Caroline E."
Processing 00000000.tx.3: Herron Department of Human Anatomy and Physiology, University College Dublin, Dublin 2,Ireland  ABSTRACT TOP ABSTRACT INTRODUCTION METHODS RESULTS DISCUSSION REFERENCES Freir, Darragh B., Christian Holscher, and Caroline E. 

Phrase: "Herron Department of Human Anatomy"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1704729:Department [Organization]

Phrase: "and"

Phrase: "Physiology,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0031842:Physiology [Biomedical Occupation or Discipline]
  1000   C0031843:physiology [Physiologic Function]
   928 E C0205463:Physiologic [Functional Concept]

Phrase: "University College Dublin,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0454777:Dublin [Geographic Area]

Phrase: "Dublin 2,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0454777:Dublin [Geographic Area]

Phrase: "Ireland  ABSTRACT TOP ABSTRACT INTRODUCTION METHODS RESULTS DISCUSSION"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   793   C0557061:Discussion [Therapeutic or Preventive Procedure]
   793   C2584313:Discussion [Social Behavior]

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "Freir,"

Phrase: "Darragh B.,"

Phrase: "Christian Holscher,"

Phrase: "and"

Phrase: "Caroline E."
Processing 00000000.tx.4: Herron. 

Phrase: "Herron."
Processing 00000000.tx.5: Blockade of Long-Term Potentiation by -Amyloid Peptides in the CA1 Region of the Rat Hippocampus In Vivo. 

Phrase: "Blockade of Long-Term Potentiation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0332206:Blockade [Functional Concept]
   760   C3540676:Blockade [Pharmacologic Substance]

Phrase: "by -Amyloid Peptides"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0011560:Amyloid [Pathologic Function]
   861   C0030956:Peptides [Amino Acid, Peptide, or Protein]
   861   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "in the CA1 Region"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   861   C0017446:Region [Geographic Area]
   861   C0205147:Region [Spatial Concept]
   789 E C0205276:Regional [Spatial Concept]
   789 E C1947913:Regional [Spatial Concept]

Phrase: "of the Rat Hippocampus"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0019564:Hippocampus [Body Part, Organ, or Organ Component]
   861   C0949582:Hippocampus [Fish]
   861   C1029104:Hippocampus [Fish]
   861   C1284077:Hippocampus [Body Part, Organ, or Organ Component]

Phrase: "In Vivo."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1515655:In Vivo [Spatial Concept]
           vivo
Processing 00000000.tx.6: J. 

Phrase: "J."
Processing 00000000.tx.7: Neurophysiol. 

Phrase: "Neurophysiol."
Processing 00000000.tx.8: 85: 708-713, 2001. 

Phrase: "85"

Phrase: ":"

Phrase: "708-713,"

Phrase: "2001."
Processing 00000000.tx.9: The effect of intracerebroventricular (icv) injections of -amyloid peptide fragments A[15-25], A[25-35], and A[35-25] were examined on synaptic transmission and long-term potentiation (LTP) in the hippocampal CA1 region in vivo. 

Phrase: "The effect of intracerebroventricular (icv) injections of -amyloid peptide"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C1280500:Effect [Qualitative Concept]
   744   C2348382:Effect [Qualitative Concept]

Phrase: "fragments"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0332255:fragment [Functional Concept]
  1000   C0486805:Fragments [Body Substance]
  1000   C1708096:Fragment [Qualitative Concept]

Phrase: "A[15-25"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   913   C0718136:A-25 [Organic Chemical,Pharmacologic Substance,Vitamin]

Phrase: "],"

Phrase: "A[25-35"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   901   C0718136:A-25 [Organic Chemical,Pharmacologic Substance,Vitamin]

Phrase: "],"

Phrase: "and"

Phrase: "A[35-25"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   913   C0718136:A-25 [Organic Chemical,Pharmacologic Substance,Vitamin]

Phrase: "]"

Phrase: "were"

Phrase: "examined on synaptic transmission"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   833   C0027793:Synaptic Transmission [Cell Function]
   770   C0040722:transmission [Idea or Concept]
   770   C0242781:Transmission [Pathologic Function]
   770   C0332128:Examined [Finding]
   770   C1521797:Transmission [Natural Phenomenon or Process]

Phrase: "and"

Phrase: "long-term potentiation (LTP) in the hippocampal CA1 region"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   800   C0206249:Long-Term Potentiation [Organ or Tissue Function]
   800   C2984294:Long-term potentiation [Functional Concept]
   770   C0443252:Long-term [Temporal Concept]
   744   C0205166:Long [Qualitative Concept]
   744   C0279023:Potentiation [Therapeutic or Preventive Procedure]
   744   C1515273:Term [Temporal Concept]
   744   C1705313:Term [Idea or Concept]
   744   C1706317:Long [Qualitative Concept]
   744   C2826302:TERM [Intellectual Product]

Phrase: "in vivo."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1515655:In Vivo [Spatial Concept]
           vivo
Processing 00000000.tx.10: Rats were anesthetized using urethan, and changes in synaptic efficacy were determined from the slope of the excitatory postsynaptic potential (EPSP). 

Phrase: "Rats"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0034693:rats [Mammal]
  1000   C0034721:Rats [Mammal]

Phrase: "were"

Phrase: "anesthetized"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1720436:Anesthetized [Finding]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "urethan,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0041964:Urethan [Organic Chemical,Pharmacologic Substance]

Phrase: "and"

Phrase: "changes in synaptic efficacy"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   770   C0392747:Change [Functional Concept]
   770   C0443172:change [Quantitative Concept]
   770   C1280519:Efficacy [Qualitative Concept]
   770   C1705241:Change [Quantitative Concept]
   770   C1707887:EFFICACY [Research Activity]

Phrase: "were"

Phrase: "determined from the slope of the excitatory postsynaptic potential (EPSP)."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   790   C0524913:Potential, Excitatory Postsynaptic [Organ or Tissue Function]
   764   C2350339:Potential, Postsynaptic [Organ or Tissue Function]
   762   C0234121:Excitatory potential [Organ or Tissue Function]
   742   C0807955:Slope [Quantitative Concept]
   742   C3245505:Potential [Qualitative Concept]
Processing 00000000.tx.11: Baseline synaptic responses were monitored for 30min prior to icv injection of A peptides or vehicle. 

Phrase: "Baseline synaptic responses"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   827   C0871261:responses [Organism Attribute]
   793 E C1704632:Response [Finding]
   793 E C1706817:Response [Intellectual Product]
   793 E C2911692:Response [Mental Process]

Phrase: "were"

Phrase: "monitored for 30min"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   756   C0030695:monitor [Health Care Activity]
   756   C0150369:monitor [Health Care Activity]
   756   C0181904:Monitor [Medical Device]
   756   C0596972:Monitor [Medical Device]
   756   C1521743:Monitor [Professional or Occupational Group]
   756   C1704646:Monitor [Manufactured Object]

Phrase: "prior to icv injection"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0021485:injection [Therapeutic or Preventive Procedure]
   861   C1272883:Injection [Biomedical or Dental Material]
   861   C1533685:Injection [Therapeutic or Preventive Procedure]
   861   C1828121:Injection [Functional Concept]

Phrase: "of A peptides"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0030956:Peptides [Amino Acid, Peptide, or Protein]

Phrase: "or"

Phrase: "vehicle."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0042444:Vehicle [Biomedical or Dental Material]
  1000   C0348005:Vehicle [Manufactured Object]
   928 E C0445373:Vehicular [Functional Concept]
Processing 00000000.tx.12: High-frequency stimulation (HFS) to induce LTP was applied to the Schaffer-collateral pathway 5min or 1h following the icv injection. 

Phrase: "High-frequency stimulation (HFS) to"
Meta Candidates (Total=12; Excluded=1; Pruned=0; Remaining=11)
   861   C0205212:High frequency [Temporal Concept]
   812   C0205250:High [Qualitative Concept]
   812   C0376249:frequency [Quantitative Concept]
   812   C0439603:Frequency [Temporal Concept]
   812   C0871396:Frequency [Quantitative Concept]
   812   C1292856:Stimulation [Therapeutic or Preventive Procedure]
   812   C1299351:High [Qualitative Concept]
   812   C1561548:Frequency [Qualitative Concept]
   812   C1705502:Frequency [Quantitative Concept]
   812   C1948023:Stimulation [Natural Phenomenon or Process]
   812   C2700149:HIGH [Intellectual Product]
   741 E C0332183:Frequent [Temporal Concept]

Phrase: "induce"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205263:Induce [Functional Concept]

Phrase: "LTP"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
  1000   C0206249:Long-Term Potentiation [Organ or Tissue Function]
  1000   C2984294:Long-term potentiation [Functional Concept]
   901   C0443252:Long-term [Temporal Concept]
   827   C0205166:Long [Qualitative Concept]
   827   C0279023:Potentiation [Therapeutic or Preventive Procedure]
   827   C1515273:Term [Temporal Concept]
   827   C1705313:Term [Idea or Concept]
   827   C1706317:Long [Qualitative Concept]
   827   C2826302:TERM [Intellectual Product]

Phrase: "was"

Phrase: "applied to the Schaffer-collateral pathway 5min"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
   778   C3544403:Schaffer collateral [Cell Component]
   748   C0185125:Applied [Health Care Activity]
   748   C1275670:Collateral [Body Part, Organ, or Organ Component]
   748   C1704259:Pathway [Molecular Function]
   748   C1705987:Pathway [Conceptual Entity]
   748   C1948058:Collateral [Spatial Concept]
   714 E C1632850:Apply [Functional Concept]
   714 E C1879355:Apply [Functional Concept]

Phrase: "or"

Phrase: "1h"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1442450:1H [Temporal Concept]

Phrase: "following"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332282:Following [Temporal Concept]
   966 E C0332283:follow [Temporal Concept]
   966 E C1719822:Follow [Intellectual Product]

Phrase: "the icv injection."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0021485:injection [Therapeutic or Preventive Procedure]
   861   C1272883:Injection [Biomedical or Dental Material]
   861   C1533685:Injection [Therapeutic or Preventive Procedure]
   861   C1828121:Injection [Functional Concept]
Processing 00000000.tx.13: HFS comprised 3episodes of 10stimuli at 200Hz, 10times, applied at 30-s intervals. 

Phrase: "HFS comprised 3episodes of 10stimuli"

Phrase: "at 200Hz,"

Phrase: "10times,"

Phrase: "applied at 30-s intervals."
Meta Candidates (Total=6; Excluded=4; Pruned=0; Remaining=2)
   760   C0185125:Applied [Health Care Activity]
   760   C1272706:intervals [Temporal Concept]
   726 E C1552654:Interval [Idea or Concept]
   726 E C1552713:Interval [Intellectual Product]
   726 E C1632850:Apply [Functional Concept]
   726 E C1879355:Apply [Functional Concept]
Processing 00000000.tx.14: Normal LTP measured 30min following HFS, was produced following icv injection of vehicle (19117%, meanSE, n=6) or A[15-25; 

Phrase: "Normal LTP"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   923   C0206249:Long-Term Potentiation [Organ or Tissue Function]
   923   C2984294:Long-term potentiation [Functional Concept]
   861   C0443252:Long-term [Temporal Concept]
   812   C0205166:Long [Qualitative Concept]
   812   C0279023:Potentiation [Therapeutic or Preventive Procedure]
   812   C1515273:Term [Temporal Concept]
   812   C1705313:Term [Idea or Concept]
   812   C1706317:Long [Qualitative Concept]
   812   C2826302:TERM [Intellectual Product]

Phrase: "measured"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0444706:Measured [Qualitative Concept]
  1000   C3541902:MEASURED [Diagnostic Procedure]
   966 E C0079809:Measure [Quantitative Concept]
   966 E C0242485:Measure [Functional Concept]

Phrase: "30min"

Phrase: "following"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332282:Following [Temporal Concept]
   966 E C0332283:follow [Temporal Concept]
   966 E C1719822:Follow [Intellectual Product]

Phrase: "HFS,"
Meta Candidates (Total=12; Excluded=1; Pruned=0; Remaining=11)
   901   C0205212:High frequency [Temporal Concept]
   827   C0205250:High [Qualitative Concept]
   827   C0376249:frequency [Quantitative Concept]
   827   C0439603:Frequency [Temporal Concept]
   827   C0871396:Frequency [Quantitative Concept]
   827   C1292856:Stimulation [Therapeutic or Preventive Procedure]
   827   C1299351:High [Qualitative Concept]
   827   C1561548:Frequency [Qualitative Concept]
   827   C1705502:Frequency [Quantitative Concept]
   827   C1948023:Stimulation [Natural Phenomenon or Process]
   827   C2700149:HIGH [Intellectual Product]
   755 E C0332183:Frequent [Temporal Concept]

Phrase: "was"

Phrase: "produced"

Phrase: "following"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332282:Following [Temporal Concept]
   966 E C0332283:follow [Temporal Concept]
   966 E C1719822:Follow [Intellectual Product]

Phrase: "icv injection of vehicle"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0021485:injection [Therapeutic or Preventive Procedure]
   770   C1272883:Injection [Biomedical or Dental Material]
   770   C1533685:Injection [Therapeutic or Preventive Procedure]
   770   C1828121:Injection [Functional Concept]

Phrase: "(19117%,"

Phrase: "meanSE,"

Phrase: "n=6"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441922:N+ [Intellectual Product]
   861   C1553036:[n] [Quantitative Concept]

Phrase: ")"

Phrase: "or"

Phrase: "A[15-25"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   913   C0718136:A-25 [Organic Chemical,Pharmacologic Substance,Vitamin]

Phrase: ";"
Processing 00000000.tx.15: 100nmol] (1776%, n=6) 1h prior to HFS. 

Phrase: "100nmol"

Phrase: "]"

Phrase: "(1776%,"

Phrase: "n=6"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441922:N+ [Intellectual Product]
   861   C1553036:[n] [Quantitative Concept]

Phrase: ")"

Phrase: "1h prior to HFS."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C1442450:1H [Temporal Concept]
Processing 00000000.tx.16: LTP was, however, markedly reduced by A[25-35; 

Phrase: "LTP"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
  1000   C0206249:Long-Term Potentiation [Organ or Tissue Function]
  1000   C2984294:Long-term potentiation [Functional Concept]
   901   C0443252:Long-term [Temporal Concept]
   827   C0205166:Long [Qualitative Concept]
   827   C0279023:Potentiation [Therapeutic or Preventive Procedure]
   827   C1515273:Term [Temporal Concept]
   827   C1705313:Term [Idea or Concept]
   827   C1706317:Long [Qualitative Concept]
   827   C2826302:TERM [Intellectual Product]

Phrase: "was"

Phrase: ","

Phrase: "however,"

Phrase: "markedly"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0522501:Markedly [Qualitative Concept]

Phrase: "reduced by A[25-35"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0392756:Reduced [Qualitative Concept]

Phrase: ";"
Processing 00000000.tx.17: 10nmol] (1299%, n=6,P<0.001) and blocked by A[25-35; 

Phrase: "10nmol"

Phrase: "]"

Phrase: "(1299%,"

Phrase: "n=6,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441922:N+ [Intellectual Product]
   861   C1553036:[n] [Quantitative Concept]

Phrase: "P<0.001"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: ")"

Phrase: "and"

Phrase: "blocked by A[25-35"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   760   C0028778:Blocked [Pathologic Function]
   760   C0332206:Blocked [Functional Concept]
   760   C2983591:BLOCKED [Research Activity]
   726 E C1533157:Block [Substance]
   726 E C1706084:Block [Geographic Area]
   726 E C2828370:Block [Quantitative Concept]

Phrase: ";"
Processing 00000000.tx.18: 100nmol] (996%, n=6,P<0.001). 

Phrase: "100nmol"

Phrase: "]"

Phrase: "(996%,"

Phrase: "n=6,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441922:N+ [Intellectual Product]
   861   C1553036:[n] [Quantitative Concept]

Phrase: "P<0.001"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: ")."
Processing 00000000.tx.19: Injection of the reverse peptide, A[35-25], also impaired LTP at concentrations of 10nmol (1363%, n=6,P<0.01) and 100nmol (1447,n=8,P<0.05). 

Phrase: "Injection of the reverse peptide,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0021485:injection [Therapeutic or Preventive Procedure]
   760   C1272883:Injection [Biomedical or Dental Material]
   760   C1533685:Injection [Therapeutic or Preventive Procedure]
   760   C1828121:Injection [Functional Concept]

Phrase: "A[35-25"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   913   C0718136:A-25 [Organic Chemical,Pharmacologic Substance,Vitamin]

Phrase: "],"

Phrase: "also"

Phrase: "impaired"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0221099:Impaired [Functional Concept]
  1000   C0684336:Impaired [Pathologic Function]

Phrase: "LTP at concentrations of 10nmol"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   814   C0206249:Long-Term Potentiation [Organ or Tissue Function]
   814   C2984294:Long-term potentiation [Functional Concept]
   778   C0443252:Long-term [Temporal Concept]
   748   C0205166:Long [Qualitative Concept]
   748   C0279023:Potentiation [Therapeutic or Preventive Procedure]
   748   C1515273:Term [Temporal Concept]
   748   C1705313:Term [Idea or Concept]
   748   C1706317:Long [Qualitative Concept]
   748   C2826302:TERM [Intellectual Product]

Phrase: "(1363%,"

Phrase: "n=6,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441922:N+ [Intellectual Product]
   861   C1553036:[n] [Quantitative Concept]

Phrase: "P<0.01"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: ")"

Phrase: "and"

Phrase: "100nmol"

Phrase: "(1447,"

Phrase: "n=8,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441922:N+ [Intellectual Product]
   861   C1553036:[n] [Quantitative Concept]

Phrase: "P<0.05"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: ")."
Processing 00000000.tx.20: Using a different protocol, HFS was delivered 5min following A injections, and LTP was measured 1h post HFS. 

Phrase: "Using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "a different protocol,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0442711:Protocol [Intellectual Product]
   861   C1507394:Protocol [Intellectual Product]
   861   C1522729:Protocol [Intellectual Product]
   861   C2348563:Protocol [Intellectual Product]

Phrase: "HFS"
Meta Candidates (Total=12; Excluded=1; Pruned=0; Remaining=11)
   901   C0205212:High frequency [Temporal Concept]
   827   C0205250:High [Qualitative Concept]
   827   C0376249:frequency [Quantitative Concept]
   827   C0439603:Frequency [Temporal Concept]
   827   C0871396:Frequency [Quantitative Concept]
   827   C1292856:Stimulation [Therapeutic or Preventive Procedure]
   827   C1299351:High [Qualitative Concept]
   827   C1561548:Frequency [Qualitative Concept]
   827   C1705502:Frequency [Quantitative Concept]
   827   C1948023:Stimulation [Natural Phenomenon or Process]
   827   C2700149:HIGH [Intellectual Product]
   755 E C0332183:Frequent [Temporal Concept]

Phrase: "was"

Phrase: "delivered"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C1705822:Delivered [Activity]
   966 E C0308779:DELIVER [Organic Chemical,Pharmacologic Substance]
   966 E C1874964:DELIVER [Pharmacologic Substance]

Phrase: "5min"

Phrase: "following"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332282:Following [Temporal Concept]
   966 E C0332283:follow [Temporal Concept]
   966 E C1719822:Follow [Intellectual Product]

Phrase: "A injections,"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0021485:injections [Therapeutic or Preventive Procedure]
  1000   C1533685:INJECTIONS [Therapeutic or Preventive Procedure]
  1000   C1828121:Injections [Functional Concept]
   966 E C1272883:Injection [Biomedical or Dental Material]

Phrase: "and"

Phrase: "LTP"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
  1000   C0206249:Long-Term Potentiation [Organ or Tissue Function]
  1000   C2984294:Long-term potentiation [Functional Concept]
   901   C0443252:Long-term [Temporal Concept]
   827   C0205166:Long [Qualitative Concept]
   827   C0279023:Potentiation [Therapeutic or Preventive Procedure]
   827   C1515273:Term [Temporal Concept]
   827   C1705313:Term [Idea or Concept]
   827   C1706317:Long [Qualitative Concept]
   827   C2826302:TERM [Intellectual Product]

Phrase: "was"

Phrase: "measured"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0444706:Measured [Qualitative Concept]
  1000   C3541902:MEASURED [Diagnostic Procedure]
   966 E C0079809:Measure [Quantitative Concept]
   966 E C0242485:Measure [Functional Concept]

Phrase: "1h post HFS."
Meta Candidates (Total=12; Excluded=1; Pruned=0; Remaining=11)
   840   C0205212:High frequency [Temporal Concept]
   804   C0205250:High [Qualitative Concept]
   804   C0376249:frequency [Quantitative Concept]
   804   C0439603:Frequency [Temporal Concept]
   804   C0871396:Frequency [Quantitative Concept]
   804   C1292856:Stimulation [Therapeutic or Preventive Procedure]
   804   C1299351:High [Qualitative Concept]
   804   C1561548:Frequency [Qualitative Concept]
   804   C1705502:Frequency [Quantitative Concept]
   804   C1948023:Stimulation [Natural Phenomenon or Process]
   804   C2700149:HIGH [Intellectual Product]
   733 E C0332183:Frequent [Temporal Concept]
Processing 00000000.tx.21: Stable LTP was produced in the control group (18815%, n=7) and blocked by A[25-35, 100nmol] (10815%, n=6,P<0.001). 

Phrase: "Stable LTP"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   923   C0206249:Long-Term Potentiation [Organ or Tissue Function]
   923   C2984294:Long-term potentiation [Functional Concept]
   861   C0443252:Long-term [Temporal Concept]
   812   C0205166:Long [Qualitative Concept]
   812   C0279023:Potentiation [Therapeutic or Preventive Procedure]
   812   C1515273:Term [Temporal Concept]
   812   C1705313:Term [Idea or Concept]
   812   C1706317:Long [Qualitative Concept]
   812   C2826302:TERM [Intellectual Product]

Phrase: "was"

Phrase: "produced in the control group"
Meta Candidates (Total=12; Excluded=0; Pruned=0; Remaining=12)
   806   C0009932:Control Group [Group]
   760   C0243148:control [Qualitative Concept]
   760   C0441833:Group [Idea or Concept]
   760   C0687744:group [Population Group]
   760   C1257890:Group [Population Group]
   760   C1550141:Control [Substance]
   760   C1552516:Group [Health Care Related Organization]
   760   C1705428:Group [Conceptual Entity]
   760   C1705429:Group [Population Group]
   760   C1882979:Control [Conceptual Entity]
   760   C2587213:Control [Functional Concept]
   760   C3274648:Control [Qualitative Concept]

Phrase: "(18815%,"

Phrase: "n=7"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441922:N+ [Intellectual Product]
   861   C1553036:[n] [Quantitative Concept]

Phrase: ")"

Phrase: "and"

Phrase: "blocked by A[25-35,"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   760   C0028778:Blocked [Pathologic Function]
   760   C0332206:Blocked [Functional Concept]
   760   C2983591:BLOCKED [Research Activity]
   726 E C1533157:Block [Substance]
   726 E C1706084:Block [Geographic Area]
   726 E C2828370:Block [Quantitative Concept]

Phrase: "100nmol"

Phrase: "]"

Phrase: "(10815%,"

Phrase: "n=6,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441922:N+ [Intellectual Product]
   861   C1553036:[n] [Quantitative Concept]

Phrase: "P<0.001"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: ")."
Processing 00000000.tx.22: A lower dose of A[25-35; 

Phrase: "A lower dose of A[25-35"
Meta Candidates (Total=11; Excluded=3; Pruned=0; Remaining=8)
   762   C0445550:Low dose [Quantitative Concept]
   762   C1708745:Low-Dose [Research Activity]
   748   C0178602:Dose [Quantitative Concept]
   748   C0441994:Lower [Spatial Concept]
   748   C0869039:Dose [Quantitative Concept]
   748   C1114758:Dose # [Clinical Attribute]
   748   C1548802:Lower [Body Location or Region]
   748   C2003888:Lower [Activity]
   714 E C0205251:low [Qualitative Concept]
   714 E C1299352:Low [Qualitative Concept]
   714 E C1550472:low [Idea or Concept]

Phrase: ";"
Processing 00000000.tx.23: 10nmol] did not significantly impair LTP (17630%, n=4). 

Phrase: "10nmol"

Phrase: "]"

Phrase: "did"

Phrase: "not significantly"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1518422:Not [Functional Concept]

Phrase: "impair"

Phrase: "LTP"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
  1000   C0206249:Long-Term Potentiation [Organ or Tissue Function]
  1000   C2984294:Long-term potentiation [Functional Concept]
   901   C0443252:Long-term [Temporal Concept]
   827   C0205166:Long [Qualitative Concept]
   827   C0279023:Potentiation [Therapeutic or Preventive Procedure]
   827   C1515273:Term [Temporal Concept]
   827   C1705313:Term [Idea or Concept]
   827   C1706317:Long [Qualitative Concept]
   827   C2826302:TERM [Intellectual Product]

Phrase: "(17630%,"

Phrase: "n=4"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441922:N+ [Intellectual Product]
   861   C1553036:[n] [Quantitative Concept]

Phrase: ")."
Processing 00000000.tx.24: The A-peptides tested were also shown to have no significant effect on paired pulse facilitation (interstimulus interval of 50ms), suggesting that neither presynaptic transmitter release or activity of interneurons in vivo are affected. 

Phrase: "The A-peptides"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0030956:Peptides [Amino Acid, Peptide, or Protein]

Phrase: "tested"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0392366:tested [Intellectual Product]
   966 E C0022885:Test [Laboratory Procedure]
   966 E C0039593:Test [Functional Concept]

Phrase: "were"

Phrase: "also"

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "have"

Phrase: "no significant effect on paired pulse facilitation"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   774   C1301751:No effect [Qualitative Concept]
   748   C1280500:Effect [Qualitative Concept]
   748   C2348382:Effect [Qualitative Concept]

Phrase: "(interstimulus interval of 50ms"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C1272706:Interval [Temporal Concept]
   770   C1552654:Interval [Idea or Concept]
   770   C1552713:Interval [Intellectual Product]

Phrase: ")"

Phrase: ","

Phrase: "suggesting"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1705535:Suggest [Idea or Concept]

Phrase: "that"

Phrase: "neither presynaptic transmitter release"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   827   C0030685:Release [Health Care Activity]
   827   C0391871:Release [Functional Concept]
   827   C0439180:% release [Quantitative Concept]
   827   C0680255:release [Health Care Activity]
   827   C1283071:Release [Functional Concept]
   827   C1963578:Release [Therapeutic or Preventive Procedure]

Phrase: "or"

Phrase: "activity of interneurons"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C0205177:Activity [Functional Concept]
   790   C0439167:% activity [Quantitative Concept]
   790   C0441655:Activity [Activity]
   790   C1561536:*Activity [Idea or Concept]

Phrase: "in vivo"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1515655:In Vivo [Spatial Concept]
           vivo

Phrase: "are"

Phrase: "affected."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0392760:Affected [Functional Concept]
  1000   C1314939:Affected [Functional Concept]
   966 E C0001721:Affect [Mental Process]
Processing 00000000.tx.25: The effects of A on LTP are therefore likely to be mediated via a postsynaptic mechanism. 

Phrase: "The effects of A on LTP"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   793   C0023983:Long-Term Effects [Phenomenon or Process]
   744   C1280500:effects [Qualitative Concept]
   711 E C2348382:Effect [Qualitative Concept]

Phrase: "are"

Phrase: "therefore likely to"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0332148:Likely [Qualitative Concept]
   827   C0750492:Likely [Idea or Concept]

Phrase: "be"

Phrase: "mediated via a postsynaptic mechanism."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0086597:mediated [Social Behavior]
   760   C0127400:Mediated [Organic Chemical,Pharmacologic Substance]
   760   C0441712:Mechanism [Functional Concept]
   760   C1706376:Mechanism [Manufactured Object]
Processing 00000000.tx.26: This in vivo model of LTP is extremely sensitive to A-peptides that can impair LTP in a time- ([25-35]) and concentration-dependent manner ([25-35] and [35-25]). 

Phrase: "This in vivo model of LTP"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   800   C1515657:In Vivo Model [Research Activity]
   744   C3161035:Model [Intellectual Product]

Phrase: "is"

Phrase: "extremely sensitive to A-peptides"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   806   C0332324:Sensitive to [Functional Concept]
           Sensitive
   760   C1550474:sensitive [Idea or Concept]

Phrase: "that"

Phrase: "can"

Phrase: "impair"

Phrase: "LTP in a time-"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   833   C0206249:Long-Term Potentiation [Organ or Tissue Function]
   833   C2984294:Long-term potentiation [Functional Concept]
   790   C0443252:Long-term [Temporal Concept]
   756   C1515273:Term (temporal) [Temporal Concept]
           Term
   753   C0205166:Long [Qualitative Concept]
   753   C0279023:Potentiation [Therapeutic or Preventive Procedure]
   753   C1705313:Term [Idea or Concept]
   753   C1706317:Long [Qualitative Concept]
   753   C2826302:TERM [Intellectual Product]

Phrase: "("

Phrase: "[25-35"

Phrase: "]"

Phrase: ")"

Phrase: "and"

Phrase: "concentration-dependent manner"

Phrase: "("

Phrase: "[25-35"

Phrase: "]"

Phrase: "and ["

Phrase: "35-25"

Phrase: "]"

Phrase: ")."
Processing 00000000.tx.27: These effects of A-peptides may then contribute to the cognitive deficits associated with Alzheimer's disease.  

Phrase: "These effects of A-peptides"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   760   C1280500:effects [Qualitative Concept]
   726 E C2348382:Effect [Qualitative Concept]

Phrase: "may"

Phrase: "then"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883708:Then [Temporal Concept]

Phrase: "contribute to the cognitive deficits"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   806   C0679466:Cognitive deficits [Mental or Behavioral Dysfunction]
   760   C1516691:Cognitive [Functional Concept]
   760   C1880177:Contribute [Activity]
   760   C2987487:deficits [Qualitative Concept]
   726 E C0162429:Deficit, NOS [Disease or Syndrome]

Phrase: "associated with Alzheimer's disease."
Meta Candidates (Total=11; Excluded=5; Pruned=0; Remaining=6)
   833   C0002395:Alzheimer's Disease [Disease or Syndrome]
   833   C0332281:Associated with [Qualitative Concept]
           Associated
   833   C1521724:Alzheimer's Disease [Pathologic Function]
   819   C0243083:associated disease [Pathologic Function]
   770   C0012634:Disease [Disease or Syndrome]
   737 E C0750490:Associate [Idea or Concept]
   737 E C1706221:Associate [Professional or Occupational Group]
   715 E C1836721:MALS [Finding]
   715 E C3538764:MALS [Gene or Genome]
   715 E C3540595:MAL [Gene or Genome]
Processing 00000000.tx.28: INTRODUCTION TOP ABSTRACT INTRODUCTION METHODS RESULTS DISCUSSION REFERENCES Alzheimer's disease (AD) is a neurodegenerative disorder leading to loss of memory, progressive decline in cognitive function, and premature death. 

Phrase: "INTRODUCTION TOP ABSTRACT INTRODUCTION METHODS RESULTS DISCUSSION"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   795   C0557061:Discussion [Therapeutic or Preventive Procedure]
   795   C2584313:Discussion [Social Behavior]

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "Alzheimer's disease"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0002395:Alzheimer's Disease [Disease or Syndrome]
  1000   C1521724:Alzheimer's Disease [Pathologic Function]
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]

Phrase: "(AD)"

Phrase: "is"

Phrase: "a neurodegenerative disorder"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0524851:Neurodegenerative Disorder [Disease or Syndrome]
   861   C0012634:Disorder [Disease or Syndrome]

Phrase: "leading to loss of memory,"
Meta Candidates (Total=15; Excluded=5; Pruned=0; Remaining=10)
   862   C0002622:Loss of memory [Mental or Behavioral Dysfunction]
           Memory loss
   862   C0751295:LOSS OF MEMORY [Sign or Symptom]
           Memory Loss
   760   C0025260:Memory [Mental Process]
   760   C0332152:Leading [Temporal Concept]
   760   C0700327:memory [Finding]
   760   C1517945:Loss [Quantitative Concept]
   760   C1522538:Leading [Functional Concept]
   760   C1706377:Memory [Manufactured Object]
   726 E C0023175:???lead [Element, Ion, or Isotope,Hazardous or Poisonous Substance]
   726 E C1442948:lead [Inorganic Chemical,Pharmacologic Substance]
   726 E C2348269:Lead [Element, Ion, or Isotope]
   726 E C3275067:LEAD [Therapeutic or Preventive Procedure]
   704 E C0679055:mnemonic [Mental Process]

Phrase: "progressive decline in cognitive function,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   835   C1863063:Cognitive decline, progressive [Finding]
   797   C0338656:Cognitive decline [Mental or Behavioral Dysfunction]

Phrase: "and"

Phrase: "premature death."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1855073:Premature Death [Finding]
   861   C0011065:Death [Organism Function]
   861   C1306577:Death, NOS [Finding]
Processing 00000000.tx.29: One of the hallmarks of AD is the presence of numerous senile plaques and neurofibrillary tangles in the affected brain regions. 

Phrase: "One of the hallmarks of AD"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0205447:One [Quantitative Concept]

Phrase: "is"

Phrase: "the presence of numerous senile plaques"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0392148:Presence [Therapeutic or Preventive Procedure]

Phrase: "and"

Phrase: "neurofibrillary tangles in the affected brain regions."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   778   C0085400:Neurofibrillary Tangles [Acquired Abnormality]
   745 E C3543859:neurofibrillary tangle [Cell Component]
Processing 00000000.tx.30: The main constituent of these plaques is -amyloid peptide (A), a 39-42 amino acid peptide derived by proteolysis of amyloid precursor protein (APP). 

Phrase: "The main constituent of these plaques is -amyloid peptide"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   742   C0729650:constituent [Substance]

Phrase: "(A"

Phrase: ")"

Phrase: ","

Phrase: "a 39-42 amino acid peptide"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C0030956:Peptide [Amino Acid, Peptide, or Protein]

Phrase: "derived by proteolysis of amyloid precursor protein (APP)."
Meta Candidates (Total=12; Excluded=0; Pruned=0; Remaining=12)
   814   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
   814   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   778   C0033665:precursor protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   774   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   748   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   748   C0011560:Amyloid [Pathologic Function]
   748   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   748   C0597304:Proteolysis [Molecular Function]
   748   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   748   C1441547:Derived [Qualitative Concept]
   748   C1709634:Precursor [Idea or Concept]
   748   C3245521:derived [Idea or Concept]
Processing 00000000.tx.31: There appears to be a correlation between amyloid load in the cortex and disease progression on a cognitive level (Braak and Braak 1997). 

Phrase: "There"

Phrase: "appears"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0700364:APPEAR [Qualitative Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be"

Phrase: "a correlation between amyloid load"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1707520:Correlation [Qualitative Concept]

Phrase: "in the cortex"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0007776:Cortex [Body Part, Organ, or Organ Component]
  1000   C1176472:Cortex [Body Part, Organ, or Organ Component]
  1000   C2700441:Cortex [Plant]

Phrase: "and"

Phrase: "disease progression on a cognitive level"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C0242656:Disease Progression [Pathologic Function]
           progression
   790   C1947900:Disease progression NOS [Finding]
   753   C0449258:Progression [Functional Concept]

Phrase: "(Braak"

Phrase: "and"

Phrase: "Braak 1997"

Phrase: ")."
Processing 00000000.tx.32: It is generally accepted that A is involved in neuronal degeneration; 

Phrase: "It"

Phrase: "is"

Phrase: "generally"

Phrase: "accepted"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C1272684:Accepted [Qualitative Concept]
  1000   C1548435:Accepted [Idea or Concept]
   966 E C1548601:Accept [Idea or Concept]

Phrase: "that"

Phrase: "A"

Phrase: "is"

Phrase: "involved in neuronal degeneration"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   797   C0027746:Neuron Degeneration [Cell or Molecular Dysfunction]
   770   C0011164:Degeneration [Pathologic Function]
   770   C0521390:Neuronal [Immunologic Factor]
   770   C1314939:Involved [Functional Concept]
   770   C1880269:Degeneration [Functional Concept]

Phrase: ";"
Processing 00000000.tx.33: however, the mechanism of action and how it causes dementia have yet to be determined. 

Phrase: "however,"

Phrase: "the mechanism of action"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   909   C0031327:mechanism of action [Physiologic Function]
   909   C1524059:mechanism of action [Functional Concept]
   770   C0441712:Mechanism [Functional Concept]
   770   C1706376:Mechanism [Manufactured Object]

Phrase: "and"

Phrase: "how"

Phrase: "it"

Phrase: "causes"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0015127:cause [Functional Concept]
  1000   C1314792:Causes [Functional Concept]
  1000   C1524003:Cause [Conceptual Entity]

Phrase: "dementia"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0011265:dementia [Mental or Behavioral Dysfunction]
  1000   C0497327:Dementia [Mental or Behavioral Dysfunction]
   900 E C0860630:dement [Mental or Behavioral Dysfunction]

Phrase: "have"

Phrase: "yet to"

Phrase: "be"

Phrase: "determined."
Processing 00000000.tx.34: It has been reported previously that the synthetic A-peptides [22-35] and [25-35] produced neurotoxic effects in cell culture studies (Gray and Patel 1995; Takadera et al. 1993). 

Phrase: "It"

Phrase: "has"

Phrase: "been"

Phrase: "reported"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0684224:Reported [Intellectual Product]
  1000   C0700287:Reported [Health Care Activity]
  1000   C3496591:Reported [Clinical Attribute]
   966 E C3273238:Report [Intellectual Product]

Phrase: "previously"

Phrase: "that"

Phrase: "the synthetic A-peptides"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   896   C0597551:synthetic peptide [Amino Acid, Peptide, or Protein]
   827   C0030956:Peptides [Amino Acid, Peptide, or Protein]

Phrase: "[22-35"

Phrase: "]"

Phrase: "and ["

Phrase: "25-35"

Phrase: "]"

Phrase: "produced"

Phrase: "neurotoxic effects in cell culture studies"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   827   C0681854:cell culture study [Research Activity]
   799   C0947630:studies [Laboratory Procedure]
   766 E C0557651:Study [Manufactured Object]
   766 E C2603343:Study [Research Activity]

Phrase: "(Gray"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0556636:gray [Quantitative Concept]
  1000   C1269776:Gray [Qualitative Concept]

Phrase: "and"

Phrase: "Patel 1995"

Phrase: "; Takadera et al. 1993"

Phrase: ")."
Processing 00000000.tx.35: The proposed mechanisms suggested include increases in reactive oxygen species (Behl et al. 1994) and increased intracellular calcium levels (Mattson et al. 1992). 

Phrase: "The proposed mechanisms"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0441712:Mechanisms [Functional Concept]
   827 E C1706376:Mechanism [Manufactured Object]

Phrase: "suggested"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1705535:Suggest [Idea or Concept]

Phrase: "include"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0332257:include [Functional Concept]
  1000   C1552866:include [Idea or Concept]
  1000   C2700399:Include [Activity]

Phrase: "increases in reactive oxygen species"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0442805:increases [Functional Concept]

Phrase: "(Behl et al. 1994"

Phrase: ")"

Phrase: "and"

Phrase: "increased intracellular calcium levels"
Meta Candidates (Total=12; Excluded=3; Pruned=0; Remaining=9)
   875   C0553702:increased calcium [Finding]
   861   C0201925:calcium levels [Laboratory Procedure]
   861   C0428302:calcium levels [Laboratory or Test Result]
   812   C0006675:Calcium [Biologically Active Substance,Element, Ion, or Isotope,Pharmacologic Substance]
   812   C0006726:Calcium [Inorganic Chemical]
   812   C0175996:intracellular [Cell Component]
   812   C0178719:Intracellular [Spatial Concept]
   812   C0441889:Levels [Qualitative Concept]
   812   C2936886:Calcium [Pharmacologic Substance]
   779 E C0456079:Level [Classification]
   779 E C1547707:Level [Geographic Area]
   779 E C2946261:Level [Pharmacologic Substance]

Phrase: "(Mattson et al. 1992"

Phrase: ")."
Processing 00000000.tx.36: In vivo injection of both A[25-35] and A[1-40] produces neurodegeneration and neurite dystrophy similar to that seen in autopsy samples of AD patients (Pike et al. 1991, 1992). 

Phrase: "In vivo injection of both A[25-35"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   744   C0021485:injection [Therapeutic or Preventive Procedure]
   744   C1272883:Injection [Biomedical or Dental Material]
   744   C1533685:Injection [Therapeutic or Preventive Procedure]
   744   C1828121:Injection [Functional Concept]

Phrase: "]"

Phrase: "and"

Phrase: "A[1-40"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0439509:/40 [Temporal Concept]

Phrase: "]"

Phrase: "produces"

Phrase: "neurodegeneration"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0027746:Neurodegeneration [Cell or Molecular Dysfunction]

Phrase: "and"

Phrase: "neurite dystrophy"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0333606:Dystrophy [Pathologic Function]
   789 E C0333607:Dystrophic [Functional Concept]

Phrase: "similar to that"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C2348205:Similar [Qualitative Concept]

Phrase: "seen in autopsy samples of AD patients"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   748   C0004398:Autopsy [Diagnostic Procedure]
   748   C0030705:Patients [Patient or Disabled Group]
   748   C0205397:Seen [Qualitative Concept]
   714 E C0042789:see [Organism Function]
   714   C0370003:Sample [Substance]
   714 E C1947903:See [Activity]
   714   C2347026:Sample [Conceptual Entity]

Phrase: "(Pike et al. 1991,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   812   C0014878:Pike [Fish]
   812   C0522667:Pike [Manufactured Object]
   812   C0730321:PIC [Disease or Syndrome]

Phrase: "1992"

Phrase: ")."
Processing 00000000.tx.37: APP is expressed and localized on glutamatergic neurons (Ouimet et al. 1994), while cellular damage in the brains of patients with Alzheimer's disease is found predominantly in areas that display glutamatergic synaptic plasticity in the adult brain (Arendt et al. 1998). 

Phrase: "APP"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
  1000   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
  1000   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   913   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   901   C0033665:precursor protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0011560:Amyloid [Pathologic Function]
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C1709634:Precursor [Idea or Concept]

Phrase: "is"

Phrase: "expressed"

Phrase: "and"

Phrase: "localized on glutamatergic neurons"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0027882:Neurons [Cell]
   770   C0392752:Localized [Spatial Concept]

Phrase: "(Ouimet et al. 1994"

Phrase: ")"

Phrase: ","

Phrase: "while"

Phrase: "cellular damage in the brains of patients"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   757   C0270611:Brain damage [Injury or Poisoning]
   748   C0010957:Damage [Injury or Poisoning]
   748   C1883709:Damage [Functional Concept]

Phrase: "with Alzheimer's disease"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0002395:Alzheimer's Disease [Disease or Syndrome]
  1000   C1521724:Alzheimer's Disease [Pathologic Function]
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]

Phrase: "is"

Phrase: "found"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0150312:Found [Quantitative Concept]
   966 E C0243095:Find [Finding]

Phrase: "predominantly in areas"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   790   C0205146:areas [Spatial Concept]
   756 E C0017446:Area [Geographic Area]

Phrase: "that"

Phrase: "display"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705417:Display [Manufactured Object]

Phrase: "glutamatergic synaptic plasticity in the adult brain"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0678558:Plasticity [Natural Phenomenon or Process]

Phrase: "(Arendt et al. 1998"

Phrase: ")."
Processing 00000000.tx.38: Prolonged infusion of synthetic A into the brain can produce learning and memory deficits in rats (Nitta et al. 1997; Sweeney et al. 1997), while overexpression of A in transgenic mice is also associated with cognitive decline (Chapman et al. 1999; Nalbantoglu et al. 1997). 

Phrase: "Prolonged infusion of synthetic A"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0574032:Infusion [Therapeutic or Preventive Procedure]
   760   C1827465:Infusion [Functional Concept]

Phrase: "into the brain"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0006104:Brain [Body Part, Organ, or Organ Component]
  1000   C1269537:Brain [Body Part, Organ, or Organ Component]

Phrase: "can"

Phrase: "produce"

Phrase: "learning"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0013621:learning [Educational Activity]
  1000   C0023185:Learning [Mental Process]

Phrase: "and"

Phrase: "memory deficits in rats"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   833   C0233794:Memory Deficits [Mental or Behavioral Dysfunction]
   770   C2987487:deficits [Qualitative Concept]
   737 E C0162429:Deficit, NOS [Disease or Syndrome]

Phrase: "(Nitta et al. 1997"

Phrase: "; Sweeney et al. 1997"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0270811:Sweeney [Disease or Syndrome]

Phrase: ")"

Phrase: ","

Phrase: "while"

Phrase: "overexpression of A in transgenic mice"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C1514559:Overexpression [Genetic Function]

Phrase: "is"

Phrase: "also"

Phrase: "associated with cognitive decline"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   833   C0332281:Associated with [Qualitative Concept]
           Associated
   833   C0338656:Cognitive decline [Mental or Behavioral Dysfunction]
   770   C1516691:Cognitive [Functional Concept]
   737 E C0750490:Associate [Idea or Concept]
   737 E C1706221:Associate [Professional or Occupational Group]

Phrase: "(Chapman et al. 1999"

Phrase: "; Nalbantoglu et al. 1997"

Phrase: ")."
Processing 00000000.tx.39: A neurotoxicity has also been shown to be independent of plaque formation (Mucke et al. 2000). 

Phrase: "A neurotoxicity"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0235032:Neurotoxicity [Injury or Poisoning]

Phrase: "has"

Phrase: "also"

Phrase: "been"

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be independent of plaque formation"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   806   C0332291:Independent of [Functional Concept]
   760   C0011389:Plaque [Disease or Syndrome]
   760   C0085862:Independent [Idea or Concept]
   760   C0220781:formation [Biologic Function]
   760   C0332461:Plaque [Finding]
   760   C0333463:plaque [Acquired Abnormality]
   760   C0439634:formation [Spatial Concept]
   760   C1299583:Independent [Finding]
   760   C1522492:Formation [Functional Concept]
   760   C2987476:Be [Conceptual Entity]

Phrase: "(Mucke et al. 2000"

Phrase: ")."
Processing 00000000.tx.40: Chronic infusion of low doses of A[1-40] have also been shown to reduce long-term potentiation (LTP) in vivo (Itoh et al. 1999). 

Phrase: "Chronic infusion of low doses of A[1-40"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   742   C0574032:Infusion [Therapeutic or Preventive Procedure]
   742   C1827465:Infusion [Functional Concept]

Phrase: "]"

Phrase: "have"

Phrase: "also"

Phrase: "been"

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "reduce"

Phrase: "long-term potentiation"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
  1000   C0206249:Long-Term Potentiation [Organ or Tissue Function]
  1000   C2984294:Long-term potentiation [Functional Concept]
   901   C0443252:Long-term [Temporal Concept]
   827   C0205166:Long [Qualitative Concept]
   827   C0279023:Potentiation [Therapeutic or Preventive Procedure]
   827   C1515273:Term [Temporal Concept]
   827   C1705313:Term [Idea or Concept]
   827   C1706317:Long [Qualitative Concept]
   827   C2826302:TERM [Intellectual Product]

Phrase: "(LTP"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
  1000   C0206249:Long-Term Potentiation [Organ or Tissue Function]
  1000   C2984294:Long-term potentiation [Functional Concept]
   901   C0443252:Long-term [Temporal Concept]
   827   C0205166:Long [Qualitative Concept]
   827   C0279023:Potentiation [Therapeutic or Preventive Procedure]
   827   C1515273:Term [Temporal Concept]
   827   C1705313:Term [Idea or Concept]
   827   C1706317:Long [Qualitative Concept]
   827   C2826302:TERM [Intellectual Product]

Phrase: ")"

Phrase: "in vivo"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1515655:In Vivo [Spatial Concept]
           vivo

Phrase: "(Itoh et al. 1999"

Phrase: ")."
Processing 00000000.tx.41: Hippocampal LTP is an activity-dependent increase in the synaptic response that is used as a cellular model of learning and memory. 

Phrase: "Hippocampal LTP"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   923   C0206249:Long-Term Potentiation [Organ or Tissue Function]
   923   C2984294:Long-term potentiation [Functional Concept]
   861   C0443252:Long-term [Temporal Concept]
   812   C0205166:Long [Qualitative Concept]
   812   C0279023:Potentiation [Therapeutic or Preventive Procedure]
   812   C1515273:Term [Temporal Concept]
   812   C1705313:Term [Idea or Concept]
   812   C1706317:Long [Qualitative Concept]
   812   C2826302:TERM [Intellectual Product]

Phrase: "is"

Phrase: "an activity-dependent increase in the synaptic response"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C0442805:Increase [Functional Concept]

Phrase: "that"

Phrase: "is"

Phrase: "used as a cellular model of learning"
Meta Candidates (Total=10; Excluded=3; Pruned=0; Remaining=7)
   757   C1524063:Use of [Functional Concept]
   748   C0007634:Cellular [Cell]
   748   C0013621:learning [Educational Activity]
   748   C0023185:Learning [Mental Process]
   748   C0178539:Cellular [Functional Concept]
   748   C1273517:used [Finding]
   748   C3161035:Model [Intellectual Product]
   714 E C0042153:use [Functional Concept]
   714 E C0457083:Use [Functional Concept]
   714 E C1947944:Use [Intellectual Product]

Phrase: "and"

Phrase: "memory."
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0025260:Memory [Mental Process]
  1000   C0700327:memory [Finding]
  1000   C1706377:Memory [Manufactured Object]
   944 E C0679055:mnemonic [Mental Process]
Processing 00000000.tx.42: It is dependent on Ca2+ influx and subsequent activation of calcium-dependent second-messenger processes including protein synthesis and phosphorylation. 

Phrase: "It"

Phrase: "is"

Phrase: "dependent on Ca2+ influx"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0851827:Dependent [Qualitative Concept]
   770   C1701901:Dependent [Qualitative Concept]
   770   C3244310:dependent [Functional Concept]

Phrase: "and"

Phrase: "subsequent activation of calcium-dependent second-messenger processes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C1879547:Activation [Activity]

Phrase: "including"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332257:Including [Functional Concept]
   966 E C1552866:include [Idea or Concept]
   966 E C2700399:Include [Activity]

Phrase: "protein synthesis"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0597295:Protein Synthesis [Molecular Function]
   861   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0220781:synthesis [Biologic Function]
   861   C1883254:Synthesis [Activity]

Phrase: "and"

Phrase: "phosphorylation."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0031715:Phosphorylation [Molecular Function]
  1000   C1158886:Phosphorylation [Molecular Function]
Processing 00000000.tx.43: Experiments using transgenic mouse models and gene targeting have shown a close association between impaired hippocampal LTP and behavioral learning and memory deficits. 

Phrase: "Experiments"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0681814:Experiments [Research Activity]
   966 E C1706386:Experiment [Conceptual Entity]
   916 E C1517586:Experimental [Qualitative Concept]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "transgenic mouse models"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   896   C1519606:Transgenic Model [Experimental Model of Disease]
   884   C2986594:Mouse Model [Experimental Model of Disease]
   827   C3161035:Models [Intellectual Product]
   734   C0025936:Mouse, Transgenic [Mammal]

Phrase: "and"

Phrase: "gene targeting"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0242613:Gene Targeting [Molecular Biology Research Technique]
   861   C1521840:Targeting [Functional Concept]
   827 E C2986546:TARGET [Diagnostic Procedure]

Phrase: "have"

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "a close association between impaired hippocampal LTP"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   742   C0004083:Association [Mental Process]
   742   C0439849:Association [Qualitative Concept]
   742   C0596306:Association [Phenomenon or Process]
   742   C0699792:association [Social Behavior]

Phrase: "and"

Phrase: "behavioral learning"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0013621:learning [Educational Activity]
   861   C0023185:Learning [Mental Process]

Phrase: "and"

Phrase: "memory deficits."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0233794:Memory Deficits [Mental or Behavioral Dysfunction]
   861   C2987487:deficits [Qualitative Concept]
   827 E C0162429:Deficit, NOS [Disease or Syndrome]
Processing 00000000.tx.44: LTP may then represent a good model with which to examine the neuronal mechanisms involved in diseases associated with cognitive decline. 

Phrase: "LTP"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
  1000   C0206249:Long-Term Potentiation [Organ or Tissue Function]
  1000   C2984294:Long-term potentiation [Functional Concept]
   901   C0443252:Long-term [Temporal Concept]
   827   C0205166:Long [Qualitative Concept]
   827   C0279023:Potentiation [Therapeutic or Preventive Procedure]
   827   C1515273:Term [Temporal Concept]
   827   C1705313:Term [Idea or Concept]
   827   C1706317:Long [Qualitative Concept]
   827   C2826302:TERM [Intellectual Product]

Phrase: "may"

Phrase: "then"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883708:Then [Temporal Concept]

Phrase: "represent"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1882932:Represent [Activity]

Phrase: "a good model with which to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C3161035:Model [Intellectual Product]

Phrase: "examine"

Phrase: "the neuronal mechanisms"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0441712:Mechanisms [Functional Concept]
   827 E C1706376:Mechanism [Manufactured Object]

Phrase: "involved in diseases"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   790   C0012634:Diseases [Disease or Syndrome]
   790   C1314939:Involved [Functional Concept]
   718 E C1836721:MALS [Finding]
   718 E C3538764:MALS [Gene or Genome]
   718 E C3540595:MAL [Gene or Genome]

Phrase: "associated with cognitive decline."
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   833   C0332281:Associated with [Qualitative Concept]
           Associated
   833   C0338656:Cognitive decline [Mental or Behavioral Dysfunction]
   770   C1516691:Cognitive [Functional Concept]
   737 E C0750490:Associate [Idea or Concept]
   737 E C1706221:Associate [Professional or Occupational Group]
Processing 00000000.tx.45: In the CA1 region, LTP requires activation of N-methyl-D-aspartate (NMDA)-type glutamate receptors (Collingridge et al. 1983) and/or L-type voltage-gated calcium channels (Grover and Teyler 1990; Morgan and Teyler 1999). 

Phrase: "In the CA1 region,"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   861   C0017446:Region [Geographic Area]
   861   C0205147:Region [Spatial Concept]
   789 E C0205276:Regional [Spatial Concept]
   789 E C1947913:Regional [Spatial Concept]

Phrase: "LTP"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
  1000   C0206249:Long-Term Potentiation [Organ or Tissue Function]
  1000   C2984294:Long-term potentiation [Functional Concept]
   901   C0443252:Long-term [Temporal Concept]
   827   C0205166:Long [Qualitative Concept]
   827   C0279023:Potentiation [Therapeutic or Preventive Procedure]
   827   C1515273:Term [Temporal Concept]
   827   C1705313:Term [Idea or Concept]
   827   C1706317:Long [Qualitative Concept]
   827   C2826302:TERM [Intellectual Product]

Phrase: "requires"

Phrase: "activation of N-methyl-D-aspartate (NMDA)-type glutamate receptors"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   745   C1514758:Receptor Activation [Cell Function]
   742   C1879547:Activation [Activity]

Phrase: "(Collingridge et al. 1983"

Phrase: ")"

Phrase: "and/or"

Phrase: "L-type voltage-gated calcium channels"
Meta Candidates (Total=17; Excluded=1; Pruned=0; Remaining=16)
   913   C0288263:L-Type Calcium Channels [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   902 E C3538943:L-type calcium channel [Molecular Function]
   867   C0814022:voltage gated calcium channel [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   850   C0597675:voltage gated channel [Physiologic Function]
   827   C0006685:Calcium Channels [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C3258486:Voltage-gated [Qualitative Concept]
   799   C0006675:Calcium [Biologically Active Substance,Element, Ion, or Isotope,Pharmacologic Substance]
   799   C0006726:Calcium [Inorganic Chemical]
   799   C0332307:Type [Qualitative Concept]
   799   C0439394:l's [Quantitative Concept]
   799   C0598352:Voltage [Quantitative Concept]
   799   C1547052:*Type [Quantitative Concept]
   799   C1706495:L- [Intellectual Product]
   799   C2936886:Calcium [Pharmacologic Substance]
   799   C3642217:/L [Quantitative Concept]
   766   C0439799:Channel [Spatial Concept]
   766   C1706095:Channel [Conceptual Entity]

Phrase: "(Grover"

Phrase: "and"

Phrase: "Teyler 1990"

Phrase: "; Morgan"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0582521:morgan [Quantitative Concept]

Phrase: "and"

Phrase: "Teyler 1999"

Phrase: ")."
Processing 00000000.tx.46: It has been used as a model of activity-dependent synaptic plasticity that may underlie some forms of learning and memory. 

Phrase: "It"

Phrase: "has"

Phrase: "been"

Phrase: "used as a model of activity-dependent synaptic plasticity"
Meta Candidates (Total=14; Excluded=3; Pruned=0; Remaining=11)
   745   C1524063:Use of [Functional Concept]
   742   C0205177:Activity [Functional Concept]
   742   C0439167:% activity [Quantitative Concept]
   742   C0441655:Activity [Activity]
   742   C0678558:Plasticity [Natural Phenomenon or Process]
   742   C0851827:Dependent [Qualitative Concept]
   742   C1273517:used [Finding]
   742   C1561536:*Activity [Idea or Concept]
   742   C1701901:Dependent [Qualitative Concept]
   742   C3161035:Model [Intellectual Product]
   742   C3244310:dependent [Functional Concept]
   708 E C0042153:use [Functional Concept]
   708 E C0457083:Use [Functional Concept]
   708 E C1947944:Use [Intellectual Product]

Phrase: "that"

Phrase: "may"

Phrase: "underlie"

Phrase: "some"

Phrase: "forms of learning"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   790   C0013621:learning [Educational Activity]
   790   C0023185:Learning [Mental Process]
   790   C0348078:Form [Qualitative Concept]
   790   C0376315:Form [Manufactured Object]
   790   C1522492:Form [Functional Concept]

Phrase: "and"

Phrase: "memory."
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0025260:Memory [Mental Process]
  1000   C0700327:memory [Finding]
  1000   C1706377:Memory [Manufactured Object]
   944 E C0679055:mnemonic [Mental Process]
Processing 00000000.tx.47: Previous reports have indicated that -amyloid peptide can alter the activation kinetics of L-type calcium channels (Ekinci et al. 1999; Ueda et al. 1997) in addition to increasing NMDA receptor-mediated synaptic responses (Wu et al. 1995b). 

Phrase: "Previous reports"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0684224:Reports [Intellectual Product]
   861   C0700287:reports [Health Care Activity]
   827 E C3273238:Report [Intellectual Product]

Phrase: "have"

Phrase: "indicated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1444656:Indicated [Finding]

Phrase: "that -amyloid peptide"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0011560:Amyloid [Pathologic Function]
   861   C0030956:Peptide [Amino Acid, Peptide, or Protein]
   861   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "can"

Phrase: "alter"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   916   C0392747:Altered [Functional Concept]

Phrase: "the activation kinetics of L-type calcium channels"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   744   C0022702:Kinetics [Natural Phenomenon or Process]
   744   C0220865:kinetics [Functional Concept]
   744   C2825046:Kinetics [Occupation or Discipline]

Phrase: "(Ekinci et al. 1999"

Phrase: "; Ueda et al. 1997"

Phrase: ")"

Phrase: "in addition to increasing NMDA receptor-mediated synaptic responses"
Meta Candidates (Total=14; Excluded=4; Pruned=0; Remaining=10)
   812   C0332287:In addition to [Qualitative Concept]
   807   C0870868:mediated responses [Mental Process]
   799   C0052536:receptor, aspartate [Amino Acid, Peptide, or Protein,Receptor]
   787   C0085845:Aspartate [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   787   C0086597:mediated [Social Behavior]
   787   C0127400:Mediated [Organic Chemical,Pharmacologic Substance]
   787   C0442808:Increasing [Functional Concept]
   787   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]
   787   C0871261:responses [Organism Attribute]
   787   C1883712:Addition [Functional Concept]
   754 E C1704632:Response [Finding]
   754 E C1706817:Response [Intellectual Product]
   754 E C2911692:Response [Mental Process]
   716 E C1524062:Additional [Functional Concept]

Phrase: "(Wu et al. 1995b"

Phrase: ")."
Processing 00000000.tx.48: We decided therefore to examine the effects of A-peptides on hippocampal LTP and synaptic transmission. 

Phrase: "We"

Phrase: "decided"

Phrase: "therefore to"

Phrase: "examine"

Phrase: "the effects of A-peptides"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   760   C1280500:effects [Qualitative Concept]
   726 E C2348382:Effect [Qualitative Concept]

Phrase: "on hippocampal LTP"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   923   C0206249:Long-Term Potentiation [Organ or Tissue Function]
   923   C2984294:Long-term potentiation [Functional Concept]
   861   C0443252:Long-term [Temporal Concept]
   812   C0205166:Long [Qualitative Concept]
   812   C0279023:Potentiation [Therapeutic or Preventive Procedure]
   812   C1515273:Term [Temporal Concept]
   812   C1705313:Term [Idea or Concept]
   812   C1706317:Long [Qualitative Concept]
   812   C2826302:TERM [Intellectual Product]

Phrase: "and"

Phrase: "synaptic transmission."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0027793:Synaptic Transmission [Cell Function]
   861   C0040722:transmission [Idea or Concept]
   861   C0242781:Transmission [Pathologic Function]
   861   C1521797:Transmission [Natural Phenomenon or Process]
Processing 00000000.tx.49: In this report we document our investigation of the effects of intracerebroventricular (icv) injections of several A-peptides on synaptic transmission and LTP in the CA1 region of the rat hippocampus in vivo. 

Phrase: "In this report"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0684224:Report [Intellectual Product]
  1000   C0700287:Report [Health Care Activity]
  1000   C3273238:Report [Intellectual Product]

Phrase: "we"

Phrase: "document"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1301746:document [Intellectual Product]
  1000   C1547673:Document [Intellectual Product]

Phrase: "our investigation of the effects of intracerebroventricular"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C1261322:Investigation [Health Care Activity]
   748   C1552578:investigation [Idea or Concept]

Phrase: "(icv"

Phrase: ")"

Phrase: "injections of several A-peptides"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   760   C0021485:injections [Therapeutic or Preventive Procedure]
   760   C1533685:INJECTIONS [Therapeutic or Preventive Procedure]
   760   C1828121:Injections [Functional Concept]
   726 E C1272883:Injection [Biomedical or Dental Material]

Phrase: "on synaptic transmission"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0027793:Synaptic Transmission [Cell Function]
   861   C0040722:transmission [Idea or Concept]
   861   C0242781:Transmission [Pathologic Function]
   861   C1521797:Transmission [Natural Phenomenon or Process]

Phrase: "and"

Phrase: "LTP in the CA1 region of the rat hippocampus"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   775   C0206249:Long-Term Potentiation [Organ or Tissue Function]
   775   C2984294:Long-term potentiation [Functional Concept]
   756   C0443252:Long-term [Temporal Concept]
   738   C0205166:Long [Qualitative Concept]
   738   C0279023:Potentiation [Therapeutic or Preventive Procedure]
   738   C1515273:Term [Temporal Concept]
   738   C1705313:Term [Idea or Concept]
   738   C1706317:Long [Qualitative Concept]
   738   C2826302:TERM [Intellectual Product]

Phrase: "in vivo."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1515655:In Vivo [Spatial Concept]
           vivo
Processing 00000000.tx.50: The peptides examined included A[15-25], which is part of the extracellular hydrophilic domain and does not contain the active sequence of A (Pike et al. 1995), as such A[15-25] was used as a control peptide. 

Phrase: "The peptides"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0030956:Peptides [Amino Acid, Peptide, or Protein]

Phrase: "examined"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332128:Examined [Finding]

Phrase: "included"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0332257:included [Functional Concept]
  1000   C3538986:INCLUDED [Gene or Genome]
   966 E C1552866:include [Idea or Concept]
   966 E C2700399:Include [Activity]

Phrase: "A[15-25"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   913   C0718136:A-25 [Organic Chemical,Pharmacologic Substance,Vitamin]

Phrase: "],"

Phrase: "which"

Phrase: "is"

Phrase: "part of the extracellular hydrophilic domain"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C1292711:Part of [Spatial Concept]
   753   C0449719:Part [Spatial Concept]
   753   C1709471:Part [Quantitative Concept]

Phrase: "and"

Phrase: "does"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "contain"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:contain [Functional Concept]
  1000   C2700400:Contain [Activity]

Phrase: "the active sequence of A (Pike et al. 1995"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   742   C0004793:Sequence [Nucleotide Sequence]
   742   C0162326:Sequence [Nucleotide Sequence]
   742   C0162327:Sequence [Nucleotide Sequence]
   742   C1519249:Sequence [Functional Concept]

Phrase: ")"

Phrase: ","

Phrase: "as"

Phrase: "such A[15-25"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   913   C0718136:A-25 [Organic Chemical,Pharmacologic Substance,Vitamin]

Phrase: "]"

Phrase: "was"

Phrase: "used as a control peptide."
Meta Candidates (Total=10; Excluded=3; Pruned=0; Remaining=7)
   760   C0030956:Peptide [Amino Acid, Peptide, or Protein]
   760   C0243148:control [Qualitative Concept]
   760   C1273517:used [Finding]
   760   C1550141:Control [Substance]
   760   C1882979:Control [Conceptual Entity]
   760   C2587213:Control [Functional Concept]
   760   C3274648:Control [Qualitative Concept]
   726 E C0042153:use [Functional Concept]
   726 E C0457083:Use [Functional Concept]
   726 E C1947944:Use [Intellectual Product]
Processing 00000000.tx.51: A [25-35] is the most neurotoxic fragment (Yankner et al. 1990) that comprises part of the membrane spanning region and includes a hydrophopic domain. 

Phrase: "A [25-35"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   901   C0718136:A-25 [Organic Chemical,Pharmacologic Substance,Vitamin]

Phrase: "]"

Phrase: "is"

Phrase: "the most neurotoxic fragment"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0332255:fragment [Functional Concept]
   827   C1708096:Fragment [Qualitative Concept]

Phrase: "(Yankner et al. 1990"

Phrase: ")"

Phrase: "that"

Phrase: "comprises"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2700400:Comprise [Activity]

Phrase: "part of the membrane spanning region"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   790   C1292711:Part of [Spatial Concept]
   783   C1513111:Membrane Part [Tissue]
   753   C0449719:Part [Spatial Concept]
   753   C1709471:Part [Quantitative Concept]
   748 E C1184749:Membranous part [Body Part, Organ, or Organ Component]

Phrase: "and"

Phrase: "includes"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0332257:Includes [Functional Concept]
  1000   C1552866:include [Idea or Concept]
  1000   C2700399:Include [Activity]

Phrase: "a hydrophopic domain."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C1880389:Domain [Functional Concept]
   861   C1883221:Domain [Conceptual Entity]
   861   C3541951:Domain [Intellectual Product]
Processing 00000000.tx.52: Finally, A [35-25] was used to examine the effects of reversing the sequence of the active region to determine whether biological activity of the peptide was affected.  

Phrase: "Finally,"

Phrase: "A [35-25"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   913   C0718136:A-25 [Organic Chemical,Pharmacologic Substance,Vitamin]

Phrase: "]"

Phrase: "was"

Phrase: "used"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "examine"

Phrase: "the effects of reversing"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   770   C1280500:effects [Qualitative Concept]
   737 E C2348382:Effect [Qualitative Concept]

Phrase: "the sequence of the active region to"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   748   C0004793:Sequence [Nucleotide Sequence]
   748   C0162326:Sequence [Nucleotide Sequence]
   748   C0162327:Sequence [Nucleotide Sequence]
   748   C1519249:Sequence [Functional Concept]

Phrase: "determine"

Phrase: "whether"

Phrase: "biological activity of the peptide"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   760   C0005532:Biological [Biomedical Occupation or Discipline]
   760   C0205177:Activity [Functional Concept]
   760   C0205460:biological [Qualitative Concept]
   760   C0439167:% activity [Quantitative Concept]
   760   C0441655:Activity [Activity]
   760   C1561536:*Activity [Idea or Concept]

Phrase: "was"

Phrase: "affected."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0392760:Affected [Functional Concept]
  1000   C1314939:Affected [Functional Concept]
   966 E C0001721:Affect [Mental Process]
Processing 00000000.tx.53: METHODS TOP ABSTRACT INTRODUCTION METHODS RESULTS DISCUSSION REFERENCES Male Wistar rats (150-200 g) were surgically prepared for acute recordings. 

Phrase: "METHODS TOP ABSTRACT INTRODUCTION METHODS RESULTS DISCUSSION"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   795   C0557061:Discussion [Therapeutic or Preventive Procedure]
   795   C2584313:Discussion [Social Behavior]

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "Male Wistar rats"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   901   C0034716:Rats, Wistar [Mammal]
   827   C0034693:rats [Mammal]
   827   C0034721:Rats [Mammal]
   827   C2700262:Wistar [Mammal]

Phrase: "(150-200 g)"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0439267:g% [Quantitative Concept]

Phrase: "were"

Phrase: "surgically"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0543467:Surgically [Health Care Activity]

Phrase: "prepared for acute recordings."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0205178:acute [Temporal Concept]
   737   C1521827:Prepare [Functional Concept]
Processing 00000000.tx.54: Rats were anesthetized with 1.5g/kg urethan (ethyl carbamate) and placed in a stereotaxic device for surgery and recording. 

Phrase: "Rats"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0034693:rats [Mammal]
  1000   C0034721:Rats [Mammal]

Phrase: "were"

Phrase: "anesthetized with 1.5g/kg urethan"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   753   C0022718:KG [Geographic Area]
   753   C0041964:Urethan [Organic Chemical,Pharmacologic Substance]
   753   C0439209:kg [Quantitative Concept]
   753   C1720436:Anesthetized [Finding]

Phrase: "(ethyl carbamate"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0041964:Ethyl Carbamate [Organic Chemical,Pharmacologic Substance]
   861   C0006948:Carbamate [Organic Chemical]

Phrase: ")"

Phrase: "and"

Phrase: "placed in a stereotaxic device"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   760   C0025080:Device [Medical Device]
   760   C0699733:Device [Manufactured Object]
   726   C0442504:Place [Spatial Concept]
   726   C1704765:Place [Functional Concept]
   726   C1882509:Place [Activity]
   726   C3496241:place [Disease or Syndrome]

Phrase: "for surgery"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0038894:Surgery [Biomedical Occupation or Discipline]
  1000   C0038895:surgery [Functional Concept]
  1000   C0543467:Surgery [Health Care Activity]

Phrase: "and"

Phrase: "recording."
Processing 00000000.tx.55: Heating pads (Braintree Scientific) were used to maintain the temperature of the animals at 37.00.5C. 

Phrase: "Heating pads"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
  1000   C0181154:heating pads [Medical Device]
   861   C0018851:Heating [Environmental Effect of Humans]
   861   C0182158:Pads [Medical Device]
   861   C0332568:Pad [Neoplastic Process]
   861   C1706529:Pads [Biomedical or Dental Material]
   861   C3540603:PAD [Gene or Genome]
   827 E C0018837:Heat [Natural Phenomenon or Process]

Phrase: "(Braintree"

Phrase: "Scientific"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0036397:Scientific [Occupation or Discipline]

Phrase: ")"

Phrase: "were"

Phrase: "used"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "maintain"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0024501:Maintain [Activity]

Phrase: "the temperature of the animals"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0005903:temperature [Organism Attribute]
   760   C0039476:*Temperature [Quantitative Concept]

Phrase: "at 37.00.5C."
Processing 00000000.tx.56: Small holes were drilled in the skull at the sites of the reference, recording, and stimulating electrodes. 

Phrase: "Small holes"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0544726:Holes [Finding]
   827 E C1823381:hole [Gene or Genome]
   827 E C1881060:HOLE [Event]

Phrase: "were"

Phrase: "drilled in the skull"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0037303:Skull [Body Part, Organ, or Organ Component]
   737   C0324815:Drill [Mammal]

Phrase: "at the sites"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0205145:Sites [Spatial Concept]
   966 E C1515974:Site [Body Location or Region]
   966 E C2825164:Site [Spatial Concept]

Phrase: "of the reference,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "recording"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0034869:Record [Intellectual Product]

Phrase: ","

Phrase: "and"

Phrase: "stimulating electrodes."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0013812:Electrodes [Medical Device]
   827 E C1705652:Electrode [Medical Device]
Processing 00000000.tx.57: An additional hole was drilled to introduce a cannula for icv injection of drugs/vehicle. 

Phrase: "An additional hole"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0544726:Hole [Finding]
   861   C1823381:hole [Gene or Genome]
   861   C1881060:HOLE [Event]

Phrase: "was"

Phrase: "drilled"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0324815:Drill [Mammal]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "introduce"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1292748:introduce [Functional Concept]

Phrase: "a cannula for icv injection of drugs/vehicle."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   767   C0491005:CANNULA, INJECTION [Medical Device]
   744   C0520453:Cannula [Medical Device]
   744   C1706091:Cannula [Medical Device]
   744   C3463845:Cannula [Eukaryote]
Processing 00000000.tx.58: The recording electrode was positioned in the stratum radiatum area of CA1 (3mm posterior to bregma, 2mm lateral to bregma). 

Phrase: "The recording electrode"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0013812:electrode [Medical Device]
   861   C1705652:Electrode [Medical Device]

Phrase: "was"

Phrase: "positioned in the stratum radiatum area of CA1"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C2340164:Stratum radiatum [Body Part, Organ, or Organ Component]
   744   C0017446:Area [Geographic Area]
   744   C0205146:Area [Spatial Concept]
   711   C0733755:Position [Spatial Concept]

Phrase: "(3mm"

Phrase: "posterior to bregma,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0205095:Posterior [Spatial Concept]

Phrase: "2mm"

Phrase: "lateral to bregma"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0205093:Lateral [Spatial Concept]

Phrase: ")."
Processing 00000000.tx.59: A bipolar stimulating electrode was placed in the Schaffer collateral/commissural pathway, distal to the recording electrode (4mm posterior, 3mm lateral). 

Phrase: "A bipolar stimulating electrode"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0013812:electrode [Medical Device]
   827   C1705652:Electrode [Medical Device]

Phrase: "was"

Phrase: "placed in the Schaffer collateral/commissural pathway,"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   778   C3544403:Schaffer collateral [Cell Component]
   748   C1275670:Collateral [Body Part, Organ, or Organ Component]
   748   C1704259:Pathway [Molecular Function]
   748   C1705987:Pathway [Conceptual Entity]
   748   C1948058:Collateral [Spatial Concept]
   714   C0442504:Place [Spatial Concept]
   714   C1704765:Place [Functional Concept]
   714   C1882509:Place [Activity]
   714   C3496241:place [Disease or Syndrome]

Phrase: "distal to the recording electrode"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0205108:Distal [Spatial Concept]

Phrase: "(4mm posterior, 3mm"

Phrase: "lateral"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205093:Lateral [Spatial Concept]

Phrase: ")."
Processing 00000000.tx.60: Physiological (Leung 1980) and steriotaxic indicators were used to lower electrodes slowly through the cortex into the hippocampus. 

Phrase: "Physiological"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0205463:Physiological [Functional Concept]
   928 E C0031842:Physiology [Biomedical Occupation or Discipline]
   928 E C0031843:physiology [Physiologic Function]

Phrase: "(Leung 1980"

Phrase: ")"

Phrase: "and"

Phrase: "steriotaxic indicators"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0021212:Indicators [Indicator, Reagent, or Diagnostic Aid]
   827 E C1235732:Indicator [Bird]
   827 E C1522602:Indicator [Functional Concept]

Phrase: "were"

Phrase: "used"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "lower"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0441994:Lower [Spatial Concept]
  1000   C1548802:Lower [Body Location or Region]
  1000   C2003888:Lower [Activity]

Phrase: "electrodes slowly through the cortex"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   760   C0013812:Electrodes [Medical Device]
   726 E C1705652:Electrode [Medical Device]

Phrase: "into the hippocampus."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0019564:Hippocampus [Body Part, Organ, or Organ Component]
  1000   C0949582:Hippocampus [Fish]
  1000   C1029104:Hippocampus [Fish]
  1000   C1284077:Hippocampus [Body Part, Organ, or Organ Component]
Processing 00000000.tx.61: Test stimuli were delivered to the Schaffer-collateral commissural pathway every 30s. 

Phrase: "Test stimuli"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0234402:Stimuli [Phenomenon or Process]

Phrase: "were"

Phrase: "delivered to the Schaffer-collateral commissural pathway"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
   778   C3544403:Schaffer collateral [Cell Component]
   748   C1275670:Collateral [Body Part, Organ, or Organ Component]
   748   C1704259:Pathway [Molecular Function]
   748   C1705822:Delivered [Activity]
   748   C1705987:Pathway [Conceptual Entity]
   748   C1948058:Collateral [Spatial Concept]
   714 E C0308779:DELIVER [Organic Chemical,Pharmacologic Substance]
   714 E C1874964:DELIVER [Pharmacologic Substance]

Phrase: "every 30s."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0227073:30S [Body Part, Organ, or Organ Component]
Processing 00000000.tx.62: Electrodes were positioned to record a maximal evoked field excitatory postsynaptic potential (EPSP). 

Phrase: "Electrodes"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0013812:Electrodes [Medical Device]
   966 E C1705652:Electrode [Medical Device]

Phrase: "were"

Phrase: "positioned"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0733755:Position [Spatial Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "record"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0034869:Record [Intellectual Product]

Phrase: "a maximal evoked field excitatory postsynaptic potential"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   876   C0015214:Evoked potential [Organ or Tissue Function]
   861   C0524913:Potential, Excitatory Postsynaptic [Organ or Tissue Function]
   839   C0234121:Excitatory potential [Organ or Tissue Function]
   827   C2350339:Potential, Postsynaptic [Organ or Tissue Function]
   799   C0440042:Field's [Indicator, Reagent, or Diagnostic Aid]
   799   C1521738:Field [Conceptual Entity]
   799   C2346620:Field [Conceptual Entity]
   799   C2349184:Field [Conceptual Entity]
   799   C3245505:Potential [Qualitative Concept]
   799   C3539073:FIELD [Spatial Concept]

Phrase: "(EPSP"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0524913:Potential, Excitatory Postsynaptic [Organ or Tissue Function]
   913   C0234121:Excitatory potential [Organ or Tissue Function]
   901   C2350339:Potential, Postsynaptic [Organ or Tissue Function]
   827   C3245505:Potential [Qualitative Concept]

Phrase: ")."
Processing 00000000.tx.63: Baseline EPSPs were set within the range 0.8-1 mV, which corresponded to 40% of the maximal response. 

Phrase: "Baseline EPSPs"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   923   C0524913:Excitatory Postsynaptic Potentials [Organ or Tissue Function]
   861   C2350339:Postsynaptic Potentials [Organ or Tissue Function]
   858   C0234121:Excitatory potential [Organ or Tissue Function]
   812   C3245505:potentials [Qualitative Concept]

Phrase: "were"

Phrase: "set within the range 0.8-1 mV,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   744   C0036849:Set [Mental Process]
   744   C1442518:Set [Functional Concept]
   744   C1514721:Range [Quantitative Concept]
   744   C1705195:Set [Conceptual Entity]
   744   C2348147:Range [Quantitative Concept]
   744   C3542016:Range [Intellectual Product]

Phrase: "which"

Phrase: "corresponded to 40% of the maximal response."
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   748   C0205289:Maximal [Qualitative Concept]
   748   C0439509:/40 [Temporal Concept]
   748   C0806909:Maximal [Quantitative Concept]
   748   C0871261:Response [Organism Attribute]
   748   C1704632:Response [Finding]
   748   C1706817:Response [Intellectual Product]
   748   C2911692:Response [Mental Process]
Processing 00000000.tx.64: Rats were injected icv with A-peptide fragments (100or 10nmol in 5L) or vehicle (distilled water; 5L). 

Phrase: "Rats"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0034693:rats [Mammal]
  1000   C0034721:Rats [Mammal]

Phrase: "were"

Phrase: "injected"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1720154:Inject [Functional Concept]

Phrase: "icv with A-peptide fragments"

Phrase: "(100or 10nmol in 5L"

Phrase: ")"

Phrase: "or"

Phrase: "vehicle"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0042444:Vehicle [Biomedical or Dental Material]
  1000   C0348005:Vehicle [Manufactured Object]
   928 E C0445373:Vehicular [Functional Concept]

Phrase: "(distilled water"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
  1000   C0790233:Distilled water [Inorganic Chemical,Pharmacologic Substance]
   861   C0043047:Water [Inorganic Chemical,Pharmacologic Substance]
   861   C0599638:WATER [Substance]
   861   C0681549:distilled [Occupational Activity]
   861   C1550678:Water [Inorganic Chemical]
   789 E C0443350:Watery [Qualitative Concept]

Phrase: "; 5L"

Phrase: ")."
Processing 00000000.tx.65: In each protocol used, LTP was induced by applying high-frequency stimuli (HFS; 310trains of 10stimuli at 200Hz) at a stimulus intensity that evoked a field EPSP of approximately 1.5-2.0 mV, approximately 80% of maximal EPSP. 

Phrase: "In each protocol"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0442711:Protocol [Intellectual Product]
  1000   C1507394:Protocol [Intellectual Product]
  1000   C1522729:Protocol [Intellectual Product]
  1000   C2348563:Protocol [Intellectual Product]

Phrase: "used"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: ","

Phrase: "LTP"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
  1000   C0206249:Long-Term Potentiation [Organ or Tissue Function]
  1000   C2984294:Long-term potentiation [Functional Concept]
   901   C0443252:Long-term [Temporal Concept]
   827   C0205166:Long [Qualitative Concept]
   827   C0279023:Potentiation [Therapeutic or Preventive Procedure]
   827   C1515273:Term [Temporal Concept]
   827   C1705313:Term [Idea or Concept]
   827   C1706317:Long [Qualitative Concept]
   827   C2826302:TERM [Intellectual Product]

Phrase: "was"

Phrase: "induced by applying high-frequency stimuli"
Meta Candidates (Total=15; Excluded=0; Pruned=0; Remaining=15)
   790   C0205212:High frequency [Temporal Concept]
   767   C0237630:Stimulus frequency [Temporal Concept]
   753   C0205250:High [Qualitative Concept]
   753   C0205263:Induced [Functional Concept]
   753   C0234402:Stimuli [Phenomenon or Process]
   753   C0376249:frequency [Quantitative Concept]
   753   C0439603:Frequency [Temporal Concept]
   753   C0871396:Frequency [Quantitative Concept]
   753   C1299351:High [Qualitative Concept]
   753   C1561548:Frequency [Qualitative Concept]
   753   C1705502:Frequency [Quantitative Concept]
   753   C2700149:HIGH [Intellectual Product]
   719   C0185125:Apply [Health Care Activity]
   719   C1632850:Apply [Functional Concept]
   719   C1879355:Apply [Functional Concept]

Phrase: "(HFS"
Meta Candidates (Total=12; Excluded=1; Pruned=0; Remaining=11)
   901   C0205212:High frequency [Temporal Concept]
   827   C0205250:High [Qualitative Concept]
   827   C0376249:frequency [Quantitative Concept]
   827   C0439603:Frequency [Temporal Concept]
   827   C0871396:Frequency [Quantitative Concept]
   827   C1292856:Stimulation [Therapeutic or Preventive Procedure]
   827   C1299351:High [Qualitative Concept]
   827   C1561548:Frequency [Qualitative Concept]
   827   C1705502:Frequency [Quantitative Concept]
   827   C1948023:Stimulation [Natural Phenomenon or Process]
   827   C2700149:HIGH [Intellectual Product]
   755 E C0332183:Frequent [Temporal Concept]

Phrase: "; 310trains of 10stimuli"

Phrase: "at 200Hz"

Phrase: ")"

Phrase: "at a stimulus intensity"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0237686:Stimulus Intensity [Quantitative Concept]
   861   C0522510:Intensity [Qualitative Concept]

Phrase: "that"

Phrase: "evoked"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1444748:Evoked [Qualitative Concept]

Phrase: "a field EPSP"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   923   C0524913:Potential, Excitatory Postsynaptic [Organ or Tissue Function]
   875   C0234121:Excitatory potential [Organ or Tissue Function]
   861   C2350339:Potential, Postsynaptic [Organ or Tissue Function]
   812   C0440042:Field's [Indicator, Reagent, or Diagnostic Aid]
   812   C1521738:Field [Conceptual Entity]
   812   C2346620:Field [Conceptual Entity]
   812   C2349184:Field [Conceptual Entity]
   812   C3245505:Potential [Qualitative Concept]
   812   C3539073:FIELD [Spatial Concept]

Phrase: "of approximately 1.5-2.0 mV,"

Phrase: "approximately 80% of maximal EPSP."
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   814   C0524913:Potential, Excitatory Postsynaptic [Organ or Tissue Function]
   778   C2350339:Potential, Postsynaptic [Organ or Tissue Function]
   774   C0234121:Excitatory potential [Organ or Tissue Function]
   748   C0205289:Maximal [Qualitative Concept]
   748   C0332232:Approximately [Qualitative Concept]
   748   C0806909:Maximal [Quantitative Concept]
   748   C3245505:Potential [Qualitative Concept]
Processing 00000000.tx.66: Stimulating (bi-polar stainless steel; 0.125mm diam) and recording (mono-polar stainless steel; 0.125mm diam) electrodes were obtained from Plastics One. 

Phrase: "Stimulating"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1948023:Stimulating [Natural Phenomenon or Process]

Phrase: "(bi-polar stainless steel"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0038126:Stainless Steel [Biomedical or Dental Material,Inorganic Chemical]
   812   C0038239:Steel [Biomedical or Dental Material,Inorganic Chemical]

Phrase: "; 0.125mm diam)"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1301886:Diam [Quantitative Concept]

Phrase: "and"

Phrase: "recording"

Phrase: "(mono-polar stainless steel"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0038126:Stainless Steel [Biomedical or Dental Material,Inorganic Chemical]
   812   C0038239:Steel [Biomedical or Dental Material,Inorganic Chemical]

Phrase: "; 0.125mm diam) electrodes"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   812   C0013812:Electrodes [Medical Device]
   779 E C1705652:Electrode [Medical Device]

Phrase: "were"

Phrase: "obtained from Plastics One."
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   770   C0032167:Plastics [Substance]
   770   C0205447:One [Quantitative Concept]
   770   C1301820:Obtained [Functional Concept]
   737 E C1706701:Obtain [Activity]
Processing 00000000.tx.67: Peptides were obtained from Bachem (Saffron Walden, UK). 

Phrase: "Peptides"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0030956:Peptides [Amino Acid, Peptide, or Protein]

Phrase: "were"

Phrase: "obtained from Bachem"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   790   C1301820:Obtained [Functional Concept]
   756 E C1706701:Obtain [Activity]
   718 E C1517378:Gain [Quantitative Concept]

Phrase: "(Saffron Walden,"

Phrase: "UK"

Phrase: ")."
Processing 00000000.tx.68: Data analysis Extracellular field potentials were amplified (100), filtered at 5kHz, digitized, and recorded using Mac Lab software acquisition system. 

Phrase: "Data analysis Extracellular field potentials"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   804   C3245505:potentials [Qualitative Concept]
   708   C1521738:Data Field [Conceptual Entity]

Phrase: "were"

Phrase: "amplified"

Phrase: "(100"

Phrase: ")"

Phrase: ","

Phrase: "filtered at 5kHz,"
Meta Candidates (Total=11; Excluded=5; Pruned=0; Remaining=6)
   756   C0180860:Filter [Manufactured Object]
   756   C0581406:Filter [Medical Device]
   756   C1522664:Filter [Intellectual Product]
   756   C1704449:Filter [Conceptual Entity]
   756   C1704684:Filter [Medical Device]
   756   C1875155:FILTER [Medical Device]
   718 E C0080194:Strain [Injury or Poisoning]
   718 E C0442694:Straining [Physiologic Function]
   718 E C0456178:strain [Intellectual Product]
   718 E C1518614:Strain [Organism]
   718 E C2987481:Strain [Mental Process]

Phrase: "digitized"

Phrase: ","

Phrase: "and"

Phrase: "recorded"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0034869:Record [Intellectual Product]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "Mac Lab software acquisition system."
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   804   C0449913:System [Functional Concept]
   804   C1553451:System [Manufactured Object]
   804   C1704459:System [Medical Device]
   733 E C0205373:Systemic [Functional Concept]
Processing 00000000.tx.69: The EPSP slope was used to measure synaptic efficacy. 

Phrase: "The EPSP slope"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   812   C0807955:Slope [Quantitative Concept]
   756   C0524913:Potential, Excitatory Postsynaptic [Organ or Tissue Function]
   708   C0234121:Excitatory potential [Organ or Tissue Function]

Phrase: "was"

Phrase: "used"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "measure"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0079809:Measure [Quantitative Concept]
  1000   C0242485:Measure [Functional Concept]

Phrase: "synaptic efficacy."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1280519:Efficacy [Qualitative Concept]
   861   C1707887:EFFICACY [Research Activity]
Processing 00000000.tx.70: EPSPs are expressed as a percentage of the mean initial slope measured during the first 10min of the baseline-recording period. 

Phrase: "EPSPs"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0524913:Excitatory Postsynaptic Potentials [Organ or Tissue Function]
   901   C2350339:Postsynaptic Potentials [Organ or Tissue Function]
   896   C0234121:Excitatory potential [Organ or Tissue Function]
   827   C3245505:potentials [Qualitative Concept]

Phrase: "are"

Phrase: "expressed as a percentage of the mean initial slope"
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
   742   C0205265:Initial [Temporal Concept]
   742   C0439165:Percentage [Quantitative Concept]
   742   C0444504:Mean [Quantitative Concept]
   742   C0807955:Slope [Quantitative Concept]
   742   C1279901:Initial [Qualitative Concept]
   742   C1549488:Percentage [Idea or Concept]
   742   C1555582:Initial [Idea or Concept]
   742   C1561533:Percentage [Idea or Concept]
   742   C1705685:INITIAL [Functional Concept]
   742   C2347634:Mean [Quantitative Concept]
   742   C2348143:Mean [Quantitative Concept]

Phrase: "measured during the first 10min of the baseline-recording period."
Meta Candidates (Total=11; Excluded=2; Pruned=0; Remaining=9)
   739   C0168634:baseline [Biomedical or Dental Material]
   739   C0205435:First [Quantitative Concept]
   739   C0439531:/period [Temporal Concept]
   739   C0444706:Measured [Qualitative Concept]
   739   C1279901:First [Qualitative Concept]
   739   C1442488:Baseline [Quantitative Concept]
   739   C1948053:Period [Temporal Concept]
   739   C3541902:MEASURED [Diagnostic Procedure]
   706   C0034869:Record [Intellectual Product]
   706 E C0079809:Measure [Quantitative Concept]
   706 E C0242485:Measure [Functional Concept]
Processing 00000000.tx.71: Data were analyzed using ANOVA measured over 5min prior to LTP induction and either at 25-30 or 55-60 min following the induction of LTP. 

Phrase: "Data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "were"

Phrase: "analyzed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0936012:Analyzed [Research Activity]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "ANOVA"

Phrase: "measured over 5min"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   790   C0444706:Measured [Qualitative Concept]
   790   C3541902:MEASURED [Diagnostic Procedure]
   756 E C0079809:Measure [Quantitative Concept]
   756 E C0242485:Measure [Functional Concept]

Phrase: "prior to LTP induction"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   812   C0205263:Induction [Functional Concept]
   812   C0857127:induction [Therapeutic or Preventive Procedure]
   756   C0206249:Long-Term Potentiation [Organ or Tissue Function]
   756   C2984294:Long-term potentiation [Functional Concept]

Phrase: "and"

Phrase: "either at 25-30"

Phrase: "or"

Phrase: "55-60 min"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0702093:/min [Temporal Concept]

Phrase: "following"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332282:Following [Temporal Concept]
   966 E C0332283:follow [Temporal Concept]
   966 E C1719822:Follow [Intellectual Product]

Phrase: "the induction of LTP."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0205263:Induction [Functional Concept]
   753   C0857127:induction [Therapeutic or Preventive Procedure]
Processing 00000000.tx.72: The Tukey-Kramer multiple comparisons test was used to determine statistical significance. 

Phrase: "The Tukey-Kramer multiple comparisons"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   779   C1707455:Comparison [Activity]

Phrase: "test"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0022885:Test [Laboratory Procedure]
  1000   C0039593:Test [Functional Concept]
  1000   C0392366:test [Intellectual Product]

Phrase: "was"

Phrase: "used"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "determine"

Phrase: "statistical significance."
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
  1000   C0237881:Statistical Significance [Quantitative Concept]
           Significance
  1000   C1709380:Statistical Significance [Quantitative Concept]
   861   C0038215:Statistical [Occupation or Discipline]
   861   C0750502:Significance [Idea or Concept]
   789 E C1546944:Significant [Qualitative Concept]
Processing 00000000.tx.73: Stimulation protocol Field EPSPs were evoked in the CA1 region using low-frequency stimulation (0.033Hz) to obtain at least 30min of stable baseline prior to icv injection of A-fragment or vehicle. 

Phrase: "Stimulation protocol Field EPSPs"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   861   C0524913:Excitatory Postsynaptic Potentials [Organ or Tissue Function]
   827   C2350339:Postsynaptic Potentials [Organ or Tissue Function]
   822   C0234121:Excitatory potential [Organ or Tissue Function]
   799   C0440042:Field's [Indicator, Reagent, or Diagnostic Aid]
   799   C1521738:Field [Conceptual Entity]
   799   C2346620:Field [Conceptual Entity]
   799   C2349184:Field [Conceptual Entity]
   799   C3245505:potentials [Qualitative Concept]
   799   C3539073:FIELD [Spatial Concept]

Phrase: "were"

Phrase: "evoked in the CA1 region"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0017446:Region [Geographic Area]
   760   C0205147:Region [Spatial Concept]
   760   C1444748:Evoked [Qualitative Concept]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "low-frequency stimulation"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C1292856:Stimulation [Therapeutic or Preventive Procedure]
   827   C1948023:Stimulation [Natural Phenomenon or Process]
   734   C0205213:Low frequency [Temporal Concept]

Phrase: "(0.033Hz"

Phrase: ")"

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "obtain at least 30min of stable baseline"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   748   C0168634:baseline [Biomedical or Dental Material]
   748   C0205360:Stable [Qualitative Concept]
   748   C1301820:Obtain [Functional Concept]
   748   C1442488:Baseline [Quantitative Concept]
   748   C1547311:Stable [Intellectual Product]
   748   C1706701:Obtain [Activity]

Phrase: "prior to icv injection"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0021485:injection [Therapeutic or Preventive Procedure]
   861   C1272883:Injection [Biomedical or Dental Material]
   861   C1533685:Injection [Therapeutic or Preventive Procedure]
   861   C1828121:Injection [Functional Concept]

Phrase: "of A-fragment"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0332255:fragment [Functional Concept]
   861   C1708096:Fragment [Qualitative Concept]

Phrase: "or"

Phrase: "vehicle."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0042444:Vehicle [Biomedical or Dental Material]
  1000   C0348005:Vehicle [Manufactured Object]
   928 E C0445373:Vehicular [Functional Concept]
Processing 00000000.tx.74: At a time of either 5min or 1h following the icv injection, a series of high-frequency stimuli were delivered to induce potentiation of the synaptic response. 

Phrase: "At a time"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0040223:Time [Temporal Concept]
  1000   C3541383:Time [Temporal Concept]
   944 E C0442043:Temporal [Spatial Concept]
   944 E C2362314:Temporal [Temporal Concept]
   916 E C1632851:Times [Quantitative Concept]

Phrase: "of either 5min"

Phrase: "or"

Phrase: "1h"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1442450:1H [Temporal Concept]

Phrase: "following"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332282:Following [Temporal Concept]
   966 E C0332283:follow [Temporal Concept]
   966 E C1719822:Follow [Intellectual Product]

Phrase: "the icv injection,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0021485:injection [Therapeutic or Preventive Procedure]
   861   C1272883:Injection [Biomedical or Dental Material]
   861   C1533685:Injection [Therapeutic or Preventive Procedure]
   861   C1828121:Injection [Functional Concept]

Phrase: "a series of high-frequency stimuli"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0205549:Series [Quantitative Concept]
   753   C2348044:Series [Intellectual Product]

Phrase: "were"

Phrase: "delivered"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C1705822:Delivered [Activity]
   966 E C0308779:DELIVER [Organic Chemical,Pharmacologic Substance]
   966 E C1874964:DELIVER [Pharmacologic Substance]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "induce"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205263:Induce [Functional Concept]

Phrase: "potentiation of the synaptic response."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0279023:Potentiation [Therapeutic or Preventive Procedure]
Processing 00000000.tx.75: Low-frequency stimulation was then used to evoke EPSPs for a further period of 30min to 1h to monitor any change in the synaptic response. 

Phrase: "Low-frequency stimulation"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C1292856:Stimulation [Therapeutic or Preventive Procedure]
   827   C1948023:Stimulation [Natural Phenomenon or Process]
   734   C0205213:Low frequency [Temporal Concept]

Phrase: "was"

Phrase: "then"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883708:Then [Temporal Concept]

Phrase: "used"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "evoke"

Phrase: "EPSPs for a further period of 30min"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C0524913:Excitatory Postsynaptic Potentials [Organ or Tissue Function]
   764   C2350339:Postsynaptic Potentials [Organ or Tissue Function]
   745   C0234121:Excitatory potential [Organ or Tissue Function]
   742   C3245505:potentials [Qualitative Concept]

Phrase: "to 1h to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1442450:1H [Temporal Concept]

Phrase: "monitor"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0030695:monitor [Health Care Activity]
  1000   C0150369:monitor [Health Care Activity]
  1000   C0181904:Monitor [Medical Device]
  1000   C0596972:Monitor [Medical Device]
  1000   C1521743:Monitor [Professional or Occupational Group]
  1000   C1704646:Monitor [Manufactured Object]

Phrase: "any change in the synaptic response."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0392747:Change [Functional Concept]
   753   C0443172:change [Quantitative Concept]
   753   C1705241:Change [Quantitative Concept]
Processing 00000000.tx.76: Paired-pulse facilitation (PPF) with an inter-stimulus interval of 50ms was also examined before icv injection of A-peptides and again 90min following icv injection (30min following induction of LTP).  

Phrase: "Paired-pulse facilitation"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   827   C0232117:PULSE [Clinical Attribute]
   827   C0234112:Facilitation [Organ or Tissue Function]
   827   C0391850:Pulse [Physiologic Function]
   827   C1709450:Paired [Qualitative Concept]
   827   C1947910:Pulse [Phenomenon or Process]
   743 E C0034107:Pulses [Health Care Activity]

Phrase: "(PPF) with an inter-stimulus interval of 50ms"

Phrase: "was"

Phrase: "also"

Phrase: "examined before icv injection of A-peptides"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   748   C0021485:injection [Therapeutic or Preventive Procedure]
   748   C0030956:Peptides [Amino Acid, Peptide, or Protein]
   748   C0332128:Examined [Finding]
   748   C1272883:Injection [Biomedical or Dental Material]
   748   C1533685:Injection [Therapeutic or Preventive Procedure]
   748   C1828121:Injection [Functional Concept]

Phrase: "and"

Phrase: "again 90min"

Phrase: "following"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332282:Following [Temporal Concept]
   966 E C0332283:follow [Temporal Concept]
   966 E C1719822:Follow [Intellectual Product]

Phrase: "icv injection"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0021485:injection [Therapeutic or Preventive Procedure]
   861   C1272883:Injection [Biomedical or Dental Material]
   861   C1533685:Injection [Therapeutic or Preventive Procedure]
   861   C1828121:Injection [Functional Concept]

Phrase: "(30min"

Phrase: "following"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332282:Following [Temporal Concept]
   966 E C0332283:follow [Temporal Concept]
   966 E C1719822:Follow [Intellectual Product]

Phrase: "induction of LTP"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0205263:Induction [Functional Concept]
   760   C0857127:induction [Therapeutic or Preventive Procedure]

Phrase: ")."
Processing 00000000.tx.77: RESULTS TOP ABSTRACT INTRODUCTION METHODS RESULTS DISCUSSION REFERENCES In control experiments, icv administration of vehicle had no effect on baseline synaptic transmission, or PPF monitored for up to 1h following injection. 

Phrase: "RESULTS TOP ABSTRACT INTRODUCTION METHODS RESULTS DISCUSSION"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   795   C0557061:Discussion [Therapeutic or Preventive Procedure]
   795   C2584313:Discussion [Social Behavior]

Phrase: "REFERENCES In control experiments,"
Meta Candidates (Total=10; Excluded=1; Pruned=0; Remaining=9)
   833   C0009932:control experiments [Group]
   770   C0243148:control [Qualitative Concept]
   770   C0681814:Experiments [Research Activity]
   770   C1514811:Reference [Idea or Concept]
   770   C1550141:Control [Substance]
   770   C1706462:Reference [Conceptual Entity]
   770   C1882979:Control [Conceptual Entity]
   770   C2587213:Control [Functional Concept]
   770   C3274648:Control [Qualitative Concept]
   737 E C1706386:Experiment [Conceptual Entity]

Phrase: "icv administration of vehicle"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0001554:Administration [Occupational Activity]
   770   C1533734:Administration [Therapeutic or Preventive Procedure]

Phrase: "had"

Phrase: "no effect on baseline synaptic transmission,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C1301751:No effect [Qualitative Concept]
   753   C1280500:Effect [Qualitative Concept]
   753   C2348382:Effect [Qualitative Concept]

Phrase: "or"

Phrase: "PPF"

Phrase: "monitored for"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   799   C0030695:monitor [Health Care Activity]
   799   C0150369:monitor [Health Care Activity]
   799   C0181904:Monitor [Medical Device]
   799   C0596972:Monitor [Medical Device]
   799   C1521743:Monitor [Professional or Occupational Group]
   799   C1704646:Monitor [Manufactured Object]

Phrase: "up to 1h"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1442450:1H [Temporal Concept]

Phrase: "following"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332282:Following [Temporal Concept]
   966 E C0332283:follow [Temporal Concept]
   966 E C1719822:Follow [Intellectual Product]

Phrase: "injection."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0021485:injection [Therapeutic or Preventive Procedure]
  1000   C1272883:Injection [Biomedical or Dental Material]
  1000   C1533685:Injection [Therapeutic or Preventive Procedure]
  1000   C1828121:Injection [Functional Concept]
Processing 00000000.tx.78: When HFS was applied 1h following vehicle injection, LTP measured 19117% (n=6,meanSE, P<0.05,ANOVA, 30min following HFS; Fig. 1). 

Phrase: "When"

Phrase: "HFS"
Meta Candidates (Total=12; Excluded=1; Pruned=0; Remaining=11)
   901   C0205212:High frequency [Temporal Concept]
   827   C0205250:High [Qualitative Concept]
   827   C0376249:frequency [Quantitative Concept]
   827   C0439603:Frequency [Temporal Concept]
   827   C0871396:Frequency [Quantitative Concept]
   827   C1292856:Stimulation [Therapeutic or Preventive Procedure]
   827   C1299351:High [Qualitative Concept]
   827   C1561548:Frequency [Qualitative Concept]
   827   C1705502:Frequency [Quantitative Concept]
   827   C1948023:Stimulation [Natural Phenomenon or Process]
   827   C2700149:HIGH [Intellectual Product]
   755 E C0332183:Frequent [Temporal Concept]

Phrase: "was"

Phrase: "applied"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0185125:Applied [Health Care Activity]
   966 E C1632850:Apply [Functional Concept]
   966 E C1879355:Apply [Functional Concept]

Phrase: "1h"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1442450:1H [Temporal Concept]

Phrase: "following"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332282:Following [Temporal Concept]
   966 E C0332283:follow [Temporal Concept]
   966 E C1719822:Follow [Intellectual Product]

Phrase: "vehicle injection,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0021485:injection [Therapeutic or Preventive Procedure]
   861   C1272883:Injection [Biomedical or Dental Material]
   861   C1533685:Injection [Therapeutic or Preventive Procedure]
   861   C1828121:Injection [Functional Concept]

Phrase: "LTP"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
  1000   C0206249:Long-Term Potentiation [Organ or Tissue Function]
  1000   C2984294:Long-term potentiation [Functional Concept]
   901   C0443252:Long-term [Temporal Concept]
   827   C0205166:Long [Qualitative Concept]
   827   C0279023:Potentiation [Therapeutic or Preventive Procedure]
   827   C1515273:Term [Temporal Concept]
   827   C1705313:Term [Idea or Concept]
   827   C1706317:Long [Qualitative Concept]
   827   C2826302:TERM [Intellectual Product]

Phrase: "measured"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0444706:Measured [Qualitative Concept]
  1000   C3541902:MEASURED [Diagnostic Procedure]
   966 E C0079809:Measure [Quantitative Concept]
   966 E C0242485:Measure [Functional Concept]

Phrase: "19117%"

Phrase: "(n=6,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441922:N+ [Intellectual Product]
   861   C1553036:[n] [Quantitative Concept]

Phrase: "meanSE,"

Phrase: "P<0.05,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: "ANOVA,"

Phrase: "30min"

Phrase: "following"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332282:Following [Temporal Concept]
   966 E C0332283:follow [Temporal Concept]
   966 E C1719822:Follow [Intellectual Product]

Phrase: "HFS"
Meta Candidates (Total=12; Excluded=1; Pruned=0; Remaining=11)
   901   C0205212:High frequency [Temporal Concept]
   827   C0205250:High [Qualitative Concept]
   827   C0376249:frequency [Quantitative Concept]
   827   C0439603:Frequency [Temporal Concept]
   827   C0871396:Frequency [Quantitative Concept]
   827   C1292856:Stimulation [Therapeutic or Preventive Procedure]
   827   C1299351:High [Qualitative Concept]
   827   C1561548:Frequency [Qualitative Concept]
   827   C1705502:Frequency [Quantitative Concept]
   827   C1948023:Stimulation [Natural Phenomenon or Process]
   827   C2700149:HIGH [Intellectual Product]
   755 E C0332183:Frequent [Temporal Concept]

Phrase: "; Fig. 1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: ")."
Processing 00000000.tx.79: LTP of a similar magnitude was also produced following vehicle injection 5min prior to HFS (LTP measured 1h following HFS; 18815%; n=7; Fig. 2). 

Phrase: "LTP of a similar magnitude"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   814   C0206249:Long-Term Potentiation [Organ or Tissue Function]
   814   C2984294:Long-term potentiation [Functional Concept]
   778   C0443252:Long-term [Temporal Concept]
   748   C0205166:Long [Qualitative Concept]
   748   C0279023:Potentiation [Therapeutic or Preventive Procedure]
   748   C1515273:Term [Temporal Concept]
   748   C1705313:Term [Idea or Concept]
   748   C1706317:Long [Qualitative Concept]
   748   C2826302:TERM [Intellectual Product]

Phrase: "was"

Phrase: "also"

Phrase: "produced"

Phrase: "following"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332282:Following [Temporal Concept]
   966 E C0332283:follow [Temporal Concept]
   966 E C1719822:Follow [Intellectual Product]

Phrase: "vehicle injection 5min prior to HFS"

Phrase: "(LTP"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
  1000   C0206249:Long-Term Potentiation [Organ or Tissue Function]
  1000   C2984294:Long-term potentiation [Functional Concept]
   901   C0443252:Long-term [Temporal Concept]
   827   C0205166:Long [Qualitative Concept]
   827   C0279023:Potentiation [Therapeutic or Preventive Procedure]
   827   C1515273:Term [Temporal Concept]
   827   C1705313:Term [Idea or Concept]
   827   C1706317:Long [Qualitative Concept]
   827   C2826302:TERM [Intellectual Product]

Phrase: "measured"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0444706:Measured [Qualitative Concept]
  1000   C3541902:MEASURED [Diagnostic Procedure]
   966 E C0079809:Measure [Quantitative Concept]
   966 E C0242485:Measure [Functional Concept]

Phrase: "1h"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1442450:1H [Temporal Concept]

Phrase: "following"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332282:Following [Temporal Concept]
   966 E C0332283:follow [Temporal Concept]
   966 E C1719822:Follow [Intellectual Product]

Phrase: "HFS"
Meta Candidates (Total=12; Excluded=1; Pruned=0; Remaining=11)
   901   C0205212:High frequency [Temporal Concept]
   827   C0205250:High [Qualitative Concept]
   827   C0376249:frequency [Quantitative Concept]
   827   C0439603:Frequency [Temporal Concept]
   827   C0871396:Frequency [Quantitative Concept]
   827   C1292856:Stimulation [Therapeutic or Preventive Procedure]
   827   C1299351:High [Qualitative Concept]
   827   C1561548:Frequency [Qualitative Concept]
   827   C1705502:Frequency [Quantitative Concept]
   827   C1948023:Stimulation [Natural Phenomenon or Process]
   827   C2700149:HIGH [Intellectual Product]
   755 E C0332183:Frequent [Temporal Concept]

Phrase: "; 18815%"

Phrase: "; n=7"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441922:N+ [Intellectual Product]
   861   C1553036:[n] [Quantitative Concept]

Phrase: "; Fig. 2"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: ")."
Processing 00000000.tx.80: View larger version (14K): [in this window] [in a new window]  Fig. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(14K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Fig."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.81: 1. 

Phrase: "1."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]
Processing 00000000.tx.82: Effect of icv injection of 100nmol A[15-25] on normalized low-frequency synaptic transmission 1h prior to the induction of long-term potentiation (LTP). 

Phrase: "Effect of icv injection of 100nmol A[15-25"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   742   C1280500:Effect [Qualitative Concept]
   742   C2348382:Effect [Qualitative Concept]

Phrase: "]"

Phrase: "on normalized low-frequency synaptic transmission 1h"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   799   C1442450:1H [Temporal Concept]

Phrase: "prior to the induction"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205263:Induction [Functional Concept]
  1000   C0857127:induction [Therapeutic or Preventive Procedure]

Phrase: "of long-term potentiation"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
  1000   C0206249:Long-Term Potentiation [Organ or Tissue Function]
  1000   C2984294:Long-term potentiation [Functional Concept]
   901   C0443252:Long-term [Temporal Concept]
   827   C0205166:Long [Qualitative Concept]
   827   C0279023:Potentiation [Therapeutic or Preventive Procedure]
   827   C1515273:Term [Temporal Concept]
   827   C1705313:Term [Idea or Concept]
   827   C1706317:Long [Qualitative Concept]
   827   C2826302:TERM [Intellectual Product]

Phrase: "(LTP"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
  1000   C0206249:Long-Term Potentiation [Organ or Tissue Function]
  1000   C2984294:Long-term potentiation [Functional Concept]
   901   C0443252:Long-term [Temporal Concept]
   827   C0205166:Long [Qualitative Concept]
   827   C0279023:Potentiation [Therapeutic or Preventive Procedure]
   827   C1515273:Term [Temporal Concept]
   827   C1705313:Term [Idea or Concept]
   827   C1706317:Long [Qualitative Concept]
   827   C2826302:TERM [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.83: A[15-25] does not contain the neurotoxic sequence of A peptide. 

Phrase: "A[15-25"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   913   C0718136:A-25 [Organic Chemical,Pharmacologic Substance,Vitamin]

Phrase: "]"

Phrase: "does"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "contain"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:contain [Functional Concept]
  1000   C2700400:Contain [Activity]

Phrase: "the neurotoxic sequence of A peptide."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   783   C0920679:peptide sequence [Amino Acid Sequence]
   753   C0004793:Sequence [Nucleotide Sequence]
   753   C0162326:Sequence [Nucleotide Sequence]
   753   C0162327:Sequence [Nucleotide Sequence]
   753   C1519249:Sequence [Functional Concept]
Processing 00000000.tx.84: Averaged (n=3) field excitatory postsynaptic potentials (EPSPs) are shown 5-10 min pretetanus and 30min following tetanus for control (vehicle; 1,2) and A[15-25] (100nmol; 3,4) injected rats. 

Phrase: "Averaged"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C1510992:Average [Quantitative Concept]
   966   C2825518:AVERAGE [Quantitative Concept]

Phrase: "(n=3"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441922:N+ [Intellectual Product]
   861   C1553036:[n] [Quantitative Concept]

Phrase: ")"

Phrase: "field excitatory postsynaptic potentials (EPSPs)"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   923   C0524913:Excitatory Postsynaptic Potentials [Organ or Tissue Function]
   861   C2350339:Postsynaptic Potentials [Organ or Tissue Function]
   858   C0234121:Excitatory potential [Organ or Tissue Function]
   812   C0440042:Field's [Indicator, Reagent, or Diagnostic Aid]
   812   C1521738:Field [Conceptual Entity]
   812   C2346620:Field [Conceptual Entity]
   812   C2349184:Field [Conceptual Entity]
   812   C3245505:potentials [Qualitative Concept]
   812   C3539073:FIELD [Spatial Concept]

Phrase: "are"

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "5-10 min"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   901   C0456692:/10 min [Temporal Concept]
   827   C0702093:/min [Temporal Concept]

Phrase: "pretetanus"

Phrase: "and"

Phrase: "30min"

Phrase: "following"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332282:Following [Temporal Concept]
   966 E C0332283:follow [Temporal Concept]
   966 E C1719822:Follow [Intellectual Product]

Phrase: "tetanus for control"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0039614:Tetanus [Disease or Syndrome]

Phrase: "(vehicle"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0042444:Vehicle [Biomedical or Dental Material]
  1000   C0348005:Vehicle [Manufactured Object]
   928 E C0445373:Vehicular [Functional Concept]

Phrase: "; 1,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: "2"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]

Phrase: ")"

Phrase: "and"

Phrase: "A[15-25"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   913   C0718136:A-25 [Organic Chemical,Pharmacologic Substance,Vitamin]

Phrase: "]"

Phrase: "(100nmol"

Phrase: "; 3,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]

Phrase: "4"

Phrase: ")"

Phrase: "injected rats."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0034693:rats [Mammal]
   861   C0034721:Rats [Mammal]
Processing 00000000.tx.85: Calibration bars: 1mV; 

Phrase: "Calibration bars"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C1707156:BARS [Gene or Genome]
   861   C3274014:BARS [Intellectual Product]
   861   C3541345:BARS [Intellectual Product]

Phrase: ":"

Phrase: "1mV"

Phrase: ";"
Processing 00000000.tx.86: 5ms. 

Phrase: "5ms."
Processing 00000000.tx.87: Injection of A[15-25] (100nmol; ) does not affect low-frequency (0.033Hz) synaptic transmission compared with control () monitored for 1h following injection. 

Phrase: "Injection of A[15-25"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0021485:injection [Therapeutic or Preventive Procedure]
   760   C1272883:Injection [Biomedical or Dental Material]
   760   C1533685:Injection [Therapeutic or Preventive Procedure]
   760   C1828121:Injection [Functional Concept]

Phrase: "]"

Phrase: "(100nmol"

Phrase: ";"

Phrase: ")"

Phrase: "does"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "affect"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0001721:Affect [Mental Process]

Phrase: "low-frequency"
Meta Candidates (Total=10; Excluded=1; Pruned=0; Remaining=9)
  1000   C0205213:Low frequency [Temporal Concept]
   861   C0205251:low [Qualitative Concept]
   861   C0376249:frequency [Quantitative Concept]
   861   C0439603:Frequency [Temporal Concept]
   861   C0871396:Frequency [Quantitative Concept]
   861   C1299352:Low [Qualitative Concept]
   861   C1550472:low [Idea or Concept]
   861   C1561548:Frequency [Qualitative Concept]
   861   C1705502:Frequency [Quantitative Concept]
   789 E C0332183:Frequent [Temporal Concept]

Phrase: "(0.033Hz"

Phrase: ")"

Phrase: "synaptic transmission"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0027793:Synaptic Transmission [Cell Function]
   861   C0040722:transmission [Idea or Concept]
   861   C0242781:Transmission [Pathologic Function]
   861   C1521797:Transmission [Natural Phenomenon or Process]

Phrase: "compared with control"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   790   C0243148:control [Qualitative Concept]
   790   C1550141:Control [Substance]
   790   C1707455:Compared [Activity]
   790   C1882979:Control [Conceptual Entity]
   790   C2587213:Control [Functional Concept]
   790   C3274648:Control [Qualitative Concept]

Phrase: "("

Phrase: ")"

Phrase: "monitored for 1h"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   790   C1442450:1H [Temporal Concept]
   756   C0030695:monitor [Health Care Activity]
   756   C0150369:monitor [Health Care Activity]
   756   C0181904:Monitor [Medical Device]
   756   C0596972:Monitor [Medical Device]
   756   C1521743:Monitor [Professional or Occupational Group]
   756   C1704646:Monitor [Manufactured Object]

Phrase: "following"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332282:Following [Temporal Concept]
   966 E C0332283:follow [Temporal Concept]
   966 E C1719822:Follow [Intellectual Product]

Phrase: "injection."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0021485:injection [Therapeutic or Preventive Procedure]
  1000   C1272883:Injection [Biomedical or Dental Material]
  1000   C1533685:Injection [Therapeutic or Preventive Procedure]
  1000   C1828121:Injection [Functional Concept]
Processing 00000000.tx.88: LTP was measured 30min following a 200-Hz tetanus with an increase in the EPSP slope of 19117% (n=7) for control (vehicle) and 1776% (n=6) for A[15-25] (100nmol). 

Phrase: "LTP"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
  1000   C0206249:Long-Term Potentiation [Organ or Tissue Function]
  1000   C2984294:Long-term potentiation [Functional Concept]
   901   C0443252:Long-term [Temporal Concept]
   827   C0205166:Long [Qualitative Concept]
   827   C0279023:Potentiation [Therapeutic or Preventive Procedure]
   827   C1515273:Term [Temporal Concept]
   827   C1705313:Term [Idea or Concept]
   827   C1706317:Long [Qualitative Concept]
   827   C2826302:TERM [Intellectual Product]

Phrase: "was"

Phrase: "measured"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0444706:Measured [Qualitative Concept]
  1000   C3541902:MEASURED [Diagnostic Procedure]
   966 E C0079809:Measure [Quantitative Concept]
   966 E C0242485:Measure [Functional Concept]

Phrase: "30min"

Phrase: "following"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332282:Following [Temporal Concept]
   966 E C0332283:follow [Temporal Concept]
   966 E C1719822:Follow [Intellectual Product]

Phrase: "a 200-Hz tetanus with an increase"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0039614:Tetanus [Disease or Syndrome]

Phrase: "in the EPSP slope"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   812   C0807955:Slope [Quantitative Concept]
   756   C0524913:Potential, Excitatory Postsynaptic [Organ or Tissue Function]
   708   C0234121:Excitatory potential [Organ or Tissue Function]

Phrase: "of 19117%"

Phrase: "(n=7"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441922:N+ [Intellectual Product]
   861   C1553036:[n] [Quantitative Concept]

Phrase: ")"

Phrase: "for control"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0243148:control [Qualitative Concept]
  1000   C1550141:Control [Substance]
  1000   C1882979:Control [Conceptual Entity]
  1000   C2587213:Control [Functional Concept]
  1000   C3274648:Control [Qualitative Concept]

Phrase: "(vehicle"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0042444:Vehicle [Biomedical or Dental Material]
  1000   C0348005:Vehicle [Manufactured Object]
   928 E C0445373:Vehicular [Functional Concept]

Phrase: ")"

Phrase: "and"

Phrase: "1776%"

Phrase: "(n=6"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441922:N+ [Intellectual Product]
   861   C1553036:[n] [Quantitative Concept]

Phrase: ")"

Phrase: "for A[15-25"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   913   C0718136:A-25 [Organic Chemical,Pharmacologic Substance,Vitamin]

Phrase: "]"

Phrase: "(100nmol"

Phrase: ")."
Processing 00000000.tx.89: View larger version (21K): [in this window] [in a new window]  Fig. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(21K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Fig."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.90: 2. 

Phrase: "2."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]
Processing 00000000.tx.91: Effect of A[25-35] at 10and 100nmol, injected icv 5min prior to tetanic stimulation. 

Phrase: "Effect of A[25-35"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C1280500:Effect [Qualitative Concept]
   760   C2348382:Effect [Qualitative Concept]

Phrase: "]"

Phrase: "at 10and 100nmol,"

Phrase: "injected"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1720154:Inject [Functional Concept]

Phrase: "icv 5min prior to tetanic stimulation."
Processing 00000000.tx.92: Injection (icv) of 10nmol A[25-35] () had no effect on LTP (17630%, n=4) compared with control (; 18815%, n=7). 

Phrase: "Injection"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0021485:injection [Therapeutic or Preventive Procedure]
  1000   C1272883:Injection [Biomedical or Dental Material]
  1000   C1533685:Injection [Therapeutic or Preventive Procedure]
  1000   C1828121:Injection [Functional Concept]

Phrase: "(icv"

Phrase: ")"

Phrase: "of 10nmol A[25-35"

Phrase: "]"

Phrase: "("

Phrase: ")"

Phrase: "had"

Phrase: "no effect on LTP"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   820   C0023983:Long-Term Effect [Phenomenon or Process]
   790   C1301751:No effect [Qualitative Concept]
   753   C1280500:Effect [Qualitative Concept]
   753   C2348382:Effect [Qualitative Concept]

Phrase: "(17630%,"

Phrase: "n=4"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441922:N+ [Intellectual Product]
   861   C1553036:[n] [Quantitative Concept]

Phrase: ")"

Phrase: "compared with control"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   790   C0243148:control [Qualitative Concept]
   790   C1550141:Control [Substance]
   790   C1707455:Compared [Activity]
   790   C1882979:Control [Conceptual Entity]
   790   C2587213:Control [Functional Concept]
   790   C3274648:Control [Qualitative Concept]

Phrase: "("

Phrase: "; 18815%,"

Phrase: "n=7"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441922:N+ [Intellectual Product]
   861   C1553036:[n] [Quantitative Concept]

Phrase: ")."
Processing 00000000.tx.93: Following injection of 100nmol A[25-35] (), tetanic stimulation produced only short-term potentiation (STP; 10815%, n=6,P<0.01). 

Phrase: "Following"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332282:Following [Temporal Concept]
   966 E C0332283:follow [Temporal Concept]
   966 E C1719822:Follow [Intellectual Product]

Phrase: "injection of 100nmol A[25-35"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   753   C0021485:injection [Therapeutic or Preventive Procedure]
   753   C1272883:Injection [Biomedical or Dental Material]
   753   C1533685:Injection [Therapeutic or Preventive Procedure]
   753   C1828121:Injection [Functional Concept]

Phrase: "]"

Phrase: "("

Phrase: ")"

Phrase: ","

Phrase: "tetanic stimulation"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C1292856:Stimulation [Therapeutic or Preventive Procedure]
   861   C1948023:Stimulation [Natural Phenomenon or Process]
   789   C0039621:Tetanies [Disease or Syndrome]

Phrase: "produced"

Phrase: "only short-term potentiation"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   861   C0443303:Short-term [Temporal Concept]
   812   C0279023:Potentiation [Therapeutic or Preventive Procedure]
   812   C1282927:short [Qualitative Concept]
   812   C1515273:Term [Temporal Concept]
   812   C1705313:Term [Idea or Concept]
   812   C1806781:Short [Quantitative Concept]
   812   C2350002:Short [Quantitative Concept]
   812   C2826302:TERM [Intellectual Product]

Phrase: "(STP"

Phrase: "; 10815%,"

Phrase: "n=6,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441922:N+ [Intellectual Product]
   861   C1553036:[n] [Quantitative Concept]

Phrase: "P<0.01"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: ")."
Processing 00000000.tx.94: Averaged EPSPs (n=3) are shown recorded 5min pretetanus (1,3,5) and 1h posttetanus (2,4,6). 

Phrase: "Averaged EPSPs"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   923   C0524913:Excitatory Postsynaptic Potentials [Organ or Tissue Function]
   861   C2350339:Postsynaptic Potentials [Organ or Tissue Function]
   858   C0234121:Excitatory potential [Organ or Tissue Function]
   812   C3245505:potentials [Qualitative Concept]

Phrase: "(n=3"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441922:N+ [Intellectual Product]
   861   C1553036:[n] [Quantitative Concept]

Phrase: ")"

Phrase: "are"

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "recorded"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0034869:Record [Intellectual Product]

Phrase: "5min"

Phrase: "pretetanus"

Phrase: "(1,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: "3,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]

Phrase: "5"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439084:>5 [Quantitative Concept]
  1000   C0728893:+5 [Quantitative Concept]

Phrase: ")"

Phrase: "and"

Phrase: "1h"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1442450:1H [Temporal Concept]

Phrase: "posttetanus"

Phrase: "(2,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]

Phrase: "4,"

Phrase: "6"

Phrase: ")."
Processing 00000000.tx.95: Calibration bars: 1mV; 

Phrase: "Calibration bars"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C1707156:BARS [Gene or Genome]
   861   C3274014:BARS [Intellectual Product]
   861   C3541345:BARS [Intellectual Product]

Phrase: ":"

Phrase: "1mV"

Phrase: ";"
Processing 00000000.tx.96: 5ms. 

Phrase: "5ms."
Processing 00000000.tx.97: The effects of A[15-25], A[25-35], and the reverse peptide A[35-25] were examined. 

Phrase: "The effects of A[15-25"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   753   C1280500:effects [Qualitative Concept]
   719 E C2348382:Effect [Qualitative Concept]

Phrase: "],"

Phrase: "A[25-35"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   901   C0718136:A-25 [Organic Chemical,Pharmacologic Substance,Vitamin]

Phrase: "],"

Phrase: "and"

Phrase: "the reverse peptide A[35-25"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   804   C0030956:Peptide [Amino Acid, Peptide, or Protein]
   804   C1555029:Reverse [Idea or Concept]

Phrase: "]"

Phrase: "were"

Phrase: "examined."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332128:Examined [Finding]
Processing 00000000.tx.98: Baseline synaptic transmission was monitored for periods of up to 1h following icv injection of A-peptides. 

Phrase: "Baseline synaptic transmission"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   901   C0027793:Synaptic Transmission [Cell Function]
   827   C0040722:transmission [Idea or Concept]
   827   C0242781:Transmission [Pathologic Function]
   827   C1521797:Transmission [Natural Phenomenon or Process]

Phrase: "was"

Phrase: "monitored for periods of"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   737   C0030695:monitor [Health Care Activity]
   737   C0150369:monitor [Health Care Activity]
   737   C0181904:Monitor [Medical Device]
   737   C0439531:/period [Temporal Concept]
   737   C0596972:Monitor [Medical Device]
   737   C1521743:Monitor [Professional or Occupational Group]
   737   C1704646:Monitor [Manufactured Object]
   737   C1948053:Period [Temporal Concept]

Phrase: "up to 1h"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1442450:1H [Temporal Concept]

Phrase: "following"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332282:Following [Temporal Concept]
   966 E C0332283:follow [Temporal Concept]
   966 E C1719822:Follow [Intellectual Product]

Phrase: "icv injection of A-peptides."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0021485:injection [Therapeutic or Preventive Procedure]
   760   C1272883:Injection [Biomedical or Dental Material]
   760   C1533685:Injection [Therapeutic or Preventive Procedure]
   760   C1828121:Injection [Functional Concept]
Processing 00000000.tx.99: There was found to be no significant effect on baseline EPSPs evoked at low frequency (0.033Hz, Figs. 1, 3, and 4) or on PPF (Table 1).  

Phrase: "There"

Phrase: "was"

Phrase: "found"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0150312:Found [Quantitative Concept]
   966 E C0243095:Find [Finding]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be"

Phrase: "no significant effect on baseline EPSPs"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   767   C1301751:No effect [Qualitative Concept]
   744   C1280500:Effect [Qualitative Concept]
   744   C2348382:Effect [Qualitative Concept]

Phrase: "evoked at low frequency"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   833   C0205213:Low frequency [Temporal Concept]
   770   C0205251:low [Qualitative Concept]
   770   C0376249:frequency [Quantitative Concept]
   770   C0439603:Frequency [Temporal Concept]
   770   C0871396:Frequency [Quantitative Concept]
   770   C1299352:Low [Qualitative Concept]
   770   C1444748:Evoked [Qualitative Concept]
   770   C1550472:low [Idea or Concept]
   770   C1561548:Frequency [Qualitative Concept]
   770   C1705502:Frequency [Quantitative Concept]

Phrase: "(0.033Hz,"

Phrase: "Figs. 1,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0349966:Figs [Food]
   827 E C1337208:FIG [Food]

Phrase: "3,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]

Phrase: "and"

Phrase: "4"

Phrase: ")"

Phrase: "or on PPF (Table 1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0039224:Table [Manufactured Object]
   760   C1706073:Table [Medical Device]
   760   C1706074:Table [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.100: View this table: [in this window] [in a new window]  Table 1. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "this table"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0039224:Table [Manufactured Object]
  1000   C1706073:Table [Medical Device]
  1000   C1706074:Table [Intellectual Product]

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Table 1."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0039224:Table [Manufactured Object]
   861   C1706073:Table [Medical Device]
   861   C1706074:Table [Intellectual Product]
Processing 00000000.tx.101: PPF recorded before and following A/vehicle injection for each of the peptide fragments Injection of A[15-25], 1h before the application of HFS had no significant effect on LTP (1776%, n=6) compared with the control group (19117%, n=6; Fig. 1). 

Phrase: "PPF"

Phrase: "recorded"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0034869:Record [Intellectual Product]

Phrase: "before"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332152:Before [Temporal Concept]
  1000   C1705850:Before [Intellectual Product]

Phrase: "and"

Phrase: "following"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332282:Following [Temporal Concept]
   966 E C0332283:follow [Temporal Concept]
   966 E C1719822:Follow [Intellectual Product]

Phrase: "A/vehicle injection for each of the peptide fragments Injection"

Phrase: "of A[15-25"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   913   C0718136:A-25 [Organic Chemical,Pharmacologic Substance,Vitamin]

Phrase: "],"

Phrase: "1h before the application of HFS"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C1442450:1H [Temporal Concept]

Phrase: "had"

Phrase: "no significant effect on LTP"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   804   C0023983:Long-Term Effect [Phenomenon or Process]
   774   C1301751:No effect [Qualitative Concept]
   748   C1280500:Effect [Qualitative Concept]
   748   C2348382:Effect [Qualitative Concept]

Phrase: "(1776%,"

Phrase: "n=6"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441922:N+ [Intellectual Product]
   861   C1553036:[n] [Quantitative Concept]

Phrase: ")"

Phrase: "compared with the control group"
Meta Candidates (Total=13; Excluded=0; Pruned=0; Remaining=13)
   806   C0009932:Control Group [Group]
   760   C0243148:control [Qualitative Concept]
   760   C0441833:Group [Idea or Concept]
   760   C0687744:group [Population Group]
   760   C1257890:Group [Population Group]
   760   C1550141:Control [Substance]
   760   C1552516:Group [Health Care Related Organization]
   760   C1705428:Group [Conceptual Entity]
   760   C1705429:Group [Population Group]
   760   C1707455:Compared [Activity]
   760   C1882979:Control [Conceptual Entity]
   760   C2587213:Control [Functional Concept]
   760   C3274648:Control [Qualitative Concept]

Phrase: "(19117%,"

Phrase: "n=6"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441922:N+ [Intellectual Product]
   861   C1553036:[n] [Quantitative Concept]

Phrase: "; Fig. 1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: ")."
Processing 00000000.tx.102: A[15-25] does not incorporate the trans-membrane, neurotoxic sequence of A and was a good indication that injection of peptide was not causing a nonspecific effect on synaptic transmission and plasticity. 

Phrase: "A[15-25"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   913   C0718136:A-25 [Organic Chemical,Pharmacologic Substance,Vitamin]

Phrase: "]"

Phrase: "does"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "incorporate"

Phrase: "the trans-membrane, neurotoxic sequence of A"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   748   C0004793:Sequence [Nucleotide Sequence]
   748   C0162326:Sequence [Nucleotide Sequence]
   748   C0162327:Sequence [Nucleotide Sequence]
   748   C1519249:Sequence [Functional Concept]

Phrase: "and"

Phrase: "was"

Phrase: "a good indication"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0392360:indication [Idea or Concept]
   861   C3146298:Indication [Functional Concept]

Phrase: "that injection of peptide"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0021485:injection [Therapeutic or Preventive Procedure]
   770   C1272883:Injection [Biomedical or Dental Material]
   770   C1533685:Injection [Therapeutic or Preventive Procedure]
   770   C1828121:Injection [Functional Concept]

Phrase: "was"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "causing"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0678227:Causing [Functional Concept]
   966 E C0015127:cause [Functional Concept]
   966 E C1524003:Cause [Conceptual Entity]

Phrase: "a nonspecific effect on synaptic transmission"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C1280500:Effect [Qualitative Concept]
   753   C2348382:Effect [Qualitative Concept]

Phrase: "and"

Phrase: "plasticity."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0678558:Plasticity [Natural Phenomenon or Process]
   928 E C0032167:Plastic [Substance]
Processing 00000000.tx.103: Injection of the active neurotoxic portion of A, namely A[25-35] (Yankner et al. 1990), however, was found to significantly impair LTP in a time- and concentration-dependent manner. 

Phrase: "Injection of the active neurotoxic portion of A,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   744   C0021485:injection [Therapeutic or Preventive Procedure]
   744   C1272883:Injection [Biomedical or Dental Material]
   744   C1533685:Injection [Therapeutic or Preventive Procedure]
   744   C1828121:Injection [Functional Concept]

Phrase: "namely A[25-35"

Phrase: "]"

Phrase: "(Yankner et al. 1990"

Phrase: ")"

Phrase: ","

Phrase: "however,"

Phrase: "was"

Phrase: "found"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0150312:Found [Quantitative Concept]
   966 E C0243095:Find [Finding]

Phrase: "to significantly"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1883351:To [Qualitative Concept]

Phrase: "impair"

Phrase: "LTP in a time-"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   833   C0206249:Long-Term Potentiation [Organ or Tissue Function]
   833   C2984294:Long-term potentiation [Functional Concept]
   790   C0443252:Long-term [Temporal Concept]
   756   C1515273:Term (temporal) [Temporal Concept]
           Term
   753   C0205166:Long [Qualitative Concept]
   753   C0279023:Potentiation [Therapeutic or Preventive Procedure]
   753   C1705313:Term [Idea or Concept]
   753   C1706317:Long [Qualitative Concept]
   753   C2826302:TERM [Intellectual Product]

Phrase: "and"

Phrase: "concentration-dependent manner."
Processing 00000000.tx.104: When 10nmol A[25-35] was injected 5min prior to HFS, there was no effect on LTP (17630%, n=4) compared with control (18815%; n=7), while 100nmol was found to reduce significantly LTP (10815%, n=6,P<0.001; Fig. 2). 

Phrase: "When"

Phrase: "10nmol A[25-35"

Phrase: "]"

Phrase: "was"

Phrase: "injected"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1720154:Inject [Functional Concept]

Phrase: "5min prior to HFS,"

Phrase: "there"

Phrase: "was"

Phrase: "no effect on LTP"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   820   C0023983:Long-Term Effect [Phenomenon or Process]
   790   C1301751:No effect [Qualitative Concept]
   753   C1280500:Effect [Qualitative Concept]
   753   C2348382:Effect [Qualitative Concept]

Phrase: "(17630%,"

Phrase: "n=4"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441922:N+ [Intellectual Product]
   861   C1553036:[n] [Quantitative Concept]

Phrase: ")"

Phrase: "compared with control"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   790   C0243148:control [Qualitative Concept]
   790   C1550141:Control [Substance]
   790   C1707455:Compared [Activity]
   790   C1882979:Control [Conceptual Entity]
   790   C2587213:Control [Functional Concept]
   790   C3274648:Control [Qualitative Concept]

Phrase: "(18815%"

Phrase: "; n=7"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441922:N+ [Intellectual Product]
   861   C1553036:[n] [Quantitative Concept]

Phrase: ")"

Phrase: ","

Phrase: "while"

Phrase: "100nmol"

Phrase: "was"

Phrase: "found"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0150312:Found [Quantitative Concept]
   966 E C0243095:Find [Finding]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "reduce"

Phrase: "significantly LTP"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   923   C0206249:Long-Term Potentiation [Organ or Tissue Function]
   923   C2984294:Long-term potentiation [Functional Concept]
   861   C0443252:Long-term [Temporal Concept]
   812   C0205166:Long [Qualitative Concept]
   812   C0279023:Potentiation [Therapeutic or Preventive Procedure]
   812   C1515273:Term [Temporal Concept]
   812   C1705313:Term [Idea or Concept]
   812   C1706317:Long [Qualitative Concept]
   812   C2826302:TERM [Intellectual Product]

Phrase: "(10815%,"

Phrase: "n=6,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441922:N+ [Intellectual Product]
   861   C1553036:[n] [Quantitative Concept]

Phrase: "P<0.001"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: "; Fig. 2"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: ")."
Processing 00000000.tx.105: To examine the effect of prolonging the application of A[25-35], icv injections were performed 1h prior to the induction of LTP. 

Phrase: "To"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "examine"

Phrase: "the effect of prolonging"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C1280500:Effect [Qualitative Concept]
   770   C2348382:Effect [Qualitative Concept]

Phrase: "the application of A[25-35"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   753   C0185125:Application [Health Care Activity]
   753   C1947919:Application [Intellectual Product]
   753   C2347934:Application [Intellectual Product]
   753   C3539080:APPLICATION [Quantitative Concept]

Phrase: "],"

Phrase: "icv injections"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   861   C0021485:injections [Therapeutic or Preventive Procedure]
   861   C1533685:INJECTIONS [Therapeutic or Preventive Procedure]
   861   C1828121:Injections [Functional Concept]
   827 E C1272883:Injection [Biomedical or Dental Material]

Phrase: "were"

Phrase: "performed"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0884358:Performed [Functional Concept]
   966 E C2947996:Perform [Pharmacologic Substance]

Phrase: "1h prior to the induction of LTP."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   742   C1442450:1H [Temporal Concept]
Processing 00000000.tx.106: Under these conditions, the lower 10nmol concentration of A[25-35] was now found to reduce significantly LTP (1299%, n=6,P<0.01) when compared with the control group (19117%; n=6), while 100nmol blocked LTP (996%, n=6,P<0.001; Fig. 3). 

Phrase: "Under these conditions,"
Meta Candidates (Total=7; Excluded=4; Pruned=0; Remaining=3)
   966   C0012634:condition [Disease or Syndrome]
   966   C0348080:Condition [Qualitative Concept]
   966   C1705253:Condition [Conceptual Entity]
   916 E C0009647:Conditioned [Mental Process]
   916 E C1701901:Conditional [Qualitative Concept]
   916 E C1963686:Conditional [Functional Concept]
   893 E C1519605:Conditionality [Conceptual Entity]

Phrase: "the lower 10nmol concentration of A[25-35"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C0086045:Concentration [Mental Process]
   744   C1446561:Concentration [Quantitative Concept]

Phrase: "]"

Phrase: "was"

Phrase: "now"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1948052:Now [Temporal Concept]

Phrase: "found"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0150312:Found [Quantitative Concept]
   966 E C0243095:Find [Finding]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "reduce"

Phrase: "significantly LTP"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   923   C0206249:Long-Term Potentiation [Organ or Tissue Function]
   923   C2984294:Long-term potentiation [Functional Concept]
   861   C0443252:Long-term [Temporal Concept]
   812   C0205166:Long [Qualitative Concept]
   812   C0279023:Potentiation [Therapeutic or Preventive Procedure]
   812   C1515273:Term [Temporal Concept]
   812   C1705313:Term [Idea or Concept]
   812   C1706317:Long [Qualitative Concept]
   812   C2826302:TERM [Intellectual Product]

Phrase: "(1299%,"

Phrase: "n=6,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441922:N+ [Intellectual Product]
   861   C1553036:[n] [Quantitative Concept]

Phrase: "P<0.01"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: ")"

Phrase: "when"

Phrase: "compared with the control group"
Meta Candidates (Total=13; Excluded=0; Pruned=0; Remaining=13)
   806   C0009932:Control Group [Group]
   760   C0243148:control [Qualitative Concept]
   760   C0441833:Group [Idea or Concept]
   760   C0687744:group [Population Group]
   760   C1257890:Group [Population Group]
   760   C1550141:Control [Substance]
   760   C1552516:Group [Health Care Related Organization]
   760   C1705428:Group [Conceptual Entity]
   760   C1705429:Group [Population Group]
   760   C1707455:Compared [Activity]
   760   C1882979:Control [Conceptual Entity]
   760   C2587213:Control [Functional Concept]
   760   C3274648:Control [Qualitative Concept]

Phrase: "(19117%"

Phrase: "; n=6"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441922:N+ [Intellectual Product]
   861   C1553036:[n] [Quantitative Concept]

Phrase: ")"

Phrase: ","

Phrase: "while"

Phrase: "100nmol"

Phrase: "blocked"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0028778:Blocked [Pathologic Function]
  1000   C0332206:Blocked [Functional Concept]
  1000   C2983591:BLOCKED [Research Activity]
   966 E C1533157:Block [Substance]
   966 E C1706084:Block [Geographic Area]
   966 E C2828370:Block [Quantitative Concept]

Phrase: "LTP"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
  1000   C0206249:Long-Term Potentiation [Organ or Tissue Function]
  1000   C2984294:Long-term potentiation [Functional Concept]
   901   C0443252:Long-term [Temporal Concept]
   827   C0205166:Long [Qualitative Concept]
   827   C0279023:Potentiation [Therapeutic or Preventive Procedure]
   827   C1515273:Term [Temporal Concept]
   827   C1705313:Term [Idea or Concept]
   827   C1706317:Long [Qualitative Concept]
   827   C2826302:TERM [Intellectual Product]

Phrase: "(996%,"

Phrase: "n=6,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441922:N+ [Intellectual Product]
   861   C1553036:[n] [Quantitative Concept]

Phrase: "P<0.001"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: "; Fig. 3"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: ")."
Processing 00000000.tx.107: This indicates that even short-term exposure to a dose of 100nmol/5 L of A[25-35] can impair LTP, although baseline synaptic transmission remains unaffected. 

Phrase: "This"

Phrase: "indicates"

Phrase: "that even short-term exposure to a dose of 100nmol/5 L"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   753   C0332157:Exposure to [Clinical Attribute]
           Exposure
   751   C2826651:Exposure Dose [Quantitative Concept]
   736   C0274281:Exposure, NOS [Injury or Poisoning]

Phrase: "of A[25-35"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   901   C0718136:A-25 [Organic Chemical,Pharmacologic Substance,Vitamin]

Phrase: "]"

Phrase: "can"

Phrase: "impair"

Phrase: "LTP,"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
  1000   C0206249:Long-Term Potentiation [Organ or Tissue Function]
  1000   C2984294:Long-term potentiation [Functional Concept]
   901   C0443252:Long-term [Temporal Concept]
   827   C0205166:Long [Qualitative Concept]
   827   C0279023:Potentiation [Therapeutic or Preventive Procedure]
   827   C1515273:Term [Temporal Concept]
   827   C1705313:Term [Idea or Concept]
   827   C1706317:Long [Qualitative Concept]
   827   C2826302:TERM [Intellectual Product]

Phrase: "although"

Phrase: "baseline synaptic transmission remains"

Phrase: "unaffected."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2986417:Unaffected [Conceptual Entity]
Processing 00000000.tx.108: View larger version (17K): [in this window] [in a new window]  Fig. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(17K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Fig."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.109: 3. 

Phrase: "3."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]
Processing 00000000.tx.110: A: effects of the neurotoxic fragment A[25-35] injected at 10and 100nmol, 1h before the application of tetanic stimulation. 

Phrase: "A"

Phrase: ":"

Phrase: "effects of the neurotoxic"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   802   C0235032:Neurotoxic effect [Injury or Poisoning]
   770   C1280500:effects [Qualitative Concept]
   737 E C2348382:Effect [Qualitative Concept]

Phrase: "fragment"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332255:fragment [Functional Concept]
  1000   C1708096:Fragment [Qualitative Concept]

Phrase: "A[25-35"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   901   C0718136:A-25 [Organic Chemical,Pharmacologic Substance,Vitamin]

Phrase: "]"

Phrase: "injected at 10and 100nmol,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   737   C1720154:Inject [Functional Concept]

Phrase: "1h before the application of tetanic stimulation."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C1442450:1H [Temporal Concept]
Processing 00000000.tx.111: A[25-35] at either 10or 100nmol did not affect low-frequency baseline synaptic transmission. 

Phrase: "A[25-35"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   901   C0718136:A-25 [Organic Chemical,Pharmacologic Substance,Vitamin]

Phrase: "]"

Phrase: "at either 10or 100nmol"

Phrase: "did"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "affect"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0001721:Affect [Mental Process]

Phrase: "low-frequency baseline synaptic transmission."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   840   C0027793:Synaptic Transmission [Cell Function]
   804   C0040722:transmission [Idea or Concept]
   804   C0242781:Transmission [Pathologic Function]
   804   C1521797:Transmission [Natural Phenomenon or Process]
Processing 00000000.tx.112: LTP was significantly reduced by 10nmol A[25-35] (; 1299%, n=6,P<0.001) compared with control (vehicle) injected rats ; 18815%, n=7) and blocked by 100nmol [25-35] (; 10815%, n=6,P<0.001). 

Phrase: "LTP"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
  1000   C0206249:Long-Term Potentiation [Organ or Tissue Function]
  1000   C2984294:Long-term potentiation [Functional Concept]
   901   C0443252:Long-term [Temporal Concept]
   827   C0205166:Long [Qualitative Concept]
   827   C0279023:Potentiation [Therapeutic or Preventive Procedure]
   827   C1515273:Term [Temporal Concept]
   827   C1705313:Term [Idea or Concept]
   827   C1706317:Long [Qualitative Concept]
   827   C2826302:TERM [Intellectual Product]

Phrase: "was"

Phrase: "significantly"

Phrase: "reduced by 10nmol A[25-35"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0392756:Reduced [Qualitative Concept]

Phrase: "]"

Phrase: "("

Phrase: "; 1299%,"

Phrase: "n=6,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441922:N+ [Intellectual Product]
   861   C1553036:[n] [Quantitative Concept]

Phrase: "P<0.001"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: ")"

Phrase: "compared with control"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   790   C0243148:control [Qualitative Concept]
   790   C1550141:Control [Substance]
   790   C1707455:Compared [Activity]
   790   C1882979:Control [Conceptual Entity]
   790   C2587213:Control [Functional Concept]
   790   C3274648:Control [Qualitative Concept]

Phrase: "(vehicle"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0042444:Vehicle [Biomedical or Dental Material]
  1000   C0348005:Vehicle [Manufactured Object]
   928 E C0445373:Vehicular [Functional Concept]

Phrase: ")"

Phrase: "injected rats"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0034693:rats [Mammal]
   861   C0034721:Rats [Mammal]

Phrase: "; 18815%,"

Phrase: "n=7"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441922:N+ [Intellectual Product]
   861   C1553036:[n] [Quantitative Concept]

Phrase: ")"

Phrase: "and"

Phrase: "blocked by 100nmol"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   790   C0028778:Blocked [Pathologic Function]
   790   C0332206:Blocked [Functional Concept]
   790   C2983591:BLOCKED [Research Activity]
   756 E C1533157:Block [Substance]
   756 E C1706084:Block [Geographic Area]
   756 E C2828370:Block [Quantitative Concept]

Phrase: "[25-35"

Phrase: "]"

Phrase: "("

Phrase: "; 10815%,"

Phrase: "n=6,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441922:N+ [Intellectual Product]
   861   C1553036:[n] [Quantitative Concept]

Phrase: "P<0.001"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: ")."
Processing 00000000.tx.113: EPSPs (averaged, n=3) recorded 5-10 min pretetanus and 30min posttetanus are shown for control (vehicle; 1,2); 

Phrase: "EPSPs"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0524913:Excitatory Postsynaptic Potentials [Organ or Tissue Function]
   901   C2350339:Postsynaptic Potentials [Organ or Tissue Function]
   896   C0234121:Excitatory potential [Organ or Tissue Function]
   827   C3245505:potentials [Qualitative Concept]

Phrase: "("

Phrase: "averaged"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C1510992:Average [Quantitative Concept]
   966   C2825518:AVERAGE [Quantitative Concept]

Phrase: ","

Phrase: "n=3"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441922:N+ [Intellectual Product]
   861   C1553036:[n] [Quantitative Concept]

Phrase: ")"

Phrase: "recorded"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0034869:Record [Intellectual Product]

Phrase: "5-10 min"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   901   C0456692:/10 min [Temporal Concept]
   827   C0702093:/min [Temporal Concept]

Phrase: "pretetanus"

Phrase: "and"

Phrase: "30min"

Phrase: "posttetanus"

Phrase: "are"

Phrase: "shown for control"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   790   C0243148:control [Qualitative Concept]
   790   C1550141:Control [Substance]
   790   C1882979:Control [Conceptual Entity]
   790   C2587213:Control [Functional Concept]
   790   C3274648:Control [Qualitative Concept]
   756   C1547282:Show [Intellectual Product]

Phrase: "(vehicle"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0042444:Vehicle [Biomedical or Dental Material]
  1000   C0348005:Vehicle [Manufactured Object]
   928 E C0445373:Vehicular [Functional Concept]

Phrase: "; 1,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: "2"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]

Phrase: ")"

Phrase: ";"
Processing 00000000.tx.114: 10nmol [25-35] (3,4) and 100nmol [25-35] (5,6). 

Phrase: "10nmol"

Phrase: "[25-35"

Phrase: "]"

Phrase: "(3,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]

Phrase: "4"

Phrase: ")"

Phrase: "and"

Phrase: "100nmol"

Phrase: "[25-35"

Phrase: "]"

Phrase: "(5,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439084:>5 [Quantitative Concept]
  1000   C0728893:+5 [Quantitative Concept]

Phrase: "6"

Phrase: ")."
Processing 00000000.tx.115: Calibration bars: 1mV; 

Phrase: "Calibration bars"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C1707156:BARS [Gene or Genome]
   861   C3274014:BARS [Intellectual Product]
   861   C3541345:BARS [Intellectual Product]

Phrase: ":"

Phrase: "1mV"

Phrase: ";"
Processing 00000000.tx.116: 5ms. 

Phrase: "5ms."
Processing 00000000.tx.117: The effect of reversing the sequence of the neurotoxic A fragment on LTP and baseline synaptic transmission was also examined. 

Phrase: "The effect of reversing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C1280500:Effect [Qualitative Concept]
   770   C2348382:Effect [Qualitative Concept]

Phrase: "the sequence of the neurotoxic"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0004793:Sequence [Nucleotide Sequence]
   760   C0162326:Sequence [Nucleotide Sequence]
   760   C0162327:Sequence [Nucleotide Sequence]
   760   C1519249:Sequence [Functional Concept]

Phrase: "A fragment on LTP"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0332255:fragment [Functional Concept]
   753   C1708096:Fragment [Qualitative Concept]

Phrase: "and"

Phrase: "baseline synaptic transmission"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   901   C0027793:Synaptic Transmission [Cell Function]
   827   C0040722:transmission [Idea or Concept]
   827   C0242781:Transmission [Pathologic Function]
   827   C1521797:Transmission [Natural Phenomenon or Process]

Phrase: "was"

Phrase: "also"

Phrase: "examined."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332128:Examined [Finding]
Processing 00000000.tx.118: When A[35-25] 10and 100nmol was injected 1h prior to HFS, there was a significant reduction in LTP (1363%, n=6,P=0.01) and (1447%, n=8,P<0.05) compared with control (19117%, n=6; Fig. 4). 

Phrase: "When"

Phrase: "A[35-25"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   913   C0718136:A-25 [Organic Chemical,Pharmacologic Substance,Vitamin]

Phrase: "] 10and 100nmol"

Phrase: "was"

Phrase: "injected"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1720154:Inject [Functional Concept]

Phrase: "1h prior to HFS,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C1442450:1H [Temporal Concept]

Phrase: "there"

Phrase: "was"

Phrase: "a significant reduction in LTP"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   748   C0301630:Reduction [Natural Phenomenon or Process]
   748   C0392756:Reduction [Qualitative Concept]
   748   C0441610:Reduction [Therapeutic or Preventive Procedure]

Phrase: "(1363%,"

Phrase: "n=6,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441922:N+ [Intellectual Product]
   861   C1553036:[n] [Quantitative Concept]

Phrase: "P=0.01"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: ")"

Phrase: "and ("

Phrase: "1447%,"

Phrase: "n=8,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441922:N+ [Intellectual Product]
   861   C1553036:[n] [Quantitative Concept]

Phrase: "P<0.05"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: ")"

Phrase: "compared with control"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   790   C0243148:control [Qualitative Concept]
   790   C1550141:Control [Substance]
   790   C1707455:Compared [Activity]
   790   C1882979:Control [Conceptual Entity]
   790   C2587213:Control [Functional Concept]
   790   C3274648:Control [Qualitative Concept]

Phrase: "(19117%,"

Phrase: "n=6"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441922:N+ [Intellectual Product]
   861   C1553036:[n] [Quantitative Concept]

Phrase: "; Fig. 4"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: ")."
Processing 00000000.tx.119: View larger version (17K): [in this window] [in a new window]  Fig. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(17K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Fig."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.120: 4. 

Phrase: "4."
Processing 00000000.tx.121: A: effect of reversing the sequence of the active neurotoxic peptide on baseline synaptic transmission and LTP. 

Phrase: "A"

Phrase: ":"

Phrase: "effect of reversing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C1280500:Effect [Qualitative Concept]
   790   C2348382:Effect [Qualitative Concept]

Phrase: "the sequence of the active neurotoxic peptide"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   774   C0920679:peptide sequence [Amino Acid Sequence]
   748   C0004793:Sequence [Nucleotide Sequence]
   748   C0162326:Sequence [Nucleotide Sequence]
   748   C0162327:Sequence [Nucleotide Sequence]
   748   C1519249:Sequence [Functional Concept]

Phrase: "on baseline synaptic transmission"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   901   C0027793:Synaptic Transmission [Cell Function]
   827   C0040722:transmission [Idea or Concept]
   827   C0242781:Transmission [Pathologic Function]
   827   C1521797:Transmission [Natural Phenomenon or Process]

Phrase: "and"

Phrase: "LTP."
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
  1000   C0206249:Long-Term Potentiation [Organ or Tissue Function]
  1000   C2984294:Long-term potentiation [Functional Concept]
   901   C0443252:Long-term [Temporal Concept]
   827   C0205166:Long [Qualitative Concept]
   827   C0279023:Potentiation [Therapeutic or Preventive Procedure]
   827   C1515273:Term [Temporal Concept]
   827   C1705313:Term [Idea or Concept]
   827   C1706317:Long [Qualitative Concept]
   827   C2826302:TERM [Intellectual Product]
Processing 00000000.tx.122: A[35-25] at 10and 100nmol had no effect on baseline EPSPs recorded for up to 1h post icv injection. 

Phrase: "A[35-25"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   913   C0718136:A-25 [Organic Chemical,Pharmacologic Substance,Vitamin]

Phrase: "]"

Phrase: "at 10and 100nmol"

Phrase: "had"

Phrase: "no effect on baseline EPSPs"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   778   C1301751:No effect [Qualitative Concept]
   748   C1280500:Effect [Qualitative Concept]
   748   C2348382:Effect [Qualitative Concept]

Phrase: "recorded for"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   799   C0034869:Record [Intellectual Product]

Phrase: "up to 1h post icv injection."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   812   C0021485:injection [Therapeutic or Preventive Procedure]
   812   C1272883:Injection [Biomedical or Dental Material]
   812   C1533685:Injection [Therapeutic or Preventive Procedure]
   812   C1828121:Injection [Functional Concept]
Processing 00000000.tx.123: LTP was significantly reduced following 10nmol, A[35-25] (; 1363%, n=6,P<0.01) and 100nmol A[35-25] (; 1447%, n=8,P<0.05) compared with control (vehicle) (; 19117%, n=6). 

Phrase: "LTP"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
  1000   C0206249:Long-Term Potentiation [Organ or Tissue Function]
  1000   C2984294:Long-term potentiation [Functional Concept]
   901   C0443252:Long-term [Temporal Concept]
   827   C0205166:Long [Qualitative Concept]
   827   C0279023:Potentiation [Therapeutic or Preventive Procedure]
   827   C1515273:Term [Temporal Concept]
   827   C1705313:Term [Idea or Concept]
   827   C1706317:Long [Qualitative Concept]
   827   C2826302:TERM [Intellectual Product]

Phrase: "was"

Phrase: "significantly"

Phrase: "reduced"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0392756:Reduced [Qualitative Concept]

Phrase: "following"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332282:Following [Temporal Concept]
   966 E C0332283:follow [Temporal Concept]
   966 E C1719822:Follow [Intellectual Product]

Phrase: "10nmol,"

Phrase: "A[35-25"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   913   C0718136:A-25 [Organic Chemical,Pharmacologic Substance,Vitamin]

Phrase: "]"

Phrase: "("

Phrase: "; 1363%,"

Phrase: "n=6,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441922:N+ [Intellectual Product]
   861   C1553036:[n] [Quantitative Concept]

Phrase: "P<0.01"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: ")"

Phrase: "and"

Phrase: "100nmol A[35-25"

Phrase: "]"

Phrase: "("

Phrase: "; 1447%,"

Phrase: "n=8,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441922:N+ [Intellectual Product]
   861   C1553036:[n] [Quantitative Concept]

Phrase: "P<0.05"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: ")"

Phrase: "compared with control"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   790   C0243148:control [Qualitative Concept]
   790   C1550141:Control [Substance]
   790   C1707455:Compared [Activity]
   790   C1882979:Control [Conceptual Entity]
   790   C2587213:Control [Functional Concept]
   790   C3274648:Control [Qualitative Concept]

Phrase: "(vehicle"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0042444:Vehicle [Biomedical or Dental Material]
  1000   C0348005:Vehicle [Manufactured Object]
   928 E C0445373:Vehicular [Functional Concept]

Phrase: ")"

Phrase: "("

Phrase: "; 19117%,"

Phrase: "n=6"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441922:N+ [Intellectual Product]
   861   C1553036:[n] [Quantitative Concept]

Phrase: ")."
Processing 00000000.tx.124: Averaged EPSPs (n=3) are shown recorded 5min pretetanus and 30min posttetanus. 

Phrase: "Averaged EPSPs"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   923   C0524913:Excitatory Postsynaptic Potentials [Organ or Tissue Function]
   861   C2350339:Postsynaptic Potentials [Organ or Tissue Function]
   858   C0234121:Excitatory potential [Organ or Tissue Function]
   812   C3245505:potentials [Qualitative Concept]

Phrase: "(n=3"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441922:N+ [Intellectual Product]
   861   C1553036:[n] [Quantitative Concept]

Phrase: ")"

Phrase: "are"

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "recorded"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0034869:Record [Intellectual Product]

Phrase: "5min"

Phrase: "pretetanus"

Phrase: "and"

Phrase: "30min"

Phrase: "posttetanus."
Processing 00000000.tx.125: Control (vehicle; 1,2); 

Phrase: "Control"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0243148:control [Qualitative Concept]
  1000   C1550141:Control [Substance]
  1000   C1882979:Control [Conceptual Entity]
  1000   C2587213:Control [Functional Concept]
  1000   C3274648:Control [Qualitative Concept]

Phrase: "(vehicle"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0042444:Vehicle [Biomedical or Dental Material]
  1000   C0348005:Vehicle [Manufactured Object]
   928 E C0445373:Vehicular [Functional Concept]

Phrase: "; 1,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: "2"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]

Phrase: ")"

Phrase: ";"
Processing 00000000.tx.126: A[35-25], 100nmol (3,4) and 10nmol (5,6). 

Phrase: "A[35-25"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   913   C0718136:A-25 [Organic Chemical,Pharmacologic Substance,Vitamin]

Phrase: "],"

Phrase: "100nmol"

Phrase: "(3,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]

Phrase: "4"

Phrase: ")"

Phrase: "and"

Phrase: "10nmol"

Phrase: "(5,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439084:>5 [Quantitative Concept]
  1000   C0728893:+5 [Quantitative Concept]

Phrase: "6"

Phrase: ")."
Processing 00000000.tx.127: Calibration bars: 1mV; 

Phrase: "Calibration bars"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C1707156:BARS [Gene or Genome]
   861   C3274014:BARS [Intellectual Product]
   861   C3541345:BARS [Intellectual Product]

Phrase: ":"

Phrase: "1mV"

Phrase: ";"
Processing 00000000.tx.128: 5ms. 

Phrase: "5ms."
Processing 00000000.tx.129: PPF, induced by applying two stimuli at an inter-stimulus interval of 50ms was recorded immediately prior to injection of A fragments/vehicle and again 30min following HFS. 

Phrase: "PPF,"

Phrase: "induced by applying two stimuli"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   760   C0205263:Induced [Functional Concept]
   760   C0205448:Two [Quantitative Concept]
   760   C0234402:Stimuli [Phenomenon or Process]
   726   C0185125:Apply [Health Care Activity]
   726   C1632850:Apply [Functional Concept]
   726   C1879355:Apply [Functional Concept]

Phrase: "at an inter-stimulus interval"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   901   C0597525:stimulus interval [Temporal Concept]
   827   C1272706:Interval [Temporal Concept]
   827   C1552654:Interval [Idea or Concept]
   827   C1552713:Interval [Intellectual Product]

Phrase: "of 50ms"

Phrase: "was"

Phrase: "recorded"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0034869:Record [Intellectual Product]

Phrase: "immediately prior to injection of A fragments/vehicle"
Meta Candidates (Total=13; Excluded=1; Pruned=0; Remaining=12)
   770   C0332152:Prior to [Temporal Concept]
           Prior
   744   C0021485:injection [Therapeutic or Preventive Procedure]
   744   C0042444:Vehicle [Biomedical or Dental Material]
   744   C0205548:Immediately [Temporal Concept]
   744   C0332255:fragments [Functional Concept]
   744   C0348005:Vehicle [Manufactured Object]
   744   C0486805:Fragments [Body Substance]
   744   C1272883:Injection [Biomedical or Dental Material]
   744   C1533685:Injection [Therapeutic or Preventive Procedure]
   744   C1828121:Injection [Functional Concept]
   744   C2826257:PRIOR [Event]
   711 E C1708096:Fragment [Qualitative Concept]

Phrase: "and"

Phrase: "again 30min"

Phrase: "following"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332282:Following [Temporal Concept]
   966 E C0332283:follow [Temporal Concept]
   966 E C1719822:Follow [Intellectual Product]

Phrase: "HFS."
Meta Candidates (Total=12; Excluded=1; Pruned=0; Remaining=11)
   901   C0205212:High frequency [Temporal Concept]
   827   C0205250:High [Qualitative Concept]
   827   C0376249:frequency [Quantitative Concept]
   827   C0439603:Frequency [Temporal Concept]
   827   C0871396:Frequency [Quantitative Concept]
   827   C1292856:Stimulation [Therapeutic or Preventive Procedure]
   827   C1299351:High [Qualitative Concept]
   827   C1561548:Frequency [Qualitative Concept]
   827   C1705502:Frequency [Quantitative Concept]
   827   C1948023:Stimulation [Natural Phenomenon or Process]
   827   C2700149:HIGH [Intellectual Product]
   755 E C0332183:Frequent [Temporal Concept]
Processing 00000000.tx.130: The PPF ratio was measured as the slope of EPSP2/EPSP1 (Table 1). 

Phrase: "The PPF ratio"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0456603:Ratio [Quantitative Concept]
   861   C1547037:Ratio [Intellectual Product]

Phrase: "was"

Phrase: "measured as the slope of EPSP2/EPSP1"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   748   C0444706:Measured [Qualitative Concept]
   748   C0807955:Slope [Quantitative Concept]
   748   C3541902:MEASURED [Diagnostic Procedure]
   714 E C0079809:Measure [Quantitative Concept]
   714 E C0242485:Measure [Functional Concept]

Phrase: "(Table 1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0039224:Table [Manufactured Object]
   861   C1706073:Table [Medical Device]
   861   C1706074:Table [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.131: None of the A peptides tested had a significant effect on PPF (paired t-test), although there was a trend toward a decrease in facilitation.  

Phrase: "None of the"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0456148:None [Quantitative Concept]
   790   C0549184:None [Quantitative Concept]

Phrase: "A peptides"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0030956:Peptides [Amino Acid, Peptide, or Protein]

Phrase: "tested"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0392366:tested [Intellectual Product]
   966 E C0022885:Test [Laboratory Procedure]
   966 E C0039593:Test [Functional Concept]

Phrase: "had"

Phrase: "a significant effect on PPF (paired t-test"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C1280500:Effect [Qualitative Concept]
   744   C2348382:Effect [Qualitative Concept]

Phrase: ")"

Phrase: ","

Phrase: "although"

Phrase: "there"

Phrase: "was"

Phrase: "a trend toward a decrease"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1521798:trend [Temporal Concept]

Phrase: "in facilitation."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0234112:Facilitation [Organ or Tissue Function]
Processing 00000000.tx.132: DISCUSSION TOP ABSTRACT INTRODUCTION METHODS RESULTS DISCUSSION REFERENCES In this study we have shown for the first time in vivo that the impairment of LTP by A[25-35] peptide is both time and concentration dependent. 

Phrase: "DISCUSSION TOP ABSTRACT INTRODUCTION METHODS RESULTS DISCUSSION"

Phrase: "REFERENCES In this study"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   819   C2985663:Study Reference [Intellectual Product]
   770   C0557651:Study [Manufactured Object]
   770   C1514811:Reference [Idea or Concept]
   770   C1706462:Reference [Conceptual Entity]
   770   C2603343:Study [Research Activity]

Phrase: "we"

Phrase: "have"

Phrase: "shown for the first time"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   760   C0040223:Time [Temporal Concept]
   760   C0205435:First [Quantitative Concept]
   760   C1279901:First [Qualitative Concept]
   760   C3541383:Time [Temporal Concept]
   726   C1547282:Show [Intellectual Product]
   704 E C0442043:Temporal [Spatial Concept]
   704 E C2362314:Temporal [Temporal Concept]

Phrase: "in vivo"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1515655:In Vivo [Spatial Concept]
           vivo

Phrase: "that"

Phrase: "the impairment of LTP"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0684336:Impairment [Pathologic Function]

Phrase: "by A[25-35"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   901   C0718136:A-25 [Organic Chemical,Pharmacologic Substance,Vitamin]

Phrase: "] peptide"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0030956:Peptide [Amino Acid, Peptide, or Protein]

Phrase: "is"

Phrase: "both time"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0040223:Time [Temporal Concept]
  1000   C3541383:Time [Temporal Concept]
   944 E C0442043:Temporal [Spatial Concept]
   944 E C2362314:Temporal [Temporal Concept]
   916 E C1632851:Times [Quantitative Concept]

Phrase: "and"

Phrase: "concentration dependent."
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   861   C0086045:Concentration [Mental Process]
   861   C0851827:Dependent [Qualitative Concept]
   861   C1446561:Concentration [Quantitative Concept]
   861   C1701901:Dependent [Qualitative Concept]
   861   C3244310:dependent [Functional Concept]
   789 E C1880165:Concentrated [Biomedical or Dental Material]
Processing 00000000.tx.133: This is demonstrated by the greater decrease in LTP observed when tetanic stimulation was given 1h and not 5min post-injection. 

Phrase: "This"

Phrase: "is"

Phrase: "demonstrated by the greater decrease"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   760   C0392756:Decrease [Qualitative Concept]
   760   C0443228:greater [Quantitative Concept]
   760   C0547047:Decrease [Quantitative Concept]
   760   C1704243:Greater [Quantitative Concept]
   726 E C0549177:Great [Quantitative Concept]

Phrase: "in LTP"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
  1000   C0206249:Long-Term Potentiation [Organ or Tissue Function]
  1000   C2984294:Long-term potentiation [Functional Concept]
   901   C0443252:Long-term [Temporal Concept]
   827   C0205166:Long [Qualitative Concept]
   827   C0279023:Potentiation [Therapeutic or Preventive Procedure]
   827   C1515273:Term [Temporal Concept]
   827   C1705313:Term [Idea or Concept]
   827   C1706317:Long [Qualitative Concept]
   827   C2826302:TERM [Intellectual Product]

Phrase: "observed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1441672:Observed [Functional Concept]

Phrase: "when"

Phrase: "tetanic stimulation"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C1292856:Stimulation [Therapeutic or Preventive Procedure]
   861   C1948023:Stimulation [Natural Phenomenon or Process]
   789   C0039621:Tetanies [Disease or Syndrome]

Phrase: "was"

Phrase: "given"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C1442162:GIVEN [Conceptual Entity]
  1000   C1550718:given [Idea or Concept]
  1000   C3244317:given [Intellectual Product]
   966 E C1947971:Give [Functional Concept]

Phrase: "1h"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1442450:1H [Temporal Concept]

Phrase: "and"

Phrase: "not 5min"

Phrase: "post-injection."
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   861   C0021485:injection [Therapeutic or Preventive Procedure]
   861   C0687676:Post [Temporal Concept]
   861   C1272883:Injection [Biomedical or Dental Material]
   861   C1533685:Injection [Therapeutic or Preventive Procedure]
   861   C1704687:Post [Manufactured Object]
   861   C1828121:Injection [Functional Concept]
   789 E C1514253:Postal [Functional Concept]
Processing 00000000.tx.134: Also, 100nmol A[25-35] had a more powerful blocking effect than 10nmol A[25-35]. 

Phrase: "Also,"

Phrase: "100nmol A[25-35"

Phrase: "]"

Phrase: "had"

Phrase: "a more powerful blocking effect than 10nmol A[25-35"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   739   C1280500:Effect [Qualitative Concept]
   739   C2348382:Effect [Qualitative Concept]

Phrase: "]."
Processing 00000000.tx.135: LTP was impaired by the most neurotoxic fragment, A[25-35] (Yankner et al. 1990), containing the lipophilic portion of A (amino acids 28-35). 

Phrase: "LTP"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
  1000   C0206249:Long-Term Potentiation [Organ or Tissue Function]
  1000   C2984294:Long-term potentiation [Functional Concept]
   901   C0443252:Long-term [Temporal Concept]
   827   C0205166:Long [Qualitative Concept]
   827   C0279023:Potentiation [Therapeutic or Preventive Procedure]
   827   C1515273:Term [Temporal Concept]
   827   C1705313:Term [Idea or Concept]
   827   C1706317:Long [Qualitative Concept]
   827   C2826302:TERM [Intellectual Product]

Phrase: "was"

Phrase: "impaired by the most neurotoxic fragment,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   753   C0221099:Impaired [Functional Concept]
   753   C0332255:fragment [Functional Concept]
   753   C0684336:Impaired [Pathologic Function]
   753   C1708096:Fragment [Qualitative Concept]

Phrase: "A[25-35"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   901   C0718136:A-25 [Organic Chemical,Pharmacologic Substance,Vitamin]

Phrase: "]"

Phrase: "(Yankner et al. 1990"

Phrase: ")"

Phrase: ","

Phrase: "containing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:Containing [Functional Concept]
  1000   C2700400:Containing [Activity]

Phrase: "the lipophilic portion of A (amino acids 28-35"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   742   C0449719:Portion [Spatial Concept]

Phrase: ")."
Processing 00000000.tx.136: Interestingly, A[35-25], the "reverse" sequence peptide, previously reported to have no effect on LTP in vitro (Chen et al. 2000), caused a marked reduction in plasticity at both 10and 100nmol, while A[15-25] had no effect on LTP. 

Phrase: "Interestingly,"

Phrase: "A[35-25"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   913   C0718136:A-25 [Organic Chemical,Pharmacologic Substance,Vitamin]

Phrase: "],"

Phrase: "the """

Phrase: "reverse"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1555029:Reverse [Idea or Concept]

Phrase: """ sequence peptide,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0030956:Peptide [Amino Acid, Peptide, or Protein]

Phrase: "previously"

Phrase: "reported"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0684224:Reported [Intellectual Product]
  1000   C0700287:Reported [Health Care Activity]
  1000   C3496591:Reported [Clinical Attribute]
   966 E C3273238:Report [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "have"

Phrase: "no effect on LTP"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   820   C0023983:Long-Term Effect [Phenomenon or Process]
   790   C1301751:No effect [Qualitative Concept]
   753   C1280500:Effect [Qualitative Concept]
   753   C2348382:Effect [Qualitative Concept]

Phrase: "in vitro"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0021135:In Vitro [Intellectual Product]
  1000   C1533691:in vitro [Qualitative Concept]
           vitro
  1000   C2827718:In Vitro [Functional Concept]

Phrase: "(Chen et al. 2000"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0999213:Chen [Bird]

Phrase: ")"

Phrase: ","

Phrase: "caused"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0015127:cause [Functional Concept]
   966   C1524003:Cause [Conceptual Entity]

Phrase: "a marked reduction in plasticity"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0301630:Reduction [Natural Phenomenon or Process]
   760   C0392756:Reduction [Qualitative Concept]
   760   C0441610:Reduction [Therapeutic or Preventive Procedure]

Phrase: "at both 10and 100nmol,"

Phrase: "while"

Phrase: "A[15-25"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   913   C0718136:A-25 [Organic Chemical,Pharmacologic Substance,Vitamin]

Phrase: "]"

Phrase: "had"

Phrase: "no effect on LTP."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   820   C0023983:Long-Term Effect [Phenomenon or Process]
   790   C1301751:No effect [Qualitative Concept]
   753   C1280500:Effect [Qualitative Concept]
   753   C2348382:Effect [Qualitative Concept]
Processing 00000000.tx.137: What are the potential mechanisms involved in the effects of A-peptides on LTP? 

Phrase: "What"

Phrase: "are"

Phrase: "the potential mechanisms"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0441712:Mechanisms [Functional Concept]
   827 E C1706376:Mechanism [Manufactured Object]

Phrase: "involved in the effects of A-peptides"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   748   C0030956:Peptides [Amino Acid, Peptide, or Protein]
   748   C1280500:effects [Qualitative Concept]
   748   C1314939:Involved [Functional Concept]
   714 E C2348382:Effect [Qualitative Concept]

Phrase: "on LTP?"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
  1000   C0206249:Long-Term Potentiation [Organ or Tissue Function]
  1000   C2984294:Long-term potentiation [Functional Concept]
   901   C0443252:Long-term [Temporal Concept]
   827   C0205166:Long [Qualitative Concept]
   827   C0279023:Potentiation [Therapeutic or Preventive Procedure]
   827   C1515273:Term [Temporal Concept]
   827   C1705313:Term [Idea or Concept]
   827   C1706317:Long [Qualitative Concept]
   827   C2826302:TERM [Intellectual Product]
Processing 00000000.tx.138: There are two types of channel known to be implicated in the induction of LTP that may be disrupted by active A-peptide: namely the L-type voltage-gated calcium channel, activated by the high stimulus frequencies of 200Hz used in our study to induce LTP (Grover and Teyler 1990; Morgan and Teyler 1999) and/or the NMDA receptor/channel complex (Collingridge et al. 1983). 

Phrase: "There"

Phrase: "are"

Phrase: "two types of channel"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   770   C0332307:Types [Qualitative Concept]
   737 E C1547052:*Type [Quantitative Concept]

Phrase: "known"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205309:Known [Qualitative Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be"

Phrase: "implicated in the induction of LTP"
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
   800   C0206249:Long-Term Potentiation [Organ or Tissue Function]
   800   C2984294:Long-term potentiation [Functional Concept]
   770   C0443252:Long-term [Temporal Concept]
   744   C0205166:Long [Qualitative Concept]
   744   C0205263:Induction [Functional Concept]
   744   C0279023:Potentiation [Therapeutic or Preventive Procedure]
   744   C0857127:induction [Therapeutic or Preventive Procedure]
   744   C1515273:Term [Temporal Concept]
   744   C1705313:Term [Idea or Concept]
   744   C1706317:Long [Qualitative Concept]
   744   C2826302:TERM [Intellectual Product]

Phrase: "that"

Phrase: "may"

Phrase: "be"

Phrase: "disrupted by active A-peptide"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0030956:Peptide [Amino Acid, Peptide, or Protein]
   760   C0205177:Active [Functional Concept]
   760   C0332454:Disrupted [Qualitative Concept]

Phrase: ":"

Phrase: "namely"

Phrase: "the L-type voltage-gated calcium channel,"
Meta Candidates (Total=17; Excluded=0; Pruned=0; Remaining=17)
   913   C0288263:L-Type Calcium Channel [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   913   C3538943:L-type calcium channel [Molecular Function]
   901   C0814022:voltage gated calcium channel [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   867   C0597675:voltage gated channel [Physiologic Function]
   827   C0006685:Calcium Channel [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C3258486:Voltage-gated [Qualitative Concept]
   799   C0006675:Calcium [Biologically Active Substance,Element, Ion, or Isotope,Pharmacologic Substance]
   799   C0006726:Calcium [Inorganic Chemical]
   799   C0332307:Type [Qualitative Concept]
   799   C0439394:l's [Quantitative Concept]
   799   C0439799:Channel [Spatial Concept]
   799   C0598352:Voltage [Quantitative Concept]
   799   C1547052:*Type [Quantitative Concept]
   799   C1706095:Channel [Conceptual Entity]
   799   C1706495:L- [Intellectual Product]
   799   C2936886:Calcium [Pharmacologic Substance]
   799   C3642217:/L [Quantitative Concept]

Phrase: "activated by the high stimulus frequencies of 200Hz"
Meta Candidates (Total=13; Excluded=5; Pruned=0; Remaining=8)
   754   C0237630:Stimulus frequency [Temporal Concept]
   750   C0205212:High frequency [Temporal Concept]
   744   C0205250:High [Qualitative Concept]
   744   C0234402:Stimulus [Phenomenon or Process]
   744   C0439603:Frequencies [Temporal Concept]
   744   C1299351:High [Qualitative Concept]
   744   C1879547:Activated [Activity]
   744   C2700149:HIGH [Intellectual Product]
   711 E C0376249:frequency [Quantitative Concept]
   711 E C0871396:Frequency [Quantitative Concept]
   711 E C1515877:Activate [Functional Concept]
   711 E C1561548:Frequency [Qualitative Concept]
   711 E C1705502:Frequency [Quantitative Concept]

Phrase: "used in our study to"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   781   C0869040:study use [Research Activity]
   760   C0557651:Study [Manufactured Object]
   760   C1273517:used [Finding]
   760   C2603343:Study [Research Activity]
   726 E C0042153:use [Functional Concept]
   726 E C0457083:Use [Functional Concept]
   726 E C1947944:Use [Intellectual Product]

Phrase: "induce"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205263:Induce [Functional Concept]

Phrase: "LTP"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
  1000   C0206249:Long-Term Potentiation [Organ or Tissue Function]
  1000   C2984294:Long-term potentiation [Functional Concept]
   901   C0443252:Long-term [Temporal Concept]
   827   C0205166:Long [Qualitative Concept]
   827   C0279023:Potentiation [Therapeutic or Preventive Procedure]
   827   C1515273:Term [Temporal Concept]
   827   C1705313:Term [Idea or Concept]
   827   C1706317:Long [Qualitative Concept]
   827   C2826302:TERM [Intellectual Product]

Phrase: "(Grover"

Phrase: "and"

Phrase: "Teyler 1990"

Phrase: "; Morgan"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0582521:morgan [Quantitative Concept]

Phrase: "and"

Phrase: "Teyler 1999"

Phrase: ")"

Phrase: "and/or"

Phrase: "the NMDA receptor/channel complex"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   822   C1523873:receptor complex [Cell Component]
   812   C0052536:receptor, aspartate [Amino Acid, Peptide, or Protein,Receptor]
   793   C0085845:Aspartate [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   793   C0439799:Channel [Spatial Concept]
   793   C0439855:Complex [Qualitative Concept]
   793   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]
   793   C1704241:Complex [Chemical Viewed Structurally]
   793   C1706095:Channel [Conceptual Entity]

Phrase: "(Collingridge et al. 1983"

Phrase: ")."
Processing 00000000.tx.139: Alteration of the activation kinetics of either of these channels by A could influence LTP induction. 

Phrase: "Alteration of the activation kinetics of either of these channels"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   739   C1515926:Alteration [Idea or Concept]

Phrase: "by A"

Phrase: "could"

Phrase: "influence"

Phrase: "LTP induction."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   812   C0205263:Induction [Functional Concept]
   812   C0857127:induction [Therapeutic or Preventive Procedure]
   756   C0206249:Long-Term Potentiation [Organ or Tissue Function]
   756   C2984294:Long-term potentiation [Functional Concept]
Processing 00000000.tx.140: A can cause the formation of calcium-permeable pores in cell membranes (Engstrm et al. 1995) and block the fast inactivating potassium channel (Good and Murphy 1996); 

Phrase: "A"

Phrase: "can"

Phrase: "cause"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0015127:cause [Functional Concept]
  1000   C1524003:Cause [Conceptual Entity]

Phrase: "the formation of calcium-permeable pores in cell membranes"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   745   C1326292:pore formation [Cell Function]
   742   C0220781:formation [Biologic Function]
   742   C0439634:formation [Spatial Concept]
   742   C1522492:Formation [Functional Concept]

Phrase: "(Engstrm et al. 1995"

Phrase: ")"

Phrase: "and"

Phrase: "block"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0028778:Block [Pathologic Function]
  1000   C0332206:Block [Functional Concept]
  1000   C1533157:Block [Substance]
  1000   C1706084:Block [Geographic Area]
  1000   C2828370:Block [Quantitative Concept]

Phrase: "the fast inactivating potassium channel"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   861   C0032824:Potassium Channel [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0032821:Potassium [Element, Ion, or Isotope]
   812   C0439799:Channel [Spatial Concept]
   812   C0597277:Potassium+ [Element, Ion, or Isotope,Pharmacologic Substance]
   812   C1706095:Channel [Conceptual Entity]

Phrase: "(Good"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205170:Good [Qualitative Concept]

Phrase: "and"

Phrase: "Murphy 1996"

Phrase: ")"

Phrase: ";"
Processing 00000000.tx.141: both mechanisms would produce an increase in intracellular calcium. 

Phrase: "both mechanisms"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0441712:Mechanisms [Functional Concept]
   966 E C1706376:Mechanism [Manufactured Object]

Phrase: "would"

Phrase: "produce"

Phrase: "an increase in intracellular calcium."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0442805:Increase [Functional Concept]
Processing 00000000.tx.142: In addition, the L-type calcium channel current is increased by A (Ueda et al. 1997) acting via mitogen-activated protein (MAP) kinase (Ekinci et al. 1999). 

Phrase: "In addition,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1883712:Addition [Functional Concept]
   928 E C1524062:Additional [Functional Concept]

Phrase: "the L-type calcium channel current"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   804   C0521116:Current [Temporal Concept]
   804   C1705970:Current [Natural Phenomenon or Process]
   771   C0288263:L-Type Calcium Channel [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   771   C3538943:L-type calcium channel [Molecular Function]

Phrase: "is"

Phrase: "increased by A (Ueda et al. 1997"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   774   C0217843:ET-A [Amino Acid, Peptide, or Protein,Receptor]
   748   C0205217:Increased [Quantitative Concept]
   748   C0442805:Increased [Functional Concept]

Phrase: ")"

Phrase: "acting via mitogen-activated protein (MAP) kinase"
Meta Candidates (Total=10; Excluded=1; Pruned=0; Remaining=9)
   882   C0752312:Mitogen-Activated Protein Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   833   C1979930:Mitogen-activated protein [Amino Acid, Peptide, or Protein]
   790   C0033640:PROTEIN KINASE [Amino Acid, Peptide, or Protein,Enzyme]
   753   C0018284:Mitogen [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C0026249:Mitogen [Pharmacologic Substance]
   753   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   753   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C1879547:Activated [Activity]
   719   C0079613:ACT [Therapeutic or Preventive Procedure]
   719 E C1515877:Activate [Functional Concept]

Phrase: "(Ekinci et al. 1999"

Phrase: ")."
Processing 00000000.tx.143: The disruption of intracellular calcium homeostasis is likely to play a major role in LTP impairment. 

Phrase: "The disruption of intracellular calcium homeostasis"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0332453:Disruption [Functional Concept]

Phrase: "is"

Phrase: "likely to"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0332148:Likely [Qualitative Concept]
   861   C0750492:Likely [Idea or Concept]

Phrase: "play"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0032214:Play [Daily or Recreational Activity]
  1000   C0600138:play [Finding]

Phrase: "a major role in LTP impairment."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C0035820:Role [Social Behavior]
   744   C1705810:Role [Conceptual Entity]
Processing 00000000.tx.144: A[1-40] has been reported to cause a reduction in LTP in vivo (Cullen et al. 1997), yet can also produce a potentiation of LTP in vitro, possibly due to an increase in activation of the NMDA receptor (Wu et al. 1995a,b). 

Phrase: "A[1-40"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0439509:/40 [Temporal Concept]

Phrase: "]"

Phrase: "has"

Phrase: "been"

Phrase: "reported"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0684224:Reported [Intellectual Product]
  1000   C0700287:Reported [Health Care Activity]
  1000   C3496591:Reported [Clinical Attribute]
   966 E C3273238:Report [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "cause"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0015127:cause [Functional Concept]
  1000   C1524003:Cause [Conceptual Entity]

Phrase: "a reduction in LTP"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0301630:Reduction [Natural Phenomenon or Process]
   753   C0392756:Reduction [Qualitative Concept]
   753   C0441610:Reduction [Therapeutic or Preventive Procedure]

Phrase: "in vivo"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1515655:In Vivo [Spatial Concept]
           vivo

Phrase: "(Cullen et al. 1997"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C1051267:Cullen [Plant]

Phrase: ")"

Phrase: ","

Phrase: "yet"

Phrase: "can"

Phrase: "also"

Phrase: "produce"

Phrase: "a potentiation of LTP in vitro, possibly"

Phrase: "due to an increase"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0442805:Increase [Functional Concept]

Phrase: "in activation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1879547:Activation [Activity]

Phrase: "of the NMDA receptor"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   818   C0052536:receptor, aspartate [Amino Acid, Peptide, or Protein,Receptor]
   795   C0085845:Aspartate [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   795   C0332285:Of [Spatial Concept]
   795   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]

Phrase: "(Wu et al. 1995a,"

Phrase: "b"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: ")."
Processing 00000000.tx.145: An increase in NMDA receptor function has also been reported in hippocampal slices from transgenic mice over expressing human APP (Hsiao et al. 1999). 

Phrase: "An increase in NMDA receptor function"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   764   C0052536:receptor, aspartate [Amino Acid, Peptide, or Protein,Receptor]
   764   C0920644:receptor function [Molecular Function]
   742   C0031843:function [Physiologic Function]
   742   C0085845:Aspartate [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   742   C0442805:Increase [Functional Concept]
   742   C0542341:Function [Functional Concept]
   742   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]
   742   C0700205:FUNCTION [Classification]
   742   C1705273:Function [Intellectual Product]

Phrase: "has"

Phrase: "also"

Phrase: "been"

Phrase: "reported in hippocampal slices"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   770   C0019564:Hippocampal [Body Part, Organ, or Organ Component]
   770   C0684224:Reported [Intellectual Product]
   770   C0700287:Reported [Health Care Activity]
   770   C3496591:Reported [Clinical Attribute]
   737   C1519355:Slice [Substance]
   737 E C3273238:Report [Intellectual Product]

Phrase: "from transgenic mice"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0025936:Mice, Transgenic [Mammal]
   861   C0003069:Transgenic [Animal]
   861   C0025914:Mice [Mammal]
   861   C0025929:mice [Mammal]
   861   C0026809:Mice [Mammal]

Phrase: "over expressing"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0205136:Over [Spatial Concept]

Phrase: "human APP"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   923   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
   923   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   902   C1142652:human protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   875   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   861   C0033665:precursor protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0011560:Amyloid [Pathologic Function]
   812   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C1709634:Precursor [Idea or Concept]

Phrase: "(Hsiao et al. 1999"

Phrase: ")."
Processing 00000000.tx.146: Depending on the degree of activation of the NMDA receptor, and consequent calcium influx, it is possible to induce LTP or long-term depression (Mulkey and Malenka 1992). 

Phrase: "Depending on the degree of activation"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   753   C0441889:Degree [Qualitative Concept]
   753   C0449286:Degree [Quantitative Concept]
   753   C0542560:Degree [Intellectual Product]
   753   C1561545:degree [Quantitative Concept]
   753   C1879547:Activation [Activity]
   753   C2348088:Degree [Quantitative Concept]
   719   C0725813:depend [Medical Device]

Phrase: "of the NMDA receptor,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   818   C0052536:receptor, aspartate [Amino Acid, Peptide, or Protein,Receptor]
   795   C0085845:Aspartate [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   795   C0332285:Of [Spatial Concept]
   795   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]

Phrase: "and"

Phrase: "consequent calcium influx,"

Phrase: "it"

Phrase: "is"

Phrase: "possible to"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0332149:Possible [Qualitative Concept]
   861   C1705910:Possible [Qualitative Concept]
   861   C2362652:Possible [Qualitative Concept]

Phrase: "induce"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205263:Induce [Functional Concept]

Phrase: "LTP"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
  1000   C0206249:Long-Term Potentiation [Organ or Tissue Function]
  1000   C2984294:Long-term potentiation [Functional Concept]
   901   C0443252:Long-term [Temporal Concept]
   827   C0205166:Long [Qualitative Concept]
   827   C0279023:Potentiation [Therapeutic or Preventive Procedure]
   827   C1515273:Term [Temporal Concept]
   827   C1705313:Term [Idea or Concept]
   827   C1706317:Long [Qualitative Concept]
   827   C2826302:TERM [Intellectual Product]

Phrase: "or"

Phrase: "long-term depression"
Meta Candidates (Total=14; Excluded=1; Pruned=0; Remaining=13)
  1000   C2610415:long term depression [Organ or Tissue Function]
  1000   C2984275:Long-term depression [Functional Concept]
   901   C0443252:Long-term [Temporal Concept]
   827   C0011570:Depression [Mental or Behavioral Dysfunction]
   827   C0011581:Depression [Mental or Behavioral Dysfunction]
   827   C0205166:Long [Qualitative Concept]
   827   C0344315:Depression [Finding]
   827   C0349217:depression nos [Mental or Behavioral Dysfunction]
   827   C0460137:Depression [Functional Concept]
   827   C1515273:Term [Temporal Concept]
   827   C1705313:Term [Idea or Concept]
   827   C1706317:Long [Qualitative Concept]
   827   C2826302:TERM [Intellectual Product]
   755 E C0549249:DEPRESSED [Finding]

Phrase: "(Mulkey"

Phrase: "and"

Phrase: "Malenka 1992"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1069595:Malenka [Eukaryote]

Phrase: ")."
Processing 00000000.tx.147: Prolonged low level activation of the NMDA receptor/channel can also reduce the ability to induce subsequent changes in synaptic plasticity (Coan et al. 1989). 

Phrase: "Prolonged low level activation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C1879547:Activation [Activity]

Phrase: "of the NMDA receptor/channel"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   812   C0052536:receptor, aspartate [Amino Acid, Peptide, or Protein,Receptor]
   793   C0085845:Aspartate [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   793   C0332285:Of [Spatial Concept]
   793   C0439799:Channel [Spatial Concept]
   793   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]
   793   C1706095:Channel [Conceptual Entity]

Phrase: "can"

Phrase: "also"

Phrase: "reduce"

Phrase: "the ability to"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0085732:Ability [Organism Attribute]
   789 E C1299581:Able [Finding]

Phrase: "induce"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205263:Induce [Functional Concept]

Phrase: "subsequent changes in synaptic plasticity"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   760   C0392747:changes [Functional Concept]
   760   C0443172:changes [Quantitative Concept]
   726 E C1705241:Change [Quantitative Concept]

Phrase: "(Coan et al. 1989"

Phrase: ")."
Processing 00000000.tx.148: This may be due to a change in the dynamics of activation of calcium calmodulin kinase (CaM KII) and calcium/calcineurin (phosphatase 2B) by high and low levels of intracellular calcium, respectively (Mulkey et al. 1993, 1994). 

Phrase: "This"

Phrase: "may"

Phrase: "be due to a change"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   806   C0678226:Due to [Functional Concept]
           due
   760   C0392747:Change [Functional Concept]
   760   C0443172:change [Quantitative Concept]
   760   C1705241:Change [Quantitative Concept]
   760   C2987476:Be [Conceptual Entity]
   760   C3146286:Due [Idea or Concept]

Phrase: "in the dynamics"

Phrase: "of activation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1879547:Activation [Activity]

Phrase: "of calcium calmodulin kinase (CaM KII)"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   901   C0006776:Calmodulin-Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   827   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "and"

Phrase: "calcium/calcineurin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0054450:Calcineurin [Amino Acid, Peptide, or Protein,Enzyme]
   861   C1149946:calcineurin [Molecular Function]

Phrase: "(phosphatase 2B"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C2261653:phosphatase 2B [Molecular Function]
   861   C0450354:2b [Intellectual Product]
   861   C1706096:2B [Research Activity]

Phrase: ")"

Phrase: "by high"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205250:High [Qualitative Concept]
  1000   C1299351:High [Qualitative Concept]
  1000   C2700149:HIGH [Intellectual Product]

Phrase: "and"

Phrase: "low levels of intracellular calcium,"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   797   C0201925:calcium levels [Laboratory Procedure]
   797   C0428302:calcium levels [Laboratory or Test Result]
   760   C0441889:Levels [Qualitative Concept]
   726 E C0456079:Level [Classification]
   726 E C1547707:Level [Geographic Area]
   726 E C2946261:Level [Pharmacologic Substance]

Phrase: "respectively"

Phrase: "(Mulkey et al. 1993,"

Phrase: "1994"

Phrase: ")."
Processing 00000000.tx.149: Synaptic desensitization of the NMDA receptor and down regulation of receptor function is known to depend on activation of calcium/calcineurin (Tong et al. 1995). 

Phrase: "Synaptic desensitization of the NMDA receptor"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   764   C0052536:receptor, aspartate [Amino Acid, Peptide, or Protein,Receptor]
   762   C0039064:Synaptic receptor [Amino Acid, Peptide, or Protein,Receptor]
   762   C1709852:Receptor Desensitization [Molecular Function]
           Desensitization
   742   C0085845:Aspartate [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   742   C0178702:Desensitization [Therapeutic or Preventive Procedure]
   742   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]

Phrase: "and"

Phrase: "down regulation of receptor function"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   844   C0013081:Down-regulation, function [Cell Function,Molecular Function]
           Down-Regulation
   844   C0949469:Receptor Down-Regulation [Molecular Function]
   760   C0851285:Regulation [Governmental or Regulatory Activity]
   760   C1327622:Regulation [Biologic Function]
   704   C0423866:Lanugo [Body Part, Organ, or Organ Component]
   704   C2626739:Lanugo [Eukaryote]

Phrase: "is"

Phrase: "known"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205309:Known [Qualitative Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "depend on activation of calcium/calcineurin"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   783   C2245701:calcineurin activation [Molecular Function]
   753   C0006675:Calcium [Biologically Active Substance,Element, Ion, or Isotope,Pharmacologic Substance]
   753   C0006726:Calcium [Inorganic Chemical]
   753   C0054450:Calcineurin [Amino Acid, Peptide, or Protein,Enzyme]
   753   C0725813:depend [Medical Device]
   753   C1149946:calcineurin [Molecular Function]
   753   C1879547:Activation [Activity]
   753   C2936886:Calcium [Pharmacologic Substance]

Phrase: "(Tong et al. 1995"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0183964:Tong [Medical Device]

Phrase: ")."
Processing 00000000.tx.150: A has also been reported to inhibit the late phase of LTP in vitro via a calcium/calcineurin-dependent mechanism (Chen and Xie 1999). 

Phrase: "A"

Phrase: "has"

Phrase: "also"

Phrase: "been"

Phrase: "reported"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0684224:Reported [Intellectual Product]
  1000   C0700287:Reported [Health Care Activity]
  1000   C3496591:Reported [Clinical Attribute]
   966 E C3273238:Report [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "inhibit"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   944   C0018790:arrested [Disease or Syndrome]
   944   C0237477:Arrest [Temporal Concept]
   944   C0392351:arrest [Governmental or Regulatory Activity]
   944   C0521111:Retarded [Qualitative Concept]
   916 E C0311403:Inhibited [Qualitative Concept]
   916 E C3463820:Inhibiting [Activity]

Phrase: "the late phase of LTP"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0205087:Late [Temporal Concept]
   748   C0205390:Phase [Temporal Concept]

Phrase: "in vitro via a calcium/calcineurin-dependent mechanism"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0021135:In Vitro [Intellectual Product]
   770   C1533691:in vitro [Qualitative Concept]
           vitro
   770   C2827718:In Vitro [Functional Concept]

Phrase: "(Chen"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0999213:Chen [Bird]

Phrase: "and"

Phrase: "Xie 1999"

Phrase: ")."
Processing 00000000.tx.151: Recently, the p38 MAP kinase pathway has been implicated in the inhibitory actions of A[25-35] on LTP in vitro (Saleshando and O'Connor 2000). 

Phrase: "Recently,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332185:Recently [Temporal Concept]

Phrase: "the p38 MAP kinase pathway"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   904   C3179232:p38 Kinase Pathway [Cell Function,Molecular Function]
   799   C1704259:Pathway [Molecular Function]
   799   C1705987:Pathway [Conceptual Entity]
   780   C1456380:p38 Mitogen Activated Protein Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   760 E C1120843:p38 Mitogen-Activated Protein Kinases [Amino Acid, Peptide, or Protein,Enzyme]
           p38 Protein Kinase
   734   C0752312:Mitogen-Activated Protein Kinase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "has"

Phrase: "been"

Phrase: "implicated in the inhibitory actions of A[25-35"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   742   C0441472:actions [Functional Concept]
   742   C3463820:Inhibitory [Activity]
   708 E C3266814:Action [Activity]

Phrase: "]"

Phrase: "on LTP"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
  1000   C0206249:Long-Term Potentiation [Organ or Tissue Function]
  1000   C2984294:Long-term potentiation [Functional Concept]
   901   C0443252:Long-term [Temporal Concept]
   827   C0205166:Long [Qualitative Concept]
   827   C0279023:Potentiation [Therapeutic or Preventive Procedure]
   827   C1515273:Term [Temporal Concept]
   827   C1705313:Term [Idea or Concept]
   827   C1706317:Long [Qualitative Concept]
   827   C2826302:TERM [Intellectual Product]

Phrase: "in vitro"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0021135:In Vitro [Intellectual Product]
  1000   C1533691:in vitro [Qualitative Concept]
           vitro
  1000   C2827718:In Vitro [Functional Concept]

Phrase: "(Saleshando"

Phrase: "and"

Phrase: "O'Connor 2000"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0439114:O NOS [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.152: Icv injection of the active fragment of A may then cause disruption of calcium homeostasis (Mattson et al. 1993), including increased activation of the calcium-permeable NMDA channel and/or increased calcium influx directly or via the L-type calcium channel. 

Phrase: "Icv injection of the active fragment of A"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   744   C0021485:injection [Therapeutic or Preventive Procedure]
   744   C1272883:Injection [Biomedical or Dental Material]
   744   C1533685:Injection [Therapeutic or Preventive Procedure]
   744   C1828121:Injection [Functional Concept]

Phrase: "may"

Phrase: "then"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883708:Then [Temporal Concept]

Phrase: "cause"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0015127:cause [Functional Concept]
  1000   C1524003:Cause [Conceptual Entity]

Phrase: "disruption of calcium homeostasis"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0332453:Disruption [Functional Concept]

Phrase: "(Mattson et al. 1993"

Phrase: ")"

Phrase: ","

Phrase: "including"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332257:Including [Functional Concept]
   966 E C1552866:include [Idea or Concept]
   966 E C2700399:Include [Activity]

Phrase: "increased activation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1879547:Activation [Activity]

Phrase: "of the calcium-permeable NMDA channel"
Meta Candidates (Total=11; Excluded=1; Pruned=0; Remaining=10)
   866   C0006685:Calcium Channel [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   854   C0949222:Calcium Aspartate [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   791   C0006675:Calcium [Biologically Active Substance,Element, Ion, or Isotope,Pharmacologic Substance]
   791   C0006726:Calcium [Inorganic Chemical]
   791   C0085845:Aspartate [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   791   C0205326:Permeable [Functional Concept]
   791   C0332285:Of [Spatial Concept]
   791   C0439799:Channel [Spatial Concept]
   791   C1706095:Channel [Conceptual Entity]
   791   C2936886:Calcium [Pharmacologic Substance]
   720 E C0031164:Permeabilities [Natural Phenomenon or Process]

Phrase: "and/or"

Phrase: "increased calcium influx directly"

Phrase: "or via the L-type calcium channel."
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   778   C0006685:Calcium Channel [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   748   C0006675:Calcium [Biologically Active Substance,Element, Ion, or Isotope,Pharmacologic Substance]
   748   C0006726:Calcium [Inorganic Chemical]
   748   C0332307:Type [Qualitative Concept]
   748   C0439799:Channel [Spatial Concept]
   748   C1547052:*Type [Quantitative Concept]
   748   C1706095:Channel [Conceptual Entity]
   748   C2936886:Calcium [Pharmacologic Substance]
Processing 00000000.tx.153: The subsequent induction of LTP would then be precluded due to changes in the level of channel phosphorylation. 

Phrase: "The subsequent induction of LTP"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0205263:Induction [Functional Concept]
   748   C0857127:induction [Therapeutic or Preventive Procedure]

Phrase: "would"

Phrase: "then"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883708:Then [Temporal Concept]

Phrase: "be"

Phrase: "precluded due to changes"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   833   C0678226:Due to [Functional Concept]
           due
   770   C0392747:changes [Functional Concept]
   770   C0443172:changes [Quantitative Concept]
   770   C3146286:Due [Idea or Concept]
   737 E C1705241:Change [Quantitative Concept]

Phrase: "in the level"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0441889:Level [Qualitative Concept]
  1000   C0456079:Level [Classification]
  1000   C1547707:Level [Geographic Area]
  1000   C2946261:Level [Pharmacologic Substance]

Phrase: "of channel phosphorylation."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0031715:Phosphorylation [Molecular Function]
   861   C1158886:Phosphorylation [Molecular Function]
Processing 00000000.tx.154: A has also been shown to increase calcium influx via the N-type calcium channel in cerebellar granule cells (Price et al. 1998). 

Phrase: "A"

Phrase: "has"

Phrase: "also"

Phrase: "been"

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "increase"
Meta Candidates (Total=8; Excluded=7; Pruned=0; Remaining=1)
  1000   C0442805:Increase [Functional Concept]
   944 E C1517378:Gain [Quantitative Concept]
   916 E C0205217:Increased [Quantitative Concept]
   916 E C0439661:Acquired [Temporal Concept]
   916 E C0442808:Increasing [Functional Concept]
   916 E C1301820:Obtain [Functional Concept]
   916 E C1706701:Acquire [Activity]
   916 E C3245488:acquired [Intellectual Product]

Phrase: "calcium influx via the N-type calcium channel"

Phrase: "in cerebellar granule cells"
Meta Candidates (Total=11; Excluded=4; Pruned=0; Remaining=7)
   867   C0596630:granule cell [Cell]
   827   C0007634:Cells [Cell]
   827   C0007765:Cerebellar [Body Part, Organ, or Organ Component]
   827   C0010837:Granule [Cell Component]
   827   C0993609:Granule [Biomedical or Dental Material]
   827   C1707522:Cerebellar [Tissue]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]
   755 E C0205248:Granular [Qualitative Concept]

Phrase: "(Price et al. 1998"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0080045:Price [Quantitative Concept]

Phrase: ")."
Processing 00000000.tx.155: It is unlikely that the deficit in LTP observed following our acute application of low concentrations of A-peptides is due to cytotoxic processes (Games et al. 1992). 

Phrase: "It"

Phrase: "is"

Phrase: "unlikely"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0750558:Unlikely [Conceptual Entity]
  1000   C1710571:Unlikely [Qualitative Concept]

Phrase: "that"

Phrase: "the deficit in LTP"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0162429:Deficit, NOS [Disease or Syndrome]
   753   C2987487:Deficit [Qualitative Concept]

Phrase: "observed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1441672:Observed [Functional Concept]

Phrase: "following"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332282:Following [Temporal Concept]
   966 E C0332283:follow [Temporal Concept]
   966 E C1719822:Follow [Intellectual Product]

Phrase: "our acute application of low concentrations of A-peptides"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   742   C0185125:Application [Health Care Activity]
   742   C1947919:Application [Intellectual Product]
   742   C2347934:Application [Intellectual Product]
   742   C3539080:APPLICATION [Quantitative Concept]

Phrase: "is due to cytotoxic processes"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   806   C0678226:Due to [Functional Concept]
           due
   781   C0013277:Due Process [Regulation or Law]
   760   C0677881:Cytotoxic [Therapeutic or Preventive Procedure]
   760   C1511636:cytotoxic [Functional Concept]
   760   C3146286:Due [Idea or Concept]
   726   C1184743:Process [Body Part, Organ, or Organ Component]
   726   C1522240:Process [Phenomenon or Process]

Phrase: "(Games et al. 1992"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0150593:games [Daily or Recreational Activity]

Phrase: ")."
Processing 00000000.tx.156: The full sequence A[25-35] has been shown to be necessary for peptide aggregation, with an emphasis on the importance of methionine residue (M35) for the promotion and/or stabilization of A aggregation. 

Phrase: "The full"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0443225:Full [Qualitative Concept]

Phrase: "sequence"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0004793:Sequence [Nucleotide Sequence]
  1000   C0162326:Sequence [Nucleotide Sequence]
  1000   C0162327:Sequence [Nucleotide Sequence]
  1000   C1519249:Sequence [Functional Concept]

Phrase: "A[25-35"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   901   C0718136:A-25 [Organic Chemical,Pharmacologic Substance,Vitamin]

Phrase: "]"

Phrase: "has"

Phrase: "been"

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be"

Phrase: "necessary for peptide aggregation,"

Phrase: "with an emphasis"

Phrase: "on the importance"

Phrase: "of methionine residue"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C1709915:Residue [Conceptual Entity]
   861   C1882936:RESIDUE [Phenomenon or Process]
   789 E C1609982:Residual [Qualitative Concept]

Phrase: "(M35"

Phrase: ")"

Phrase: "for the promotion"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033414:Promotion [Activity]

Phrase: "and/or"

Phrase: "stabilization of A aggregation."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1293130:Stabilisation [Therapeutic or Preventive Procedure]
Processing 00000000.tx.157: This property also correlates with the neurotoxic effects of this peptide on cultured cells (Pike et al. 1995). 

Phrase: "This property also"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0871161:Property [Qualitative Concept]
   861   C1882134:Property [Conceptual Entity]
   861   C2347695:Property [Entity]

Phrase: "correlates with the neurotoxic effects of this peptide"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   754   C0235032:Neurotoxic effect [Injury or Poisoning]
   744   C0030956:Peptide [Amino Acid, Peptide, or Protein]
   744   C1280500:effects [Qualitative Concept]
   711 E C2348382:Effect [Qualitative Concept]

Phrase: "on cultured cells"
Meta Candidates (Total=13; Excluded=4; Pruned=0; Remaining=9)
  1000   C0007600:cultured cells [Cell]
  1000   C0007635:Cultured Cells [Cell]
  1000   C3282338:Cells, Cultured [Cell]
   966 E C0007585:culture cell [Laboratory Procedure]
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827   C0010453:Culture [Idea or Concept]
   827   C0220814:culture [Functional Concept]
   827   C0430400:Culture [Laboratory Procedure]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]
   827   C2242979:Culture [Laboratory Procedure]

Phrase: "(Pike et al. 1995"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   812   C0014878:Pike [Fish]
   812   C0522667:Pike [Manufactured Object]
   812   C0730321:PIC [Disease or Syndrome]

Phrase: ")."
Processing 00000000.tx.158: Although we have shown that A[35-25] causes a deficit in LTP in vivo, it has been shown to have no effect on LTP in vitro (Chen et al. 2000). 

Phrase: "Although"

Phrase: "we"

Phrase: "have"

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "that A[35-25"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   913   C0718136:A-25 [Organic Chemical,Pharmacologic Substance,Vitamin]

Phrase: "]"

Phrase: "causes"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0015127:cause [Functional Concept]
  1000   C1314792:Causes [Functional Concept]
  1000   C1524003:Cause [Conceptual Entity]

Phrase: "a deficit in LTP"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0162429:Deficit, NOS [Disease or Syndrome]
   753   C2987487:Deficit [Qualitative Concept]

Phrase: "in vivo,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1515655:In Vivo [Spatial Concept]
           vivo

Phrase: "it"

Phrase: "has"

Phrase: "been"

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "have"

Phrase: "no effect on LTP"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   820   C0023983:Long-Term Effect [Phenomenon or Process]
   790   C1301751:No effect [Qualitative Concept]
   753   C1280500:Effect [Qualitative Concept]
   753   C2348382:Effect [Qualitative Concept]

Phrase: "in vitro"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0021135:In Vitro [Intellectual Product]
  1000   C1533691:in vitro [Qualitative Concept]
           vitro
  1000   C2827718:In Vitro [Functional Concept]

Phrase: "(Chen et al. 2000"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0999213:Chen [Bird]

Phrase: ")."
Processing 00000000.tx.159: The reversal of the amino acid sequence in A[35-25] alters the aggregation properties of the peptide from -sheet to random coil formation, thereby reducing the neurotoxic effects on cultured cells (Buchet et al. 1996). 

Phrase: "The reversal of the amino acid sequence"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0443290:Reversal [Functional Concept]

Phrase: "in A[35-25"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   913   C0718136:A-25 [Organic Chemical,Pharmacologic Substance,Vitamin]

Phrase: "]"

Phrase: "alters"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   916   C0392747:Altered [Functional Concept]

Phrase: "the aggregation properties of the peptide"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   753   C0871161:properties [Qualitative Concept]
   753   C1292721:properties [Functional Concept]
   719 E C1882134:Property [Conceptual Entity]
   719 E C2347695:Property [Entity]

Phrase: "from -sheet"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2349187:Sheet [Quantitative Concept]

Phrase: "to random coil formation,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0220781:formation [Biologic Function]
   827   C0439634:formation [Spatial Concept]
   827   C1522492:Formation [Functional Concept]

Phrase: "thereby"

Phrase: "reducing"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0392756:Reducing [Qualitative Concept]

Phrase: "the neurotoxic effects on cultured cells"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   773   C0235032:Neurotoxic effect [Injury or Poisoning]
   753   C1280500:effects [Qualitative Concept]
   719 E C2348382:Effect [Qualitative Concept]

Phrase: "(Buchet et al. 1996"

Phrase: ")."
Processing 00000000.tx.160: It has, however, been reported previously that other peptides that are non-aggregating and non-toxic in cell culture can produce a deficit in LTP in vitro. 

Phrase: "It"

Phrase: "has"

Phrase: ","

Phrase: "however,"

Phrase: "been"

Phrase: "reported"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0684224:Reported [Intellectual Product]
  1000   C0700287:Reported [Health Care Activity]
  1000   C3496591:Reported [Clinical Attribute]
   966 E C3273238:Report [Intellectual Product]

Phrase: "previously"

Phrase: "that"

Phrase: "other peptides"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0030956:Peptides [Amino Acid, Peptide, or Protein]

Phrase: "that"

Phrase: "are"

Phrase: "non-aggregating"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0205418:aggregating [Qualitative Concept]
   861   C1518422:Non [Functional Concept]

Phrase: "and"

Phrase: "non-toxic in cell culture"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   840   C0007585:Cell Culture [Laboratory Procedure]
   804   C0010453:Culture [Idea or Concept]
   804   C0220814:culture [Functional Concept]
   804   C0430400:Culture [Laboratory Procedure]
   804   C2242979:Culture [Laboratory Procedure]

Phrase: "can"

Phrase: "produce"

Phrase: "a deficit in LTP"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0162429:Deficit, NOS [Disease or Syndrome]
   753   C2987487:Deficit [Qualitative Concept]

Phrase: "in vitro."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0021135:In Vitro [Intellectual Product]
  1000   C1533691:in vitro [Qualitative Concept]
           vitro
  1000   C2827718:In Vitro [Functional Concept]
Processing 00000000.tx.161: This suggests that it may not be necessary for a peptide to aggregate to disrupt synaptic plasticity (Chen et al. 2000). 

Phrase: "This"

Phrase: "suggests"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "that"

Phrase: "it"

Phrase: "may"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "be"

Phrase: "necessary for a peptide to"

Phrase: "aggregate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205418:Aggregate [Qualitative Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "disrupt"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332454:disrupt [Qualitative Concept]

Phrase: "synaptic plasticity"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0678558:Plasticity [Natural Phenomenon or Process]
   789 E C0032167:Plastic [Substance]

Phrase: "(Chen et al. 2000"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0999213:Chen [Bird]

Phrase: ")."
Processing 00000000.tx.162: In our study, the lower 10-nmol dose of A[35-25] had a greater inhibitory effect than the 100-nmol dose; 

Phrase: "In our study,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0557651:Study [Manufactured Object]
  1000   C2603343:Study [Research Activity]

Phrase: "the lower 10-nmol dose of A[35-25"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   742   C0178602:Dose [Quantitative Concept]
   742   C0869039:Dose [Quantitative Concept]
   742   C1114758:Dose # [Clinical Attribute]

Phrase: "]"

Phrase: "had"

Phrase: "a greater inhibitory effect than the 100-nmol dose"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   742   C1280500:Effect [Qualitative Concept]
   742   C2348382:Effect [Qualitative Concept]

Phrase: ";"
Processing 00000000.tx.163: however, when LTP was measured 30min following induction, there was little difference in the degree of potentiation observed with either dose. 

Phrase: "however,"

Phrase: "when"

Phrase: "LTP"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
  1000   C0206249:Long-Term Potentiation [Organ or Tissue Function]
  1000   C2984294:Long-term potentiation [Functional Concept]
   901   C0443252:Long-term [Temporal Concept]
   827   C0205166:Long [Qualitative Concept]
   827   C0279023:Potentiation [Therapeutic or Preventive Procedure]
   827   C1515273:Term [Temporal Concept]
   827   C1705313:Term [Idea or Concept]
   827   C1706317:Long [Qualitative Concept]
   827   C2826302:TERM [Intellectual Product]

Phrase: "was"

Phrase: "measured"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0444706:Measured [Qualitative Concept]
  1000   C3541902:MEASURED [Diagnostic Procedure]
   966 E C0079809:Measure [Quantitative Concept]
   966 E C0242485:Measure [Functional Concept]

Phrase: "30min"

Phrase: "following"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332282:Following [Temporal Concept]
   966 E C0332283:follow [Temporal Concept]
   966 E C1719822:Follow [Intellectual Product]

Phrase: "induction,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205263:Induction [Functional Concept]
  1000   C0857127:induction [Therapeutic or Preventive Procedure]

Phrase: "there"

Phrase: "was"

Phrase: "little difference in the degree of potentiation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C1705241:*Difference [Quantitative Concept]
   748   C1705242:Difference [Qualitative Concept]

Phrase: "observed with either dose."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0178602:Dose [Quantitative Concept]
   770   C0869039:Dose [Quantitative Concept]
   770   C1114758:Dose # [Clinical Attribute]
   770   C1441672:Observed [Functional Concept]
Processing 00000000.tx.164: The results obtained using A[35-25] merit further investigation with attention to how this peptide might effect either NMDA receptor-mediated responses or activity of the L-type Ca2+ channel. 

Phrase: "The results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1274040:Result [Functional Concept]
   966   C1546471:Result [Idea or Concept]
   966   C2825142:Result [Finding]

Phrase: "obtained"
Meta Candidates (Total=8; Excluded=7; Pruned=0; Remaining=1)
  1000   C1301820:Obtained [Functional Concept]
   966 E C1706701:Obtain [Activity]
   928 E C1517378:Gain [Quantitative Concept]
   907 E C0205217:Increased [Quantitative Concept]
   907 E C0439661:Acquired [Temporal Concept]
   907 E C0442805:Increase [Functional Concept]
   907 E C0442808:Increasing [Functional Concept]
   907 E C3245488:acquired [Intellectual Product]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "A[35-25"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   913   C0718136:A-25 [Organic Chemical,Pharmacologic Substance,Vitamin]

Phrase: "]"

Phrase: "merit"

Phrase: "further investigation with attention"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C1261322:Investigation [Health Care Activity]
   770   C1552578:investigation [Idea or Concept]

Phrase: "to how"

Phrase: "this peptide"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0030956:Peptide [Amino Acid, Peptide, or Protein]

Phrase: "might"

Phrase: "effect either NMDA receptor-mediated responses"
Meta Candidates (Total=12; Excluded=3; Pruned=0; Remaining=9)
   807   C0052536:receptor, aspartate [Amino Acid, Peptide, or Protein,Receptor]
   807   C0870868:mediated responses [Mental Process]
   791   C0085845:Aspartate [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   791   C0086597:mediated [Social Behavior]
   791   C0127400:Mediated [Organic Chemical,Pharmacologic Substance]
   791   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]
   791   C0871261:responses [Organism Attribute]
   791   C1280500:Effect [Qualitative Concept]
   791   C2348382:Effect [Qualitative Concept]
   758 E C1704632:Response [Finding]
   758 E C1706817:Response [Intellectual Product]
   758 E C2911692:Response [Mental Process]

Phrase: "or"

Phrase: "activity of the L-type Ca2+ channel."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   800   C0459205:Type of activity [Intellectual Product]
   774   C1153410:channel activity [Molecular Function]
   748   C0205177:Activity [Functional Concept]
   748   C0439167:% activity [Quantitative Concept]
   748   C0441655:Activity [Activity]
   748   C1561536:*Activity [Idea or Concept]
Processing 00000000.tx.165: Our results suggest that the lipophilic portion of the peptide (in the forward or reverse sequence) can impair LTP. 

Phrase: "Our results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1274040:Result [Functional Concept]
   966   C1546471:Result [Idea or Concept]
   966   C2825142:Result [Finding]

Phrase: "suggest"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "that"

Phrase: "the lipophilic portion of the peptide"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0449719:Portion [Spatial Concept]

Phrase: "("

Phrase: "in the forward"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439780:Forward [Spatial Concept]

Phrase: "or"

Phrase: "reverse sequence"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   861   C0004793:Sequence [Nucleotide Sequence]
   861   C0162326:Sequence [Nucleotide Sequence]
   861   C0162327:Sequence [Nucleotide Sequence]
   861   C1519249:Sequence [Functional Concept]
   789 E C1548958:Sequential [Idea or Concept]
   789 E C1705294:Sequential [Qualitative Concept]

Phrase: ")"

Phrase: "can"

Phrase: "impair"

Phrase: "LTP."
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
  1000   C0206249:Long-Term Potentiation [Organ or Tissue Function]
  1000   C2984294:Long-term potentiation [Functional Concept]
   901   C0443252:Long-term [Temporal Concept]
   827   C0205166:Long [Qualitative Concept]
   827   C0279023:Potentiation [Therapeutic or Preventive Procedure]
   827   C1515273:Term [Temporal Concept]
   827   C1705313:Term [Idea or Concept]
   827   C1706317:Long [Qualitative Concept]
   827   C2826302:TERM [Intellectual Product]
Processing 00000000.tx.166: In contrast, A[15-25] did not alter LTP when compared with controls. 

Phrase: "In contrast,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1979874:Contrast [Qualitative Concept]

Phrase: "A[15-25"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   913   C0718136:A-25 [Organic Chemical,Pharmacologic Substance,Vitamin]

Phrase: "]"

Phrase: "did"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "alter"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   916   C0392747:Altered [Functional Concept]

Phrase: "LTP"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
  1000   C0206249:Long-Term Potentiation [Organ or Tissue Function]
  1000   C2984294:Long-term potentiation [Functional Concept]
   901   C0443252:Long-term [Temporal Concept]
   827   C0205166:Long [Qualitative Concept]
   827   C0279023:Potentiation [Therapeutic or Preventive Procedure]
   827   C1515273:Term [Temporal Concept]
   827   C1705313:Term [Idea or Concept]
   827   C1706317:Long [Qualitative Concept]
   827   C2826302:TERM [Intellectual Product]

Phrase: "when"

Phrase: "compared with controls."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   790   C1707455:Compared [Activity]
   756   C0243148:control [Qualitative Concept]
   756   C1550141:Control [Substance]
   756   C1882979:Control [Conceptual Entity]
   756   C2587213:Control [Functional Concept]
   756   C3274648:Control [Qualitative Concept]
Processing 00000000.tx.167: This peptide, unlike A[25-35] and A[35-25], does not contain the lipophilic fragment of A[1-40/42] that is found in senile plaques of AD patients. 

Phrase: "This peptide,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0030956:Peptide [Amino Acid, Peptide, or Protein]

Phrase: "unlike A[25-35"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   901   C0718136:A-25 [Organic Chemical,Pharmacologic Substance,Vitamin]

Phrase: "]"

Phrase: "and"

Phrase: "A[35-25"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   913   C0718136:A-25 [Organic Chemical,Pharmacologic Substance,Vitamin]

Phrase: "],"

Phrase: "does"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "contain"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:contain [Functional Concept]
  1000   C2700400:Contain [Activity]

Phrase: "the lipophilic fragment of A[1-40/42"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C0332255:fragment [Functional Concept]
   744   C1708096:Fragment [Qualitative Concept]

Phrase: "]"

Phrase: "that"

Phrase: "is"

Phrase: "found in senile plaques of AD patients."
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   778   C0333463:Senile Plaques [Acquired Abnormality]
           plaques
   748   C0030705:Patients [Patient or Disabled Group]
   748   C0150312:Found [Quantitative Concept]
   748   C0392079:Senile [Finding]
   714 E C0011389:Plaque [Disease or Syndrome]
   714 E C0243095:Find [Finding]
   714 E C0332461:Plaque [Finding]
Processing 00000000.tx.168: This was a good indication that icv injections of peptide did not have an unspecific blocking action on LTP. 

Phrase: "This"

Phrase: "was"

Phrase: "a good indication"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0392360:indication [Idea or Concept]
   861   C3146298:Indication [Functional Concept]

Phrase: "that icv injections of peptide"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   760   C0021485:injections [Therapeutic or Preventive Procedure]
   760   C1533685:INJECTIONS [Therapeutic or Preventive Procedure]
   760   C1828121:Injections [Functional Concept]
   726 E C1272883:Injection [Biomedical or Dental Material]

Phrase: "did"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "have"

Phrase: "an unspecific blocking action on LTP."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C0441472:Action [Functional Concept]
   744   C3266814:Action [Activity]
Processing 00000000.tx.169: The A-peptides tested had no effect on low-frequency synaptic transmission recorded during a period of up to 1h post icv injection. 

Phrase: "The A-peptides"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0030956:Peptides [Amino Acid, Peptide, or Protein]

Phrase: "tested"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0392366:tested [Intellectual Product]
   966 E C0022885:Test [Laboratory Procedure]
   966 E C0039593:Test [Functional Concept]

Phrase: "had"

Phrase: "no effect on low-frequency synaptic transmission"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   778   C1301751:No effect [Qualitative Concept]
   748   C1280500:Effect [Qualitative Concept]
   748   C2348382:Effect [Qualitative Concept]

Phrase: "recorded during a period of"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0439531:/period [Temporal Concept]
   760   C1948053:Period [Temporal Concept]
   726   C0034869:Record [Intellectual Product]

Phrase: "up to 1h post icv injection."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   812   C0021485:injection [Therapeutic or Preventive Procedure]
   812   C1272883:Injection [Biomedical or Dental Material]
   812   C1533685:Injection [Therapeutic or Preventive Procedure]
   812   C1828121:Injection [Functional Concept]
Processing 00000000.tx.170: In addition, there was no significant change in PPF. 

Phrase: "In addition,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1883712:Addition [Functional Concept]
   928 E C1524062:Additional [Functional Concept]

Phrase: "there"

Phrase: "was"

Phrase: "no significant change in PPF."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   797   C0442739:No change [Finding]
   797   C1548568:No change [Intellectual Product]
   760   C0392747:Change [Functional Concept]
   760   C0443172:change [Quantitative Concept]
   760   C1705241:Change [Quantitative Concept]
Processing 00000000.tx.171: Changes in PPF can be associated with alterations in presynaptic release; 

Phrase: "Changes in PPF"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   790   C0392747:changes [Functional Concept]
   790   C0443172:changes [Quantitative Concept]
   756 E C1705241:Change [Quantitative Concept]

Phrase: "can"

Phrase: "be"

Phrase: "associated with alterations"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   882   C0332281:Associated with [Qualitative Concept]
           Associated
   756 E C0750490:Associate [Idea or Concept]
   756   C1515926:Alteration [Idea or Concept]
   756 E C1706221:Associate [Professional or Occupational Group]

Phrase: "in presynaptic release"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   861   C0030685:Release [Health Care Activity]
   861   C0391871:Release [Functional Concept]
   861   C0439180:% release [Quantitative Concept]
   861   C0680255:release [Health Care Activity]
   861   C1283071:Release [Functional Concept]
   861   C1963578:Release [Therapeutic or Preventive Procedure]

Phrase: ";"
Processing 00000000.tx.172: increases in PPF indicating a decrease in basal neurotransmitter release. 

Phrase: "increases in PPF"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0442805:increases [Functional Concept]

Phrase: "indicating"

Phrase: "a decrease in basal neurotransmitter release."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0392756:Decrease [Qualitative Concept]
   753   C0547047:Decrease [Quantitative Concept]
Processing 00000000.tx.173: In addition, any change in interneuron activity in vivo could also cause an alteration in PPF. 

Phrase: "In addition,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1883712:Addition [Functional Concept]
   928 E C1524062:Additional [Functional Concept]

Phrase: "any change in interneuron activity"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0392747:Change [Functional Concept]
   760   C0443172:change [Quantitative Concept]
   760   C1705241:Change [Quantitative Concept]

Phrase: "in vivo"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1515655:In Vivo [Spatial Concept]
           vivo

Phrase: "could"

Phrase: "also"

Phrase: "cause"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0015127:cause [Functional Concept]
  1000   C1524003:Cause [Conceptual Entity]

Phrase: "an alteration in PPF."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1515926:Alteration [Idea or Concept]
Processing 00000000.tx.174: Our results suggest that the A-peptides tested had a negligible effect on interneuron activity or mechanisms of neurotransmitter release in the CA1 region in vivo. 

Phrase: "Our results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1274040:Result [Functional Concept]
   966   C1546471:Result [Idea or Concept]
   966   C2825142:Result [Finding]

Phrase: "suggest"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "that"

Phrase: "the A-peptides"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0030956:Peptides [Amino Acid, Peptide, or Protein]

Phrase: "tested"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0392366:tested [Intellectual Product]
   966 E C0022885:Test [Laboratory Procedure]
   966 E C0039593:Test [Functional Concept]

Phrase: "had"

Phrase: "a negligible effect on interneuron activity"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C1280500:Effect [Qualitative Concept]
   753   C2348382:Effect [Qualitative Concept]

Phrase: "or"

Phrase: "mechanisms of neurotransmitter release"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   770   C0441712:Mechanisms [Functional Concept]
   737 E C1706376:Mechanism [Manufactured Object]

Phrase: "in the CA1 region"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   861   C0017446:Region [Geographic Area]
   861   C0205147:Region [Spatial Concept]
   789 E C0205276:Regional [Spatial Concept]
   789 E C1947913:Regional [Spatial Concept]

Phrase: "in vivo."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1515655:In Vivo [Spatial Concept]
           vivo
Processing 00000000.tx.175: There was, however, a trend toward a decrease in PPF that may suggest that A-peptides have subtle effects on these processes. 

Phrase: "There"

Phrase: "was"

Phrase: ","

Phrase: "however,"

Phrase: "a trend toward a decrease"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1521798:trend [Temporal Concept]

Phrase: "in PPF"

Phrase: "that"

Phrase: "may"

Phrase: "suggest"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "that A-peptides"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0030956:Peptides [Amino Acid, Peptide, or Protein]

Phrase: "have"

Phrase: "subtle effects on these processes."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   760   C1280500:effects [Qualitative Concept]
   726 E C2348382:Effect [Qualitative Concept]
Processing 00000000.tx.176: Our results suggest that A has an effect on the processes involved in LTP in a short period of time, since injection of 100nmol A[25-35] only 5min before the application of tetanic stimulation to induce LTP causes a change of LTP to short-term potentiation. 

Phrase: "Our results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1274040:Result [Functional Concept]
   966   C1546471:Result [Idea or Concept]
   966   C2825142:Result [Finding]

Phrase: "suggest"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "that"

Phrase: "A"

Phrase: "has"

Phrase: "an effect on the processes"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C1280500:Effect [Qualitative Concept]
   760   C2348382:Effect [Qualitative Concept]

Phrase: "involved in LTP"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   862   C0206249:Long-Term Potentiation [Organ or Tissue Function]
   862   C2984294:Long-term potentiation [Functional Concept]
   806   C0443252:Long-term [Temporal Concept]
   760   C0205166:Long [Qualitative Concept]
   760   C0279023:Potentiation [Therapeutic or Preventive Procedure]
   760   C1314939:Involved [Functional Concept]
   760   C1515273:Term [Temporal Concept]
   760   C1705313:Term [Idea or Concept]
   760   C1706317:Long [Qualitative Concept]
   760   C2826302:TERM [Intellectual Product]

Phrase: "in a short period"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0425946:short period [Finding]
   861   C0439531:/period [Temporal Concept]
   861   C1948053:Period [Temporal Concept]
   789 E C0332182:Periodic [Temporal Concept]
   789 E C1706381:PERIODIC [Intellectual Product]
   761 E C0031084:Periodicities [Temporal Concept]

Phrase: "of time,"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0040223:Time [Temporal Concept]
  1000   C3541383:Time [Temporal Concept]
   944 E C0442043:Temporal [Spatial Concept]
   944 E C2362314:Temporal [Temporal Concept]
   916 E C1632851:Times [Quantitative Concept]

Phrase: "since"

Phrase: "injection of 100nmol A[25-35"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   753   C0021485:injection [Therapeutic or Preventive Procedure]
   753   C1272883:Injection [Biomedical or Dental Material]
   753   C1533685:Injection [Therapeutic or Preventive Procedure]
   753   C1828121:Injection [Functional Concept]

Phrase: "] only 5min before the application of tetanic stimulation to"

Phrase: "induce"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205263:Induce [Functional Concept]

Phrase: "LTP"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
  1000   C0206249:Long-Term Potentiation [Organ or Tissue Function]
  1000   C2984294:Long-term potentiation [Functional Concept]
   901   C0443252:Long-term [Temporal Concept]
   827   C0205166:Long [Qualitative Concept]
   827   C0279023:Potentiation [Therapeutic or Preventive Procedure]
   827   C1515273:Term [Temporal Concept]
   827   C1705313:Term [Idea or Concept]
   827   C1706317:Long [Qualitative Concept]
   827   C2826302:TERM [Intellectual Product]

Phrase: "causes"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0015127:cause [Functional Concept]
  1000   C1314792:Causes [Functional Concept]
  1000   C1524003:Cause [Conceptual Entity]

Phrase: "a change of LTP"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0392747:Change [Functional Concept]
   753   C0443172:change [Quantitative Concept]
   753   C1705241:Change [Quantitative Concept]

Phrase: "to short-term potentiation."
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   901   C0443303:Short-term [Temporal Concept]
   827   C0279023:Potentiation [Therapeutic or Preventive Procedure]
   827   C1282927:short [Qualitative Concept]
   827   C1515273:Term [Temporal Concept]
   827   C1705313:Term [Idea or Concept]
   827   C1806781:Short [Quantitative Concept]
   827   C2350002:Short [Quantitative Concept]
   827   C2826302:TERM [Intellectual Product]
Processing 00000000.tx.177: This model of in vivo synaptic plasticity is therefore extremely sensitive to -amyloid. 

Phrase: "This model of in vivo synaptic plasticity"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   804   C1515657:In Vivo Model [Research Activity]
   748   C3161035:Model [Intellectual Product]

Phrase: "is"

Phrase: "therefore extremely sensitive to -amyloid."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   804   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   804   C0011560:Amyloid [Pathologic Function]
   804   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
Processing 00000000.tx.178: It is possible that this system could provide a working model with which to investigate the mechanism of action of A-peptides and to develop possible therapeutic interventions for the treatment of A-induced neurotoxicity, found in Alzheimer's disease. 

Phrase: "It"

Phrase: "is"

Phrase: "possible"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0332149:Possible [Qualitative Concept]
  1000   C1705910:Possible [Qualitative Concept]
  1000   C2362652:Possible [Qualitative Concept]

Phrase: "that"

Phrase: "this system"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0449913:System [Functional Concept]
  1000   C1553451:System [Manufactured Object]
  1000   C1704459:System [Medical Device]
   928 E C0205373:Systemic [Functional Concept]

Phrase: "could"

Phrase: "provide"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1999230:Provide [Activity]

Phrase: "a working model with which to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C3161035:Model [Intellectual Product]

Phrase: "investigate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1292732:investigate [Functional Concept]

Phrase: "the mechanism of action of A-peptides"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   814   C0031327:mechanism of action [Physiologic Function]
   814   C1524059:mechanism of action [Functional Concept]
   748   C0441712:Mechanism [Functional Concept]
   748   C1706376:Mechanism [Manufactured Object]

Phrase: "and"

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "develop"

Phrase: "possible therapeutic interventions for the treatment of A-induced neurotoxicity,"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   760   C0087111:Therapeutic Interventions [Therapeutic or Preventive Procedure]
   760   C0808232:therapeutic interventions [Therapeutic or Preventive Procedure]
   739   C0886296:interventions [Health Care Activity]
   739   C1273869:Interventions [Health Care Activity]
   739   C2979881:Interventions [Clinical Attribute]
   739   C3542921:Interventions [Classification]
   706 E C1948041:Intervention [Therapeutic or Preventive Procedure]

Phrase: "found in Alzheimer's disease."
Meta Candidates (Total=8; Excluded=4; Pruned=0; Remaining=4)
   833   C0002395:Alzheimer's Disease [Disease or Syndrome]
   833   C1521724:Alzheimer's Disease [Pathologic Function]
   770   C0012634:Disease [Disease or Syndrome]
   770   C0150312:Found [Quantitative Concept]
   737 E C0243095:Find [Finding]
   715 E C1836721:MALS [Finding]
   715 E C3538764:MALS [Gene or Genome]
   715 E C3540595:MAL [Gene or Genome]
Processing 00000000.tx.179: These results support the theory that -amyloid may be responsible at least in part, for the neurodegeneration and decline in cognition associated with Alzheimer's disease.  

Phrase: "These results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1274040:Result [Functional Concept]
   966   C1546471:Result [Idea or Concept]
   966   C2825142:Result [Finding]

Phrase: "support"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0183683:Support [Medical Device]
  1000   C1521721:Support [Conceptual Entity]

Phrase: "the theory"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0871935:Theory [Idea or Concept]

Phrase: "that -amyloid"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C0011560:Amyloid [Pathologic Function]
  1000   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "may"

Phrase: "be"

Phrase: "responsible at least"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1273518:Responsible [Finding]

Phrase: "in part,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0449719:Part [Spatial Concept]
  1000   C1709471:Part [Quantitative Concept]

Phrase: "for the neurodegeneration"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0027746:Neurodegeneration [Cell or Molecular Dysfunction]

Phrase: "and"

Phrase: "decline in cognition"

Phrase: "associated with Alzheimer's disease."
Meta Candidates (Total=11; Excluded=5; Pruned=0; Remaining=6)
   833   C0002395:Alzheimer's Disease [Disease or Syndrome]
   833   C0332281:Associated with [Qualitative Concept]
           Associated
   833   C1521724:Alzheimer's Disease [Pathologic Function]
   819   C0243083:associated disease [Pathologic Function]
   770   C0012634:Disease [Disease or Syndrome]
   737 E C0750490:Associate [Idea or Concept]
   737 E C1706221:Associate [Professional or Occupational Group]
   715 E C1836721:MALS [Finding]
   715 E C3538764:MALS [Gene or Genome]
   715 E C3540595:MAL [Gene or Genome]
Processing 00000000.tx.180: ACKNOWLEDGMENTS This work was supported by Enterprise Ireland and the Department of Physiology, University College Dublin.  

Phrase: "ACKNOWLEDGMENTS"

Phrase: "This work"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0043227:Work [Occupational Activity]

Phrase: "was"

Phrase: "supported by Enterprise Ireland"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   770   C0022067:Ireland [Geographic Area]
   770   C1521721:Supported [Conceptual Entity]
   737 E C0183683:Support [Medical Device]

Phrase: "and"

Phrase: "the Department of Physiology,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1704729:Department [Organization]

Phrase: "University College Dublin."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0454777:Dublin [Geographic Area]
Processing 00000000.tx.181: FOOTNOTES Present address and address for reprint requests: C.E.Herron, Dept. of Physiology, National University of Ireland, Earlsfort Terrace, Dublin 2,Ireland (E-mail: Caroline.Herron{at}ucd.ie ). 

Phrase: "FOOTNOTES Present address"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0376649:Address [Intellectual Product]
   827   C1442065:Address [Spatial Concept]

Phrase: "and"

Phrase: "address for reprint requests"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0376649:Address [Intellectual Product]
   770   C1442065:Address [Spatial Concept]

Phrase: ":"

Phrase: "C.E.Herron,"

Phrase: "Dept."

Phrase: "of Physiology,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0031842:Physiology [Biomedical Occupation or Discipline]
  1000   C0031843:physiology [Physiologic Function]
   928 E C0205463:Physiologic [Functional Concept]

Phrase: "National University of Ireland,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0041740:University [Manufactured Object,Organization]

Phrase: "Earlsfort Terrace,"

Phrase: "Dublin 2,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0454777:Dublin [Geographic Area]

Phrase: "Ireland"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0022067:Ireland [Geographic Area]

Phrase: "(E-mail"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0013849:E-Mail [Intellectual Product]
  1000   C1705961:E-mail [Intellectual Product]
   861   C0024492:Mail [Manufactured Object]
   861   C1538057:MAIL [Gene or Genome]
   861   C1547565:Mail [Idea or Concept]

Phrase: ":"

Phrase: "Caroline.Herron{at}ucd."

Phrase: "ie"

Phrase: ")."
Processing 00000000.tx.182: Received 18 July 2000; 

Phrase: "Received"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1514756:Received [Qualitative Concept]

Phrase: "18 July 2000"

Phrase: ";"
Processing 00000000.tx.183: accepted in final form 27 October 2000.  

Phrase: "accepted in final form 27 October 2000."
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   748   C0205088:Final [Temporal Concept]
   748   C0348078:Form [Qualitative Concept]
   748   C0376315:Form [Manufactured Object]
   748   C1272684:Accepted [Qualitative Concept]
   748   C1522492:Form [Functional Concept]
   748   C1546485:Final [Idea or Concept]
   748   C1548435:Accepted [Idea or Concept]
   714 E C1548601:Accept [Idea or Concept]
Processing 00000000.tx.184: REFERENCES TOP ABSTRACT INTRODUCTION METHODS RESULTS DISCUSSION REFERENCES Arendt T, Bruckner M, Gertz H, and Marcova L. 

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "TOP ABSTRACT INTRODUCTION METHODS RESULTS DISCUSSION"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   799   C0557061:Discussion [Therapeutic or Preventive Procedure]
   799   C2584313:Discussion [Social Behavior]

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "Arendt T,"

Phrase: "Bruckner M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Gertz H,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "and"

Phrase: "Marcova L."
Processing 00000000.tx.185: Cortical distribution of neurofibrillary tangles in Alzheimers disease matches the pattern of neurons that retain their capacity of plastic remodeling in the adult brain. 

Phrase: "Cortical distribution of neurofibrillary tangles"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0520511:distribution [Idea or Concept]
   760   C1704711:Distribution [Functional Concept]

Phrase: "in Alzheimers disease"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0002395:Alzheimers disease [Disease or Syndrome]
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]

Phrase: "matches"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0150103:match [Research Activity]
  1000   C0336766:Matches [Manufactured Object]
  1000   C1708943:Match [Qualitative Concept]

Phrase: "the pattern of neurons"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0449774:Pattern [Spatial Concept]

Phrase: "that"

Phrase: "retain"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0333118:Retain [Functional Concept]

Phrase: "their capacity of plastic remodeling"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1516240:Capacity [Quantitative Concept]

Phrase: "in the adult brain."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0006104:Brain [Body Part, Organ, or Organ Component]
   861   C1269537:Brain [Body Part, Organ, or Organ Component]
Processing 00000000.tx.186: Neuroscience 83: 991-1002, 1998[ISI][Medline]. 

Phrase: "Neuroscience 83"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0027910:Neuroscience [Biomedical Occupation or Discipline]
   861   C1552241:Neuroscience [Professional or Occupational Group]
   861   C1555991:Neuroscience [Professional or Occupational Group]

Phrase: ":"

Phrase: "991-1002,"

Phrase: "1998"

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "]."
Processing 00000000.tx.187: Behl C, Davis JB, Lesley R, and Schubert D. 

Phrase: "Behl C,"

Phrase: "Davis JB,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1550751:JB [Temporal Concept]

Phrase: "Lesley R,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205090:R- [Spatial Concept]
   861   C0684010:R. [Professional or Occupational Group]
   861   C2603358:R' [Clinical Attribute]

Phrase: "and"

Phrase: "Schubert D."
Processing 00000000.tx.188: Hydrogen peroxide mediates amyloid protein toxicity. 

Phrase: "Hydrogen peroxide"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0020281:Hydrogen Peroxide [Inorganic Chemical,Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   861   C0020275:Hydrogen [Element, Ion, or Isotope]
   861   C0031180:Peroxide [Inorganic Chemical]
   861   C0523702:HYDROGEN [Laboratory Procedure]
   861   C0885426:hydrogen [Inorganic Chemical]

Phrase: "mediates"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0086597:Mediate [Social Behavior]

Phrase: "amyloid protein toxicity."
Meta Candidates (Total=7; Excluded=4; Pruned=0; Remaining=3)
   827   C0040539:toxicity [Qualitative Concept]
   827   C0600688:Toxicity [Injury or Poisoning]
   755 E C1407029:Toxic [Qualitative Concept]
   734 E C0032346:Poison [Hazardous or Poisonous Substance]
   734   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   734 E C1548769:Poison [Intellectual Product]
   734 E C1550590:poison [Idea or Concept]
Processing 00000000.tx.189: Cell 77: 817-827, 1994[ISI][Medline]. 

Phrase: "Cell 77"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0007634:Cell [Cell]
   861   C1269647:Cell [Cell]
   861   C1704653:Cell [Medical Device]
   861   C1948049:Cell [Spatial Concept]

Phrase: ":"

Phrase: "817-827,"

Phrase: "1994"

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "]."
Processing 00000000.tx.190: Braak H, and Braak E. 

Phrase: "Braak H,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "and"

Phrase: "Braak E."
Processing 00000000.tx.191: Frequency of stages of Alzheimer-related lesions in different age categories. 

Phrase: "Frequency of stages of Alzheimer-related lesions"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   748   C0376249:frequency [Quantitative Concept]
   748   C0439603:Frequency [Temporal Concept]
   748   C0871396:Frequency [Quantitative Concept]
   748   C1561548:Frequency [Qualitative Concept]
   748   C1705502:Frequency [Quantitative Concept]

Phrase: "in different age categories."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   901   C2916832:Age Categories [Age Group]
   827   C0683312:Categories [Intellectual Product]
   793 E C1555713:category [Idea or Concept]
Processing 00000000.tx.192: Neurobiol Aging 18: 351-357, 1997[ISI][Medline]. 

Phrase: "Neurobiol"

Phrase: "Aging"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0001811:Aging [Organism Function]
   966 E C0001779:Age [Organism Attribute]

Phrase: "18"

Phrase: ":"

Phrase: "351-357,"

Phrase: "1997"

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "]."
Processing 00000000.tx.193: Buchet R, Tavitian E, Ristig D, Swoboda R, Stauss U, Gremlich HU, de La Fournier L, Staufienbiel M, Frey P, and Lowe DA. 

Phrase: "Buchet R,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205090:R- [Spatial Concept]
   861   C0684010:R. [Professional or Occupational Group]
   861   C2603358:R' [Clinical Attribute]

Phrase: "Tavitian E,"

Phrase: "Ristig D,"

Phrase: "Swoboda R,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205090:R- [Spatial Concept]
   861   C0684010:R. [Professional or Occupational Group]
   861   C2603358:R' [Clinical Attribute]

Phrase: "Stauss U,"

Phrase: "Gremlich HU,"

Phrase: "de La Fournier L,"

Phrase: "Staufienbiel M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Frey P,"

Phrase: "and"

Phrase: "Lowe DA."
Processing 00000000.tx.194: Conformations of synthetic beta peptides in solid state and in aqueous solution: relation to toxicity in PC12 cells. 

Phrase: "Conformations of synthetic beta peptides"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   764   C1518960:Peptide Conformation [Spatial Concept]
   726   C0026377:Conformation [Spatial Concept]

Phrase: "in solid state"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C0597486:solid state [Chemical Viewed Structurally]
   861   C0205208:Solid [Qualitative Concept]
   861   C0302909:Solid [Substance]
   861   C1301808:State [Geographic Area]
   861   C1378566:Solid [Biomedical or Dental Material]
   861   C1442792:State [Functional Concept]
   861   C3148680:State [Geographic Area]

Phrase: "and in aqueous solution"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   833   C3255993:aqueous solution [Pharmacologic Substance]
   770   C0037633:Solution [Substance]
   770   C0525069:Solution [Biomedical or Dental Material]
   770   C0599956:Aqueous [Qualitative Concept]
   770   C1515981:And [Idea or Concept]

Phrase: ":"

Phrase: "relation to toxicity"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   790   C0080103:Relation [Family Group]
   790   C0869014:relation [Social Behavior]
   718 E C0439849:Related [Qualitative Concept]
   718 E C0445223:Related [Finding]

Phrase: "in PC12 cells."
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0085262:PC12 Cells [Cell]
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]
Processing 00000000.tx.195: Biochem Biophys Acta 1315: 40-46, 1996[ISI][Medline]. 

Phrase: "Biochem Biophys Acta 1315"

Phrase: ":"

Phrase: "40-46,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439509:/40 [Temporal Concept]

Phrase: "1996"

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "]."
Processing 00000000.tx.196: Chapman PF, White GL, Jones MW, Cooper-Blacketer D, Marshall VJ, Irizarry MY, Younkin L, Good MA, Bliss TVP, Hyman BY, Younkin SG, and Hsiao KK. 

Phrase: "Chapman PF,"

Phrase: "White GL,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0018229:GL [Geographic Area]
   861   C1423073:GL [Gene or Genome]
   861   C1427674:GL [Gene or Genome]

Phrase: "Jones MW,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0024548:MW [Geographic Area]
   861   C0026385:mw [Quantitative Concept]
   861   C0556966:mW [Quantitative Concept]

Phrase: "Cooper-Blacketer D,"

Phrase: "Marshall VJ,"

Phrase: "Irizarry"

Phrase: "MY,"

Phrase: "Younkin L,"

Phrase: "Good MA,"

Phrase: "Bliss TVP,"

Phrase: "Hyman BY,"

Phrase: "Younkin SG,"

Phrase: "and"

Phrase: "Hsiao KK."
Processing 00000000.tx.197: Impaired synaptic plasticity and learning in aged amyloid precursor protein transgenic mice. 

Phrase: "Impaired synaptic plasticity"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C0678558:Plasticity [Natural Phenomenon or Process]
   755 E C0032167:Plastic [Substance]

Phrase: "and"

Phrase: "learning in aged amyloid precursor protein transgenic mice."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C0013621:learning [Educational Activity]
   744   C0023185:Learning [Mental Process]
Processing 00000000.tx.198: Nature Neurosci 2: 271-276, 1999[ISI][Medline]. 

Phrase: "Nature Neurosci 2"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   827   C0349590:Nature [Idea or Concept]
   827   C1262865:Nature [Functional Concept]
   755 E C0205296:Natural [Functional Concept]

Phrase: ":"

Phrase: "271-276,"

Phrase: "1999"

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "]."
Processing 00000000.tx.199: Chen QS, and Xie CW. 

Phrase: "Chen QS,"

Phrase: "and"

Phrase: "Xie CW."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0454665:CW [Geographic Area]
Processing 00000000.tx.200: Amyloid -peptide inhibits the late phase of LTP through a calcineurin-dependent mechanism in rat dentate gyrus. 

Phrase: "Amyloid -peptide"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0011560:Amyloid [Pathologic Function]
   861   C0030956:Peptide [Amino Acid, Peptide, or Protein]
   861   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "inhibits"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   944   C0018790:arrested [Disease or Syndrome]
   944   C0237477:Arrest [Temporal Concept]
   944   C0392351:arrest [Governmental or Regulatory Activity]
   944   C0521111:Retarded [Qualitative Concept]
   916 E C0311403:Inhibited [Qualitative Concept]
   916 E C3463820:Inhibiting [Activity]

Phrase: "the late phase of LTP"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0205087:Late [Temporal Concept]
   748   C0205390:Phase [Temporal Concept]

Phrase: "through a calcineurin-dependent mechanism"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0441712:Mechanism [Functional Concept]
   827   C1706376:Mechanism [Manufactured Object]

Phrase: "in rat dentate gyrus."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   901   C0152314:Dentate Gyrus [Body Part, Organ, or Organ Component]
   901   C1281026:Dentate gyrus [Body Part, Organ, or Organ Component]
Processing 00000000.tx.201: Soc Neurosci Abstr 25: 342, 1999. 

Phrase: "Soc Neurosci Abstr 25"

Phrase: ":"

Phrase: "342,"

Phrase: "1999."
Processing 00000000.tx.202: Chen Qi-S, Kagan BL, Hirakura Y, and Xie C-W. 

Phrase: "Chen Qi-S,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0376586:Qi [Idea or Concept]

Phrase: "Kagan BL,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0006413:BL [Neoplastic Process]
   861   C1552663:BL [Idea or Concept]
   861   C2827109:BL [Geographic Area]

Phrase: "Hirakura Y,"

Phrase: "and"

Phrase: "Xie C-W."
Processing 00000000.tx.203: Impairment of hippocampal long-term potentiation by Alzheimer amyloid -peptides. 

Phrase: "Impairment of hippocampal long-term potentiation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0684336:Impairment [Pathologic Function]

Phrase: "by Alzheimer amyloid -peptides."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0011560:Amyloid [Pathologic Function]
   827   C0030956:Peptides [Amino Acid, Peptide, or Protein]
   827   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
Processing 00000000.tx.204: J Neurosci Res 60: 65-72, 2000[ISI][Medline]. 

Phrase: "J Neurosci Res 60"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C2347379:RES [Finding]

Phrase: ":"

Phrase: "65-72,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0450385:65 [Intellectual Product]

Phrase: "2000"

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "]."
Processing 00000000.tx.205: Coan L, Irving AJ, and Collingridge GL. 

Phrase: "Coan L,"

Phrase: "Irving AJ,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0230613:AJ [Cell Component]

Phrase: "and"

Phrase: "Collingridge GL."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0018229:GL [Geographic Area]
   861   C1423073:GL [Gene or Genome]
   861   C1427674:GL [Gene or Genome]
Processing 00000000.tx.206: Low-frequency activation of the NMDA receptor system can prevent the induction of LTP. 

Phrase: "Low-frequency activation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C1879547:Activation [Activity]
   734   C0205213:Low frequency [Temporal Concept]

Phrase: "of the NMDA receptor system"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   812   C0052536:receptor, aspartate [Amino Acid, Peptide, or Protein,Receptor]
   793   C0085845:Aspartate [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   793   C0332285:Of [Spatial Concept]
   793   C0449913:System [Functional Concept]
   793   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]
   793   C1553451:System [Manufactured Object]
   793   C1704459:System [Medical Device]
   721 E C0205373:Systemic [Functional Concept]

Phrase: "can"

Phrase: "prevent"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0309872:PREVENT [Pharmacologic Substance]

Phrase: "the induction of LTP."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0205263:Induction [Functional Concept]
   753   C0857127:induction [Therapeutic or Preventive Procedure]
Processing 00000000.tx.207: Neurosci Lett 105: 205-210, 1989[ISI][Medline]. 

Phrase: "Neurosci Lett 105"

Phrase: ":"

Phrase: "205-210,"

Phrase: "1989"

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "]."
Processing 00000000.tx.208: Collingridge GL, Kehl SJ, and McLennan H. 

Phrase: "Collingridge GL,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0018229:GL [Geographic Area]
   861   C1423073:GL [Gene or Genome]
   861   C1427674:GL [Gene or Genome]

Phrase: "Kehl SJ,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1515101:SJ [Geographic Area]
   861   C2986905:SJ [Idea or Concept]

Phrase: "and"

Phrase: "McLennan H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.209: Excitatory amino acids in synaptic transmissionin the Schaffer collateral-commissural pathway of the rat hippocampus. 

Phrase: "Excitatory amino acids in synaptic transmissionin"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   833   C0243046:Excitatory Amino Acids [Amino Acid, Peptide, or Protein]
   790   C0002520:Amino Acids [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   756 E C2917660:Amino Acid [Pharmacologic Substance]
   753   C0001128:Acids [Chemical]
   719 E C0202406:Acid [Laboratory Procedure]

Phrase: "the Schaffer collateral-commissural pathway of the rat hippocampus."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   742   C1704259:Pathway [Molecular Function]
   742   C1705987:Pathway [Conceptual Entity]
Processing 00000000.tx.210: J Physiol (Lond) 334: 33-46, 1983[Abstract]. 

Phrase: "J Physiol"

Phrase: "(Lond) 334"

Phrase: ":"

Phrase: "33-46,"

Phrase: "1983"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "]."
Processing 00000000.tx.211: Cullen WK, Suh YH, Anwyl R, and Rowan MJ. 

Phrase: "Cullen WK,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0332174:/wk [Temporal Concept]
   861   C0439230:wk [Temporal Concept]

Phrase: "Suh YH,"

Phrase: "Anwyl R,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205090:R- [Spatial Concept]
   861   C0684010:R. [Professional or Occupational Group]
   861   C2603358:R' [Clinical Attribute]

Phrase: "and"

Phrase: "Rowan MJ."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439254:MJ [Medical Device]
Processing 00000000.tx.212: Block of LTP in rat hippocampus in vivo by beta amyloid precursor protein fragments. 

Phrase: "Block of LTP"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   760   C0028778:Block [Pathologic Function]
   760   C0332206:Block [Functional Concept]
   760   C1533157:Block [Substance]
   760   C1706084:Block [Geographic Area]
   760   C2828370:Block [Quantitative Concept]

Phrase: "in rat hippocampus"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0019564:Hippocampus [Body Part, Organ, or Organ Component]
   861   C0949582:Hippocampus [Fish]
   861   C1029104:Hippocampus [Fish]
   861   C1284077:Hippocampus [Body Part, Organ, or Organ Component]

Phrase: "in vivo by beta amyloid precursor protein fragments."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C1515655:In Vivo [Spatial Concept]
           vivo
Processing 00000000.tx.213: Neuroreport 8: 3213-3217, 1997[ISI][Medline]. 

Phrase: "Neuroreport 8"

Phrase: ":"

Phrase: "3213-3217,"

Phrase: "1997"

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "]."
Processing 00000000.tx.214: Ekinci FJ, Malik KU, and Shea TB. 

Phrase: "Ekinci FJ,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0016080:FJ [Geographic Area]

Phrase: "Malik KU,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1532717:ku [Quantitative Concept]
   861   C1881335:kU [Quantitative Concept]

Phrase: "and"

Phrase: "Shea TB."
Processing 00000000.tx.215: Activation of the L-voltage-sensitive calcium channel by mitogen-activated protein (MAP) kinase following exposure of neuronal cells to -amyloid. 

Phrase: "Activation of the L-voltage-sensitive calcium channel"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   881   C3547348:activation of voltage-sensitive calcium channel [Molecular Function]
   744   C1879547:Activation [Activity]

Phrase: "by mitogen-activated protein"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1979930:Mitogen-activated protein [Amino Acid, Peptide, or Protein]
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "(MAP) kinase"
Meta Candidates (Total=9; Excluded=1; Pruned=0; Remaining=8)
  1000   C0752312:Mitogen-Activated Protein Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   923   C1979930:Mitogen-activated protein [Amino Acid, Peptide, or Protein]
   861   C0033640:PROTEIN KINASE [Amino Acid, Peptide, or Protein,Enzyme]
   812   C0018284:Mitogen [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0026249:Mitogen [Pharmacologic Substance]
   812   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   812   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C1879547:Activated [Activity]
   779 E C1515877:Activate [Functional Concept]

Phrase: "following"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332282:Following [Temporal Concept]
   966 E C0332283:follow [Temporal Concept]
   966 E C1719822:Follow [Intellectual Product]

Phrase: "exposure of neuronal cells to -amyloid."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   783   C0332157:Exposure to [Clinical Attribute]
           Exposure
   753   C0274281:Exposure, NOS [Injury or Poisoning]
Processing 00000000.tx.216: J Biol Chem 274: 30322-30327, 1999[Abstract/Free FullText]. 

Phrase: "J Biol Chem 274"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0201682:CHEM [Laboratory Procedure]

Phrase: ":"

Phrase: "30322-30327,"

Phrase: "1999"

Phrase: "[Abstract/Free FullText"

Phrase: "]."
Processing 00000000.tx.217: Engstrm I, Ronquist G, Petterson L, and Waldenstrm A. 

Phrase: "Engstrm I,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0021966:I- [Inorganic Chemical]
   861   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "Ronquist G,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439267:g% [Quantitative Concept]

Phrase: "Petterson L,"

Phrase: "and"

Phrase: "Waldenstrm A."
Processing 00000000.tx.218: Alzheimer amyloid -peptides exhibit ionophore like properties in human erythrocytes. 

Phrase: "Alzheimer amyloid -peptides"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0011560:Amyloid [Pathologic Function]
   827   C0030956:Peptides [Amino Acid, Peptide, or Protein]
   827   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "exhibit"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0015272:Exhibit [Intellectual Product]

Phrase: "ionophore like properties"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0022022:Ionophore [Pharmacologic Substance]
   790   C1517596:ionophore [Molecular Function]

Phrase: "in human erythrocytes."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0014772:Erythrocytes [Laboratory Procedure]
   861   C0014792:Erythrocytes [Cell]
Processing 00000000.tx.219: Eur J Clin Invest 25: 471-476, 1995[ISI][Medline]. 

Phrase: "Eur J"

Phrase: "Clin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1315013:CLIN [Intellectual Product]

Phrase: "Invest"

Phrase: "25"

Phrase: ":"

Phrase: "471-476,"

Phrase: "1995"

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "]."
Processing 00000000.tx.220: Games D, Khan KM, Soriano FG, Keim PS, Davis DL, Bryant K, and Lieberburg I. 

Phrase: "Games"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0150593:game [Daily or Recreational Activity]

Phrase: "D,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0073187:D NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "Khan KM,"

Phrase: "Soriano FG,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0439214:fg [Quantitative Concept]
   861   C2348814:FG [Quantitative Concept]

Phrase: "Keim PS,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C1418867:Ps [Gene or Genome]
   861   C1518860:PS [Geographic Area]
   861   C1552158:Ps [Body Part, Organ, or Organ Component]

Phrase: "Davis DL,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C3642216:/dL [Quantitative Concept]

Phrase: "Bryant K,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
   861   C1708601:K' [Quantitative Concept]

Phrase: "and"

Phrase: "Lieberburg I."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0021966:I- [Inorganic Chemical]
   861   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
Processing 00000000.tx.221: Lack of Alzheimer pathology after beta-amyloid protein injections in rat brain. 

Phrase: "Lack of Alzheimer pathology"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0332268:lack [Qualitative Concept]

Phrase: "after beta-amyloid protein injections"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   812   C0021485:injections [Therapeutic or Preventive Procedure]
   812   C1533685:INJECTIONS [Therapeutic or Preventive Procedure]
   812   C1828121:Injections [Functional Concept]
   779 E C1272883:Injection [Biomedical or Dental Material]
   756   C0078939:beta-Amyloid Protein [Amino Acid, Peptide, or Protein]
   708   C1750295:beta protein [Genetic Function]
   708   C2362547:Beta protein [Amino Acid, Peptide, or Protein]

Phrase: "in rat brain."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1882598:Rat Brain [Body Part, Organ, or Organ Component]
   861   C0006104:Brain [Body Part, Organ, or Organ Component]
   861   C1269537:Brain [Body Part, Organ, or Organ Component]
Processing 00000000.tx.222: Neurobiol Aging 13: 569-576, 1992[ISI][Medline]. 

Phrase: "Neurobiol"

Phrase: "Aging"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0001811:Aging [Organism Function]
   966 E C0001779:Age [Organism Attribute]

Phrase: "13"

Phrase: ":"

Phrase: "569-576,"

Phrase: "1992"

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "]."
Processing 00000000.tx.223: Good TA, and Murphy RM. 

Phrase: "Good TA,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1506978:Ta [Immunologic Factor]
   861   C1705538:TA [Idea or Concept]

Phrase: "and"

Phrase: "Murphy RM."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2951520:RM [Body Location or Region]
Processing 00000000.tx.224: Effect of -amyloid block of the fast-inactivating K+ channel on intracellular Ca2+ and excitability in a modeled neuron. 

Phrase: "Effect of -amyloid block of the fast-inactivating K+ channel"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   739   C0028778:Block [Pathologic Function]
   739   C0332206:Block [Functional Concept]
   739   C1533157:Block [Substance]
   739   C1706084:Block [Geographic Area]
   739   C2828370:Block [Quantitative Concept]

Phrase: "on intracellular Ca2+"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0596235:Ca2+ [Element, Ion, or Isotope,Pharmacologic Substance]

Phrase: "and"

Phrase: "excitability in a modeled neuron."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0235169:Excitability [Sign or Symptom]
Processing 00000000.tx.225: Proc Natl Acad Sci USA 93: 15130-15135, 1996[Abstract/Free FullText]. 

Phrase: "Proc Natl Acad Sci USA 93"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   799   C0041703:USA [Geographic Area]
   799   C0268596:ACAD [Disease or Syndrome]
   799   C1418943:PROC [Gene or Genome]
   799   C2700624:ACAD [Cell Function]
   799   C3642273:SCI [Professional or Occupational Group]

Phrase: ":"

Phrase: "15130-15135,"

Phrase: "1996"

Phrase: "[Abstract/Free FullText"

Phrase: "]."
Processing 00000000.tx.226: Gray CW, and Patel AJ. 

Phrase: "Gray CW,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0454665:CW [Geographic Area]

Phrase: "and"

Phrase: "Patel AJ."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0230613:AJ [Cell Component]
Processing 00000000.tx.227: Neurodegeneration mediated by glutamate and -amyloid peptide: a comparison and possible interaction. 

Phrase: "Neurodegeneration"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0027746:Neurodegeneration [Cell or Molecular Dysfunction]

Phrase: "mediated by glutamate"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C0017789:glutamate [Amino Acid, Peptide, or Protein]
   790   C0086597:mediated [Social Behavior]
   790   C0127400:Mediated [Organic Chemical,Pharmacologic Substance]
   790   C0220839:Glutamate [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "and -"

Phrase: "amyloid peptide"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0011560:Amyloid [Pathologic Function]
   861   C0030956:Peptide [Amino Acid, Peptide, or Protein]
   861   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: ":"

Phrase: "a comparison"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1707455:Comparison [Activity]

Phrase: "and"

Phrase: "possible interaction."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1704675:Interaction [Functional Concept]
Processing 00000000.tx.228: Brain Res 691: 169-179, 1995[ISI][Medline]. 

Phrase: "Brain Res 691"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0006104:Brain [Body Part, Organ, or Organ Component]
   827   C1269537:Brain [Body Part, Organ, or Organ Component]
   827   C2347379:RES [Finding]

Phrase: ":"

Phrase: "169-179,"

Phrase: "1995"

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "]."
Processing 00000000.tx.229: Grover LM, and Teyler TJ. 

Phrase: "Grover LM,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C1261082:LM [Body Part, Organ, or Organ Component]
   861   C1551056:lm [Quantitative Concept]
   861   C2981682:LM [Quantitative Concept]

Phrase: "and"

Phrase: "Teyler TJ."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0039247:TJ [Geographic Area]
Processing 00000000.tx.230: Two components of long-term potentiation induced by different patterns of afferent stimulation. 

Phrase: "Two components of long-term potentiation"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   753   C0449432:Components [Manufactured Object]
   719 E C1705248:Component [Conceptual Entity]

Phrase: "induced by different patterns of afferent stimulation."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   748   C0205115:Afferent [Spatial Concept]
   748   C0205263:Induced [Functional Concept]
   748   C0449774:Patterns [Spatial Concept]
   748   C1292856:Stimulation [Therapeutic or Preventive Procedure]
   748   C1705242:Different [Qualitative Concept]
   748   C1948023:Stimulation [Natural Phenomenon or Process]
Processing 00000000.tx.231: Nature 347: 477-479, 1990[ISI][Medline]. 

Phrase: "Nature 347"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0349590:Nature [Idea or Concept]
   861   C1262865:Nature [Functional Concept]
   789 E C0205296:Natural [Functional Concept]

Phrase: ":"

Phrase: "477-479,"

Phrase: "1990"

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "]."
Processing 00000000.tx.232: Hsiao AY, Masliah E, McConlogue L, Yu G-Q, Tatsuno G, Hu K, Kholodenko D, Malenka RC, Nicoll RA, and Mucke L. 

Phrase: "Hsiao AY,"

Phrase: "Masliah E,"

Phrase: "McConlogue L,"

Phrase: "Yu G-Q,"

Phrase: "Tatsuno G,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439267:g% [Quantitative Concept]

Phrase: "Hu K,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
   861   C1708601:K' [Quantitative Concept]

Phrase: "Kholodenko D,"

Phrase: "Malenka RC,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1419366:RC [Gene or Genome]

Phrase: "Nicoll RA,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C3538806:Ra [Spatial Concept]

Phrase: "and"

Phrase: "Mucke L."
Processing 00000000.tx.233: Plaque-independent disruption of neural circuits in Alsheimer's disease mouse models. 

Phrase: "Plaque-independent disruption of neural circuits"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0332453:Disruption [Functional Concept]

Phrase: "in Alsheimer's disease mouse models."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   875   C0683033:disease models [Intellectual Product]
   875   C0684309:disease models [Experimental Model of Disease]
   844   C2986594:Mouse Model [Experimental Model of Disease]
   812   C3161035:Models [Intellectual Product]
Processing 00000000.tx.234: Proc Natl Acad Sci USA 96: 3228-3233, 1999[Abstract/Free FullText]. 

Phrase: "Proc Natl Acad Sci USA 96"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   799   C0041703:USA [Geographic Area]
   799   C0268596:ACAD [Disease or Syndrome]
   799   C1418943:PROC [Gene or Genome]
   799   C2700624:ACAD [Cell Function]
   799   C3642273:SCI [Professional or Occupational Group]

Phrase: ":"

Phrase: "3228-3233,"

Phrase: "1999"

Phrase: "[Abstract/Free FullText"

Phrase: "]."
Processing 00000000.tx.235: Itoh A, Akaike T, Sokabe M, Nitta A, Iida R, Olariu A, Yamada K, and Nabeshima T. 

Phrase: "Itoh A,"

Phrase: "Akaike T,"

Phrase: "Sokabe M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Nitta A,"

Phrase: "Iida R,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205090:R- [Spatial Concept]
   861   C0684010:R. [Professional or Occupational Group]
   861   C2603358:R' [Clinical Attribute]

Phrase: "Olariu A,"

Phrase: "Yamada K,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
   861   C1708601:K' [Quantitative Concept]

Phrase: "and"

Phrase: "Nabeshima T."
Processing 00000000.tx.236: Impairments of long-term potentiation in hippocampal slices of -amyloid-infused rats. 

Phrase: "Impairments of long-term potentiation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0684336:Impairments [Pathologic Function]
   760   C2598156:Impairments [Clinical Attribute]

Phrase: "in hippocampal slices of -amyloid-infused rats."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   799   C0034693:rats [Mammal]
   799   C0034721:Rats [Mammal]
Processing 00000000.tx.237: Eur J Pharmacol 382: 167-175, 1999[ISI][Medline]. 

Phrase: "Eur J Pharmacol 382"

Phrase: ":"

Phrase: "167-175,"

Phrase: "1999"

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "]."
Processing 00000000.tx.238: Leung LS. 

Phrase: "Leung LS."
Processing 00000000.tx.239: Behavioural-dependent evoked potentials in the hippocampal CA1 region of the rat. 

Phrase: "Behavioural-dependent evoked potentials in the hippocampal CA1 region of the rat."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0015214:Evoked Potentials [Organ or Tissue Function]
   736   C1444748:Evoked [Qualitative Concept]
   736   C3245505:potentials [Qualitative Concept]
Processing 00000000.tx.240: I.

Phrase: "I."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0021966:I- [Inorganic Chemical]
  1000   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
Processing 00000000.tx.241: Correlation with behavioural EEG. 

Phrase: "Correlation with behavioural EEG."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1707520:Correlation [Qualitative Concept]
Processing 00000000.tx.242: Brain Res 198: 95-107, 1980[ISI][Medline]. 

Phrase: "Brain Res 198"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0006104:Brain [Body Part, Organ, or Organ Component]
   827   C1269537:Brain [Body Part, Organ, or Organ Component]
   827   C2347379:RES [Finding]

Phrase: ":"

Phrase: "95-107,"

Phrase: "1980"

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "]."
Processing 00000000.tx.243: Mattson MP, Barger SW, Cheng S, Lieberburg I, Smith-Swintosky VL, and Rydel RE. 

Phrase: "Mattson MP,"

Phrase: "Barger SW,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C1420193:SW [Gene or Genome]
   861   C1832169:SW [Body System]
   861   C3538902:SW [Gene or Genome]

Phrase: "Cheng S,"

Phrase: "Lieberburg I,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0021966:I- [Inorganic Chemical]
   861   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "Smith-Swintosky VL,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0228339:VL [Body Part, Organ, or Organ Component]
   827   C1424729:VL [Gene or Genome]
   827   C1858854:VL [Disease or Syndrome]

Phrase: "and"

Phrase: "Rydel RE."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2986904:RE [Idea or Concept]
Processing 00000000.tx.244: -Amyloid precursor protein metabolites and loss of neuronal Ca2+ homeostasis in Alzheimer's disease. 

Phrase: "-Amyloid precursor protein metabolites"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   812   C0870883:Metabolites [Biologically Active Substance]
   812   C2698672:METABOLITES [Regulation or Law]
   756   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
   756   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   708   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]

Phrase: "and"

Phrase: "loss of neuronal Ca2+ homeostasis"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   838   C0598940:Loss of neurons [Finding]
       E   neuron loss
   797   C1850496:Neuronal loss [Finding]
   760   C1517945:Loss [Quantitative Concept]

Phrase: "in Alzheimer's disease."
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0002395:Alzheimer's Disease [Disease or Syndrome]
  1000   C1521724:Alzheimer's Disease [Pathologic Function]
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]
Processing 00000000.tx.245: Trends Neurosci 16: 409-414, 1993[ISI][Medline]. 

Phrase: "Trends"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0040833:trends [Temporal Concept]
  1000   C1521798:Trends [Temporal Concept]

Phrase: "Neurosci 16"

Phrase: ":"

Phrase: "409-414,"

Phrase: "1993"

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "]."
Processing 00000000.tx.246: Mattson MP, Cheng B, Davis D, Bryant K, Lieberburg I, and Rydel RE. 

Phrase: "Mattson MP,"

Phrase: "Cheng B,"

Phrase: "Davis D,"

Phrase: "Bryant K,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
   861   C1708601:K' [Quantitative Concept]

Phrase: "Lieberburg I,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0021966:I- [Inorganic Chemical]
   861   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "and"

Phrase: "Rydel RE."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2986904:RE [Idea or Concept]
Processing 00000000.tx.247: -Amyloid peptides destabilize calcium homeostasis and render human cortical neurons vulnerable to excitotoxicity. 

Phrase: "-Amyloid peptides"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0011560:Amyloid [Pathologic Function]
   861   C0030956:Peptides [Amino Acid, Peptide, or Protein]
   861   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "destabilize"

Phrase: "calcium homeostasis"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0019868:Homeostasis [Biologic Function]

Phrase: "and"

Phrase: "render"

Phrase: "human cortical neurons"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C0027882:Neurons [Cell]
   743 E C0521390:Neuronal [Immunologic Factor]

Phrase: "vulnerable to excitotoxicity."
Processing 00000000.tx.248: J Neurosci 12: 376-389, 1992[Abstract]. 

Phrase: "J Neurosci 12"

Phrase: ":"

Phrase: "376-389,"

Phrase: "1992"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "]."
Processing 00000000.tx.249: Morgan SL, and Teyler TJ. 

Phrase: "Morgan SL,"

Phrase: "and"

Phrase: "Teyler TJ."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0039247:TJ [Geographic Area]
Processing 00000000.tx.250: VDCCs and NMDARs underlie two forms of LTP in CA1 hippocampus in vivo. 

Phrase: "VDCCs"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0006685:VDCC [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "and"

Phrase: "NMDARs"

Phrase: "underlie"

Phrase: "two forms of LTP"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   753   C0348078:forms [Qualitative Concept]
   753   C0376315:Forms [Manufactured Object]
   719 E C1522492:Form [Functional Concept]

Phrase: "in CA1 hippocampus"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0019564:Hippocampus [Body Part, Organ, or Organ Component]
   861   C0949582:Hippocampus [Fish]
   861   C1029104:Hippocampus [Fish]
   861   C1284077:Hippocampus [Body Part, Organ, or Organ Component]

Phrase: "in vivo."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1515655:In Vivo [Spatial Concept]
           vivo
Processing 00000000.tx.251: J Neurophysiol 82: 736-740, 1999[Abstract/Free FullText]. 

Phrase: "J Neurophysiol 82"

Phrase: ":"

Phrase: "736-740,"

Phrase: "1999"

Phrase: "[Abstract/Free FullText"

Phrase: "]."
Processing 00000000.tx.252: Mucke L, Masliah E, Yu G-Q, Mallory M, Rockenstein EM, Tatsuno G, Hu K, Kholodenko D, Johnson-Wood K, and McConlogue L. 

Phrase: "Mucke L,"

Phrase: "Masliah E,"

Phrase: "Yu G-Q,"

Phrase: "Mallory M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Rockenstein EM,"

Phrase: "Tatsuno G,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439267:g% [Quantitative Concept]

Phrase: "Hu K,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
   861   C1708601:K' [Quantitative Concept]

Phrase: "Kholodenko D,"

Phrase: "Johnson-Wood K,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
   827   C1708601:K' [Quantitative Concept]

Phrase: "and"

Phrase: "McConlogue L."
Processing 00000000.tx.253: High-level neuronal expression of Ab1-42 in wild-type human amyloid protein precursor transgenic mice: synaptotoxicity without plaque formation. 

Phrase: "High-level neuronal expression of Ab1-42"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   774   C3244092:expression level [Idea or Concept]
   748   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "in wild-type human amyloid protein precursor transgenic mice"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   880   C1520150:Wild Type Mouse [Mammal]
   812   C0025936:Mice, Transgenic [Mammal]
   793   C0003069:Transgenic [Animal]
   793   C0025914:Mice [Mammal]
   793   C0025929:mice [Mammal]
   793   C0026809:Mice [Mammal]

Phrase: ":"

Phrase: "synaptotoxicity without plaque formation."
Processing 00000000.tx.254: J Neurosci 20: 4005-4058, 2000. 

Phrase: "J Neurosci 20"

Phrase: ":"

Phrase: "4005-4058,"

Phrase: "2000."
Processing 00000000.tx.255: Mulkey RM, Endo S, Shenolikar S, and Malenka RC. 

Phrase: "Mulkey RM,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2951520:RM [Body Location or Region]

Phrase: "Endo S,"

Phrase: "Shenolikar S,"

Phrase: "and"

Phrase: "Malenka RC."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1419366:RC [Gene or Genome]
Processing 00000000.tx.256: Involvement of a calcineurin/inhibitor-1 phosphatase cascade in hippocampal long-term depression. 

Phrase: "Involvement of a calcineurin/inhibitor-1 phosphatase cascade"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C1314939:Involvement [Functional Concept]

Phrase: "in hippocampal long-term depression."
Meta Candidates (Total=14; Excluded=1; Pruned=0; Remaining=13)
   923   C2610415:long term depression [Organ or Tissue Function]
   923   C2984275:Long-term depression [Functional Concept]
   861   C0443252:Long-term [Temporal Concept]
   812   C0011570:Depression [Mental or Behavioral Dysfunction]
   812   C0011581:Depression [Mental or Behavioral Dysfunction]
   812   C0205166:Long [Qualitative Concept]
   812   C0344315:Depression [Finding]
   812   C0349217:depression nos [Mental or Behavioral Dysfunction]
   812   C0460137:Depression [Functional Concept]
   812   C1515273:Term [Temporal Concept]
   812   C1705313:Term [Idea or Concept]
   812   C1706317:Long [Qualitative Concept]
   812   C2826302:TERM [Intellectual Product]
   741 E C0549249:DEPRESSED [Finding]
Processing 00000000.tx.257: Nature 369: 486-488, 1994[ISI][Medline]. 

Phrase: "Nature 369"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0349590:Nature [Idea or Concept]
   861   C1262865:Nature [Functional Concept]
   789 E C0205296:Natural [Functional Concept]

Phrase: ":"

Phrase: "486-488,"

Phrase: "1994"

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "]."
Processing 00000000.tx.258: Mulkey RM, Herron CE, and Malenka RC. 

Phrase: "Mulkey RM,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2951520:RM [Body Location or Region]

Phrase: "Herron CE,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2827664:CE [Idea or Concept]

Phrase: "and"

Phrase: "Malenka RC."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1419366:RC [Gene or Genome]
Processing 00000000.tx.259: An essential role for protein phosphatases in hippocampal long-term depression. 

Phrase: "An essential role for protein phosphatases"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0035820:Role [Social Behavior]
   753   C1705810:Role [Conceptual Entity]

Phrase: "in hippocampal long-term depression."
Meta Candidates (Total=14; Excluded=1; Pruned=0; Remaining=13)
   923   C2610415:long term depression [Organ or Tissue Function]
   923   C2984275:Long-term depression [Functional Concept]
   861   C0443252:Long-term [Temporal Concept]
   812   C0011570:Depression [Mental or Behavioral Dysfunction]
   812   C0011581:Depression [Mental or Behavioral Dysfunction]
   812   C0205166:Long [Qualitative Concept]
   812   C0344315:Depression [Finding]
   812   C0349217:depression nos [Mental or Behavioral Dysfunction]
   812   C0460137:Depression [Functional Concept]
   812   C1515273:Term [Temporal Concept]
   812   C1705313:Term [Idea or Concept]
   812   C1706317:Long [Qualitative Concept]
   812   C2826302:TERM [Intellectual Product]
   741 E C0549249:DEPRESSED [Finding]
Processing 00000000.tx.260: Science 261: 1051-1055, 1993[ISI][Medline]. 

Phrase: "Science 261"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0036397:Science [Occupation or Discipline]

Phrase: ":"

Phrase: "1051-1055,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0450319:1051 [Intellectual Product]

Phrase: "1993"

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "]."
Processing 00000000.tx.261: Mulkey RM, and Malenka RC. 

Phrase: "Mulkey RM,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2951520:RM [Body Location or Region]

Phrase: "and"

Phrase: "Malenka RC."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1419366:RC [Gene or Genome]
Processing 00000000.tx.262: Mechanisms underlying induction of homosynaptic long-term depression in area CA1 of the hippocampus. 

Phrase: "Mechanisms"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0441712:Mechanisms [Functional Concept]
   966 E C1706376:Mechanism [Manufactured Object]

Phrase: "underlying"

Phrase: "induction of homosynaptic long-term depression"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0205263:Induction [Functional Concept]
   753   C0857127:induction [Therapeutic or Preventive Procedure]

Phrase: "in area CA1"

Phrase: "of the hippocampus."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0019564:Hippocampus [Body Part, Organ, or Organ Component]
  1000   C0949582:Hippocampus [Fish]
  1000   C1029104:Hippocampus [Fish]
  1000   C1284077:Hippocampus [Body Part, Organ, or Organ Component]
Processing 00000000.tx.263: Neuron 9: 967-975, 1992[ISI][Medline]. 

Phrase: "Neuron 9"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0027882:Neuron [Cell]
   789 E C0521390:Neuronal [Immunologic Factor]

Phrase: ":"

Phrase: "967-975,"

Phrase: "1992"

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "]."
Processing 00000000.tx.264: Nalbantoglu I, Vwado-Santiago G, Lahsaini A, Poirier J, Goncalves O, Verge G, Momoh F, Welnwe SA, Massicote G, Julien JP, and Shapiro ML. 

Phrase: "Nalbantoglu I,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0021966:I- [Inorganic Chemical]
   861   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "Vwado-Santiago G,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0439267:g% [Quantitative Concept]

Phrase: "Lahsaini A,"

Phrase: "Poirier J,"

Phrase: "Goncalves O,"

Phrase: "Verge G,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439267:g% [Quantitative Concept]

Phrase: "Momoh F,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
   861   C0439133:(f) [Intellectual Product]
   861   C1553038:[f] [Quantitative Concept]

Phrase: "Welnwe SA,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0036243:SA [Geographic Area]
   861   C1539696:SA [Gene or Genome]
   861   C1825840:SA [Gene or Genome]
   861   C3539736:Sa [Spatial Concept]

Phrase: "Massicote G,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439267:g% [Quantitative Concept]

Phrase: "Julien JP,"

Phrase: "and"

Phrase: "Shapiro ML."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439526:/mL [Quantitative Concept]
Processing 00000000.tx.265: Impaired learning and LTP in mice expressing the carboxy terminus of the Alzheimer amyloid precursor protein. 

Phrase: "Impaired learning"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0013621:learning [Educational Activity]
   861   C0023185:Learning [Mental Process]

Phrase: "and"

Phrase: "LTP in mice"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   862   C0206249:Long-Term Potentiation [Organ or Tissue Function]
   862   C2984294:Long-term potentiation [Functional Concept]
   806   C0443252:Long-term [Temporal Concept]
   760   C0205166:Long [Qualitative Concept]
   760   C0279023:Potentiation [Therapeutic or Preventive Procedure]
   760   C1515273:Term [Temporal Concept]
   760   C1705313:Term [Idea or Concept]
   760   C1706317:Long [Qualitative Concept]
   760   C2826302:TERM [Intellectual Product]

Phrase: "expressing"

Phrase: "the carboxy terminus of the Alzheimer amyloid precursor protein."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   742   C0596260:Carboxy [Organic Chemical]
Processing 00000000.tx.266: Nature 387: 500-505, 1997[ISI][Medline]. 

Phrase: "Nature 387"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0349590:Nature [Idea or Concept]
   861   C1262865:Nature [Functional Concept]
   789 E C0205296:Natural [Functional Concept]

Phrase: ":"

Phrase: "500-505,"

Phrase: "1997"

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "]."
Processing 00000000.tx.267: Nitta A, Fukuta T, Hasegawa T, and Nabeshima T. 

Phrase: "Nitta A,"

Phrase: "Fukuta T,"

Phrase: "Hasegawa T,"

Phrase: "and"

Phrase: "Nabeshima T."
Processing 00000000.tx.268: Continuous infusion of beta-amyloid protein into the rat cerebral ventricle induces learning impairment and neuronal and morphological degeneration. 

Phrase: "Continuous infusion of beta-amyloid protein"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0444889:Continuous infusion [Therapeutic or Preventive Procedure]
   753   C0574032:Infusion [Therapeutic or Preventive Procedure]
   753   C1827465:Infusion [Functional Concept]

Phrase: "into the rat cerebral ventricle"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   901   C0007799:Cerebral ventricle [Body Space or Junction]
   865 E C0521404:Cerebral ventricular [Spatial Concept]
   827   C0018827:Ventricle [Body Part, Organ, or Organ Component]
   827   C2355627:Ventricle [Body Part, Organ, or Organ Component]
   755 E C1522565:Ventricular [Spatial Concept]
   727 E C0038351:Ventriculus [Body Part, Organ, or Organ Component]

Phrase: "induces"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205263:Induce [Functional Concept]

Phrase: "learning impairment"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0684336:Impairment [Pathologic Function]

Phrase: "and"

Phrase: "neuronal"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0521390:Neuronal [Immunologic Factor]
   928 E C0027882:Neuron [Cell]

Phrase: "and"

Phrase: "morphological degeneration."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0011164:Degeneration [Pathologic Function]
   861   C1880269:Degeneration [Functional Concept]
Processing 00000000.tx.269: Jpn J Pharmacol 73: 51-57, 1997[ISI][Medline]. 

Phrase: "Jpn J Pharmacol 73"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0022341:JPN [Geographic Area]

Phrase: ":"

Phrase: "51-57,"

Phrase: "1997"

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "]."
Processing 00000000.tx.270: Ouimet CC, Baerwald KD, Gandy SE, and Greengard P. 

Phrase: "Ouimet CC,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C3538933:CC [Cell Component]

Phrase: "Baerwald KD,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0026691:KD [Disease or Syndrome]
   861   C1705240:KD [Gene or Genome]
   861   C1839259:KD [Disease or Syndrome]

Phrase: "Gandy SE,"

Phrase: "and"

Phrase: "Greengard P."
Processing 00000000.tx.271: Immunocytochemical localization of amyloid precursor-protein in rat brain. 

Phrase: "Immunocytochemical localization of amyloid precursor-protein"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   783   C0597704:protein localisation [Cell Function]
   783   C1159772:Protein Localization [Cell Function]
   753   C0475264:Localisation [Functional Concept]
   753   C1744691:localisation [Biologic Function]

Phrase: "in rat brain."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1882598:Rat Brain [Body Part, Organ, or Organ Component]
   861   C0006104:Brain [Body Part, Organ, or Organ Component]
   861   C1269537:Brain [Body Part, Organ, or Organ Component]
Processing 00000000.tx.272: J Comp Neurol 348: 244-260, 1994[ISI][Medline]. 

Phrase: "J Comp Neurol 348"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0056167:COMP [Therapeutic or Preventive Procedure]
   812   C1456376:COMP [Gene or Genome]

Phrase: ":"

Phrase: "244-260,"

Phrase: "1994"

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "]."
Processing 00000000.tx.273: Pike CJ, Cummingings BJ, and Cotman CW. 

Phrase: "Pike CJ,"

Phrase: "Cummingings BJ,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0005005:BJ [Geographic Area]

Phrase: "and"

Phrase: "Cotman CW."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0454665:CW [Geographic Area]
Processing 00000000.tx.274: Beta-amyloid induces neuritic dystrophy in vitro: similarities with Alzheimer pathology. 

Phrase: "Beta-amyloid"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C2825879:Amyloid, Beta [Laboratory Procedure]
   861   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0011560:Amyloid [Pathologic Function]
   861   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "induces"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205263:Induce [Functional Concept]

Phrase: "neuritic dystrophy"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0333606:Dystrophy [Pathologic Function]
   789 E C0333607:Dystrophic [Functional Concept]

Phrase: "in vitro"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0021135:In Vitro [Intellectual Product]
  1000   C1533691:in vitro [Qualitative Concept]
           vitro
  1000   C2827718:In Vitro [Functional Concept]

Phrase: ":"

Phrase: "similarities with Alzheimer pathology."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   737   C2348205:Similarity [Qualitative Concept]
Processing 00000000.tx.275: Neuroreport 3: 769-772, 1992[ISI][Medline]. 

Phrase: "Neuroreport 3"

Phrase: ":"

Phrase: "769-772,"

Phrase: "1992"

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "]."
Processing 00000000.tx.276: Pike CJ, Walencewicz AJ, Glabe CG, and Cotman CW. 

Phrase: "Pike CJ,"

Phrase: "Walencewicz AJ,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0230613:AJ [Cell Component]

Phrase: "Glabe CG,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0054868:CG [Amino Acid, Peptide, or Protein,Enzyme]
   861   C3540479:CG [Gene or Genome]

Phrase: "and"

Phrase: "Cotman CW."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0454665:CW [Geographic Area]
Processing 00000000.tx.277: In vitro aging of beta-amyloid protein causes peptide aggregation and neurotoxicity. 

Phrase: "In vitro aging of beta-amyloid protein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0001811:Ageing [Organism Function]

Phrase: "causes"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0015127:cause [Functional Concept]
  1000   C1314792:Causes [Functional Concept]
  1000   C1524003:Cause [Conceptual Entity]

Phrase: "peptide aggregation"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0332621:Aggregation [Functional Concept]
   861   C0439168:% aggregation [Quantitative Concept]
   789 E C0205418:Aggregate [Qualitative Concept]

Phrase: "and"

Phrase: "neurotoxicity."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0235032:Neurotoxicity [Injury or Poisoning]
Processing 00000000.tx.278: Brain Res 563: 311-314, 1991[ISI][Medline]. 

Phrase: "Brain Res 563"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0006104:Brain [Body Part, Organ, or Organ Component]
   827   C1269537:Brain [Body Part, Organ, or Organ Component]
   827   C2347379:RES [Finding]

Phrase: ":"

Phrase: "311-314,"

Phrase: "1991"

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "]."
Processing 00000000.tx.279: Pike CJ, Walencewicz-Wasserman AJ, Kosmoski J, Cribbs DH, Glabe CG, and Cotman CW. 

Phrase: "Pike CJ,"

Phrase: "Walencewicz-Wasserman AJ,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0230613:AJ [Cell Component]

Phrase: "Kosmoski J,"

Phrase: "Cribbs DH,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1832586:DH [Disease or Syndrome]

Phrase: "Glabe CG,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0054868:CG [Amino Acid, Peptide, or Protein,Enzyme]
   861   C3540479:CG [Gene or Genome]

Phrase: "and"

Phrase: "Cotman CW."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0454665:CW [Geographic Area]
Processing 00000000.tx.280: Structure-activity analysis of -amyloid peptides: contribution of the 25-35 region to aggregation and neurotoxicity. 

Phrase: "Structure-activity analysis of -amyloid peptides"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   799   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   799   C0011560:Amyloid [Pathologic Function]
   799   C0030956:Peptides [Amino Acid, Peptide, or Protein]
   799   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: ":"

Phrase: "contribution of the 25-35 region"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C1880177:Contribution [Activity]

Phrase: "to aggregation"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0332621:Aggregation [Functional Concept]
  1000   C0439168:% aggregation [Quantitative Concept]
   928 E C0205418:Aggregate [Qualitative Concept]

Phrase: "and"

Phrase: "neurotoxicity."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0235032:Neurotoxicity [Injury or Poisoning]
Processing 00000000.tx.281: J Neurochem 64: 253-265, 1995[ISI][Medline]. 

Phrase: "J Neurochem 64"

Phrase: ":"

Phrase: "253-265,"

Phrase: "1995"

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "]."
Processing 00000000.tx.282: Price SA, Held B, and Pearson HA. 

Phrase: "Price SA,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0036243:SA [Geographic Area]
   861   C1539696:SA [Gene or Genome]
   861   C1825840:SA [Gene or Genome]
   861   C3539736:Sa [Spatial Concept]

Phrase: "Held B,"

Phrase: "and"

Phrase: "Pearson HA."
Processing 00000000.tx.283: Amyloid beta protein increases Ca2+ currents in rat cerebellar granule neurones. 

Phrase: "Amyloid beta protein"
Meta Candidates (Total=12; Excluded=0; Pruned=0; Remaining=12)
  1000   C0078939:Amyloid beta-Protein [Amino Acid, Peptide, or Protein]
   913   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   901   C1750295:beta protein [Genetic Function]
   901   C2362547:Beta protein [Amino Acid, Peptide, or Protein]
   901   C3484390:Amyloid beta [Amino Acid, Peptide, or Protein]
   827   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0011560:Amyloid [Pathologic Function]
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0330390:Beta [Plant]
   827   C0439096:Beta [Intellectual Product]
   827   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C2004068:Beta [Qualitative Concept]

Phrase: "increases"
Meta Candidates (Total=8; Excluded=7; Pruned=0; Remaining=1)
  1000   C0442805:Increase [Functional Concept]
   944 E C1517378:Gain [Quantitative Concept]
   916 E C0205217:Increased [Quantitative Concept]
   916 E C0439661:Acquired [Temporal Concept]
   916 E C0442808:Increasing [Functional Concept]
   916 E C1301820:Obtain [Functional Concept]
   916 E C1706701:Acquire [Activity]
   916 E C3245488:acquired [Intellectual Product]

Phrase: "Ca2+ currents in rat cerebellar granule neurones."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   748   C0521116:currents [Temporal Concept]
   714 E C1705970:Current [Natural Phenomenon or Process]
Processing 00000000.tx.284: Neuroreport 16: 539-545, 1998. 

Phrase: "Neuroreport 16"

Phrase: ":"

Phrase: "539-545,"

Phrase: "1998."
Processing 00000000.tx.285: Saleshando G, and O'Connor JJ. 

Phrase: "Saleshando G,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439267:g% [Quantitative Concept]

Phrase: "and"

Phrase: "O'Connor JJ."
Processing 00000000.tx.286: SB203580, the p38 mitogen-activated protein kinase inhibitor blocks the inhibitory effect of b-amyloid on long-term potentiation in the rat hippocampus. 

Phrase: "SB203580,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0297666:SB203580 [Organic Chemical,Pharmacologic Substance]

Phrase: "the p38 mitogen-activated protein kinase inhibitor"
Meta Candidates (Total=10; Excluded=1; Pruned=0; Remaining=9)
   947   C1513344:Mitogen-Activated Protein Kinase Inhibitor [Pharmacologic Substance]
   861   C1449702:Protein kinase inhibitor [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   827   C1171350:Kinase Inhibitor [Pharmacologic Substance]
   827   C3537023:kinase inhibitor [Molecular Function]
   827   C3537035:kinase inhibitor [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   799   C1999216:Inhibitor [Qualitative Concept]
   780   C1456380:p38 Mitogen Activated Protein Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   760 E C1120843:p38 Mitogen-Activated Protein Kinases [Amino Acid, Peptide, or Protein,Enzyme]
           p38 Protein Kinase
   734   C0752312:Mitogen-Activated Protein Kinase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "blocks"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0028778:Block [Pathologic Function]
  1000   C0332206:Block [Functional Concept]
  1000   C1533157:Block [Substance]
  1000   C1706084:Block [Geographic Area]
  1000   C2828370:Block [Quantitative Concept]

Phrase: "the inhibitory effect of b-amyloid"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C1280500:Effect [Qualitative Concept]
   753   C2348382:Effect [Qualitative Concept]

Phrase: "on long-term potentiation"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
  1000   C0206249:Long-Term Potentiation [Organ or Tissue Function]
  1000   C2984294:Long-term potentiation [Functional Concept]
   901   C0443252:Long-term [Temporal Concept]
   827   C0205166:Long [Qualitative Concept]
   827   C0279023:Potentiation [Therapeutic or Preventive Procedure]
   827   C1515273:Term [Temporal Concept]
   827   C1705313:Term [Idea or Concept]
   827   C1706317:Long [Qualitative Concept]
   827   C2826302:TERM [Intellectual Product]

Phrase: "in the rat hippocampus."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0019564:Hippocampus [Body Part, Organ, or Organ Component]
   861   C0949582:Hippocampus [Fish]
   861   C1029104:Hippocampus [Fish]
   861   C1284077:Hippocampus [Body Part, Organ, or Organ Component]
Processing 00000000.tx.287: Neurosci Lett 288: 119-122, 2000[ISI][Medline]. 

Phrase: "Neurosci Lett 288"

Phrase: ":"

Phrase: "119-122,"

Phrase: "2000"

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "]."
Processing 00000000.tx.288: Sweeney WA, Luedtke J, McDonald MP, and Overmier JB. 

Phrase: "Sweeney WA,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0043038:WA [Geographic Area]

Phrase: "Luedtke J,"

Phrase: "McDonald MP,"

Phrase: "and"

Phrase: "Overmier JB."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1550751:JB [Temporal Concept]
Processing 00000000.tx.289: Intrahippocampal injections of exogenous beta-amyloid induce post delay errors in an eight-arm radial maze. 

Phrase: "Intrahippocampal injections of exogenous beta-amyloid"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   753   C0021485:injections [Therapeutic or Preventive Procedure]
   753   C1533685:INJECTIONS [Therapeutic or Preventive Procedure]
   753   C1828121:Injections [Functional Concept]
   719 E C1272883:Injection [Biomedical or Dental Material]

Phrase: "induce"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205263:Induce [Functional Concept]

Phrase: "post delay errors in an eight-arm radial maze."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   742   C0743559:errors [Qualitative Concept]
   708 E C1608199:Error [Functional Concept]
Processing 00000000.tx.290: Neurobiol Learn Mem 68: 97-101, 1997[ISI][Medline]. 

Phrase: "Neurobiol"

Phrase: "Learn"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0023185:learn [Mental Process]

Phrase: "Mem 68"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0450387:68 [Intellectual Product]

Phrase: ":"

Phrase: "97-101,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0439073:97 [Intellectual Product]
   861   C0439082:>97 [Quantitative Concept]

Phrase: "1997"

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "]."
Processing 00000000.tx.291: Takadera T, Sakura N, Mohri T, and Hashimoto T. 

Phrase: "Takadera T,"

Phrase: "Sakura N,"

Phrase: "Mohri T,"

Phrase: "and"

Phrase: "Hashimoto T."
Processing 00000000.tx.292: Toxic effect of a -amyloid peptide (22-35) on the hippocampal neuron and its prevention. 

Phrase: "Toxic effect of a -amyloid peptide"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   790   C0600688:Toxic effect [Injury or Poisoning]
           toxic
   753   C1280500:Effect [Qualitative Concept]
   753   C1407029:Toxic [Qualitative Concept]
   753   C2348382:Effect [Qualitative Concept]

Phrase: "(22-35"

Phrase: ")"

Phrase: "on the hippocampal neuron"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0027882:Neuron [Cell]
   789 E C0521390:Neuronal [Immunologic Factor]

Phrase: "and"

Phrase: "its prevention."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0199176:Prevention [Therapeutic or Preventive Procedure]
  1000   C1706420:PREVENTION [Research Activity]
  1000   C2700409:prevention [Qualitative Concept]
Processing 00000000.tx.293: Neurosci Lett 161: 41-44, 1993[ISI][Medline]. 

Phrase: "Neurosci Lett 161"

Phrase: ":"

Phrase: "41-44,"

Phrase: "1993"

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "]."
Processing 00000000.tx.294: Tong G, Shepherd D, and Jahr CE. 

Phrase: "Tong G,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439267:g% [Quantitative Concept]

Phrase: "Shepherd D,"

Phrase: "and"

Phrase: "Jahr CE."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2827664:CE [Idea or Concept]
Processing 00000000.tx.295: Synaptic desensitization of NMDA receptors by calcineurin. 

Phrase: "Synaptic desensitization of NMDA receptors"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   770   C0052536:aspartate receptors [Amino Acid, Peptide, or Protein,Receptor]
   767   C0039064:Synaptic Receptors [Amino Acid, Peptide, or Protein,Receptor]
   750   C1709852:Receptor Desensitization [Molecular Function]
           Desensitization
   744   C0085845:Aspartate [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   744   C0178702:Desensitization [Therapeutic or Preventive Procedure]
   744   C0597357:receptors [Amino Acid, Peptide, or Protein,Receptor]

Phrase: "by calcineurin."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0054450:Calcineurin [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1149946:calcineurin [Molecular Function]
Processing 00000000.tx.296: Science 10: 1510-1512, 1995. 

Phrase: "Science 10"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0036397:Science [Occupation or Discipline]

Phrase: ":"

Phrase: "1510-1512,"

Phrase: "1995."
Processing 00000000.tx.297: Ueda K, Shinohara S, Yagami T, Asakura K, and Kawasaki K. 

Phrase: "Ueda K,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
   861   C1708601:K' [Quantitative Concept]

Phrase: "Shinohara S,"

Phrase: "Yagami T,"

Phrase: "Asakura K,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
   861   C1708601:K' [Quantitative Concept]

Phrase: "and"

Phrase: "Kawasaki K."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
   861   C1708601:K' [Quantitative Concept]
Processing 00000000.tx.298: Amyloid protein potentiates Ca2+ influx through L-type voltage sensitive Ca2+ channels: a possible involvement of free radicals. 

Phrase: "Amyloid protein"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   861   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "potentiates"

Phrase: "Ca2+ influx through L-type voltage sensitive Ca2+ channels"

Phrase: ":"

Phrase: "a possible involvement of free radicals."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C1314939:Involvement [Functional Concept]
Processing 00000000.tx.299: J Neurochem 68: 265-271, 1997[ISI][Medline]. 

Phrase: "J Neurochem 68"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0450387:68 [Intellectual Product]

Phrase: ":"

Phrase: "265-271,"

Phrase: "1997"

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "]."
Processing 00000000.tx.300: Wu J, Anwyl R, and Rowan MJ. 

Phrase: "Wu J,"

Phrase: "Anwyl R,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205090:R- [Spatial Concept]
   861   C0684010:R. [Professional or Occupational Group]
   861   C2603358:R' [Clinical Attribute]

Phrase: "and"

Phrase: "Rowan MJ."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439254:MJ [Medical Device]
Processing 00000000.tx.301: B-amyloid (1-40) increases long-term potentiation in rat hippocampus in vitro. 

Phrase: "B-amyloid"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0011560:Amyloid [Pathologic Function]
   861   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "(1-40"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0439509:/40 [Temporal Concept]
   861   C2827734:1+ [Quantitative Concept]
   861   C2981698:1+ [Classification]

Phrase: ")"

Phrase: "increases"
Meta Candidates (Total=8; Excluded=7; Pruned=0; Remaining=1)
  1000   C0442805:Increase [Functional Concept]
   944 E C1517378:Gain [Quantitative Concept]
   916 E C0205217:Increased [Quantitative Concept]
   916 E C0439661:Acquired [Temporal Concept]
   916 E C0442808:Increasing [Functional Concept]
   916 E C1301820:Obtain [Functional Concept]
   916 E C1706701:Acquire [Activity]
   916 E C3245488:acquired [Intellectual Product]

Phrase: "long-term potentiation in rat hippocampus"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   833   C0206249:Long-Term Potentiation [Organ or Tissue Function]
   833   C2984294:Long-term potentiation [Functional Concept]
   790   C0443252:Long-term [Temporal Concept]
   753   C0205166:Long [Qualitative Concept]
   753   C0279023:Potentiation [Therapeutic or Preventive Procedure]
   753   C1515273:Term [Temporal Concept]
   753   C1705313:Term [Idea or Concept]
   753   C1706317:Long [Qualitative Concept]
   753   C2826302:TERM [Intellectual Product]

Phrase: "in vitro."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0021135:In Vitro [Intellectual Product]
  1000   C1533691:in vitro [Qualitative Concept]
           vitro
  1000   C2827718:In Vitro [Functional Concept]
Processing 00000000.tx.302: Eur J Pharmacol 284: R1-R3, 1995a[ISI][Medline]. 

Phrase: "Eur J Pharmacol 284"

Phrase: ":"

Phrase: "R1-R3,"

Phrase: "1995a"

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "]."
Processing 00000000.tx.303: Wu J, Anwyl R, and Rowan MJ. 

Phrase: "Wu J,"

Phrase: "Anwyl R,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205090:R- [Spatial Concept]
   861   C0684010:R. [Professional or Occupational Group]
   861   C2603358:R' [Clinical Attribute]

Phrase: "and"

Phrase: "Rowan MJ."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439254:MJ [Medical Device]
Processing 00000000.tx.304: B-amyloid selectively augments NMDA receptor-mediated synaptic transmission in rat hippocampus. 

Phrase: "B-amyloid selectively"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0011560:Amyloid [Pathologic Function]
   827   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "augments"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205217:augment [Quantitative Concept]

Phrase: "NMDA receptor-mediated synaptic transmission"
Meta Candidates (Total=15; Excluded=0; Pruned=0; Remaining=15)
   890   C0080093:N methyl D aspartate receptor [Amino Acid, Peptide, or Protein,Receptor]
   861   C0079883:N-Methyl-D-aspartate [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   822   C1513911:N.D. [Intellectual Product]
   812   C0027793:Synaptic Transmission [Cell Function]
   812   C0052536:receptor, aspartate [Amino Acid, Peptide, or Protein,Receptor]
   793   C0040722:transmission [Idea or Concept]
   793   C0085845:Aspartate [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   793   C0086597:mediated [Social Behavior]
   793   C0127400:Mediated [Organic Chemical,Pharmacologic Substance]
   793   C0242781:Transmission [Pathologic Function]
   793   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   793   C0441922:N+ [Intellectual Product]
   793   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]
   793   C1521797:Transmission [Natural Phenomenon or Process]
   793   C1553036:[n] [Quantitative Concept]

Phrase: "in rat hippocampus."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0019564:Hippocampus [Body Part, Organ, or Organ Component]
   861   C0949582:Hippocampus [Fish]
   861   C1029104:Hippocampus [Fish]
   861   C1284077:Hippocampus [Body Part, Organ, or Organ Component]
Processing 00000000.tx.305: Neuroreport 6: 2409-2413, 1995b[ISI][Medline]. 

Phrase: "Neuroreport 6"

Phrase: ":"

Phrase: "2409-2413,"

Phrase: "1995b"

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "]."
Processing 00000000.tx.306: Yankner BA, Duffy LK, and Kirschner DA. 

Phrase: "Yankner BA,"

Phrase: "Duffy LK,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0038088:LK [Geographic Area]
   861   C2681928:LK [Gene or Genome]

Phrase: "and"

Phrase: "Kirschner DA."
Processing 00000000.tx.307: Neurotrophic and neurotoxic effects of amyloid protein: reversal by tachykinin neuropeptides. 

Phrase: "Neurotrophic"

Phrase: "and"

Phrase: "neurotoxic effects of amyloid protein"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   790   C0235032:Neurotoxic effect [Injury or Poisoning]
   760   C1280500:effects [Qualitative Concept]
   726 E C2348382:Effect [Qualitative Concept]

Phrase: ":"

Phrase: "reversal by tachykinin neuropeptides."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0443290:Reversal [Functional Concept]
Processing 00000000.tx.308: Science 250: 279-282, 1990[ISI][Medline]. 

Phrase: "Science 250"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0036397:Science [Occupation or Discipline]

Phrase: ":"

Phrase: "279-282,"

Phrase: "1990"

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "]."
Processing 00000000.tx.309: 0022-3077/01 $5.00 Copyright  2001 The American Physiological Society

Phrase: "0022-3077/01 $5.00 Copyright  2001"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   795   C0009993:Copyright [Intellectual Product]
   795   C1552856:copyright [Idea or Concept]

Phrase: "The American Physiological Society"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   827   C0037455:society [Organization]
   827   C0205463:Physiological [Functional Concept]
   827   C0596070:American [Population Group]
   755 E C0031842:Physiology [Biomedical Occupation or Discipline]
   755 E C0031843:physiology [Physiologic Function]

